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BIOACTIVITY AND CHEMICAL INVESTIGATIONS OF 
PERESKIA BLEO AND PERESKIA GRANDIFOLIA 
 
ABSTRACT 
 
 Ethnopharmacological data has been one of the common useful criteria in drug 
discovery. Pereskia bleo and Pereskia grandifolia (Cactaceae), commonly known as 
‘Jarum Tujuh Bilah’ in Malay and ‘Cak Sing Cam’ in Chinese have long been used as 
natural remedies in Malaysia. The experimental approach in the present study was 
based on bioassay-guided fractionation. The crude methanol and fractionated extracts 
of both Pereskia spp. were initially investigated for their biological activities such as 
antioxidant, antimicrobial and cytotoxic effect against five human cancer cell lines, 
namely nasopharyngeal epidermoid carcinoma cell line (KB), cervical carcinoma cell 
line (CasKi), colon carcinoma cell line (HCT 116), hormone-dependent breast 
carcinoma cell line (MCF7), lung carcinoma cell line (A549) and the non-cancer 
human fibroblast cell line (MRC-5) using in vitro cytotoxicity assay, in order to 
identify the bioactive extracts of both Pereskia spp. 
 The hexane and ethyl acetate extracts of both Pereskia spp. generally showed 
stronger antioxidant activities than the other extracts. Ethyl acetate extracts of both 
Pereskia spp. also showed some mild antimicrobial activities against the tested bacteria. 
In the cytotoxicity assay, both Pereskia spp. exerted no damage to MRC-5 normal cells. 
The ethyl acetate extracts of both Pereskia spp. in general gave higher inhibition and 
stimulation values against various cancerous cell lines compared to other extracts. The 
cell deaths of the selected cancer cells elicited by the cytotoxic active extracts of both 
Pereskia spp. were found to be apoptotic in nature based on a clear indication of DNA 
fragmentation, which is a hallmark of apoptosis. In addition, the LUX RT-qPCR [real-
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time reverse transcriptase–polymerase chain reaction (RT-qPCR) using LUX (Light 
Upon eXtension) primers] analysis showed that apoptosis elicited by the cytotoxic 
extracts on selected cancer cells was mediated by p53, caspase-3 and c-myc activation 
in different expression levels.  
 Methyl palmitate, methyl linoleate, methyl α-linolenate and phytol were 
identified from the hexane extract of Pereskia bleo by GCMS analysis whilst methyl 
palmitate, methyl linoleate, methyl α-linolenate and methyl stearate were identified 
from the hexane extract of Pereskia grandifolia. From the results of the biological 
screenings, it is observed that the ethyl acetate extracts generally have stronger 
biological activities than other extracts. Further chemical investigations were thus 
directed to the ethyl acetate extracts of both Pereskia spp. 
2,4-Di-tert-butylphenol (1), α-tocopherol (2), phytol (3), ß-sitosterol (4), 
dihydroactinidiolide (5) and a mixture of sterols containing campesterol (6), 
stigmasterol (7) and β-sitosterol (4) were isolated from Pereskia bleo whilst 2,4-di-tert-
butylphenol (1), α-tocopherol (2), ß-sitosterol (4) and mixture containing methyl 
palmitate (9), methyl oleate (10), methyl stearate (11) and 2,4-di-tert-butylphenol (1) 
were isolated from Pereskia grandifolia. It is interesting to note that 2,4-ditert-
butylphenol (1), α-tocopherol (2) and ß-sitosterol (4) were isolated from the ethyl 
acetate extracts of both Pereskia spp. The cytotoxic activities of the isolated 
constituents were evaluated against the above human cell lines and further studies on 
their mode of action suggested that these activities are connected with induction of 
apoptosis.  
In addition, the toxicity of both Pereskia spp. was evaluated in vivo and were 
considered safe in acute oral toxicities in experimental mice. The screening of the 
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locally grown Pereskia bleo and Pereskia grandifolia indicated the presence of 
alkaloids, but the concentration was very low. 
The findings of Pereskia bleo and Pereskia grandifolia in the present study 
provided scientific validation on the use of the leaves of both Pereskia spp. for the 
treatment of cancer. Further studies on the mutagenic and toxicity effect over a longer 
period of time involving detection of effects on vital organ functions should be carried 
out to ensure that the plants are safe for human consumption.  
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KAJIAN BIOAKTIVITI DAN KIMIA  
PERESKIA BLEO DAN PERESKIA GRANDIFOLIA 
 
ABSTRAK 
 
Data etnofarmakologi merupakan salah satu kriteria umum yang berguna dalam 
penemuan sesuatu ubat tertentu. Pereskia bleo dan Pereskia grandifolia (Cactaceae) 
yang biasa dikenali sebagai ‘Jarum Tujuh Bilah’ di kalangan orang Melayu dan ‘Cak 
Sing Cam’ di kalangan orang Cina telah lama digunakan sebagai jamu semulajadi di 
Malaysia. Eksperimen dalam penyelidikan ini dijalankan berdasarkan pemfraksian 
berpanduan bioasei. Kajian awal bioaktiviti ekstrak mentah serta fraksi daripada kedua-
dua spesies Pereskia, seperti kesan antioksidan, antimikrob dan kesitotosikan telah 
dikaji untuk mengenalpasti ekstrak bioaktif bagi kedua-dua spesies tersebut. 
Penyaringan aktiviti kesitotoksikan telah dijalankan menggunakan asei kesitotoksikan 
in vitro ke atas lima titisan sel karsinoma manusia, iaitu titisan sel karsinoma 
epidermoid nasofarinks (KB), titisan sel karsinoma serviks (CasKi), titisan sel 
karsinoma kolon (HCT 116), titisan sel karsinoma payu dara yang melibatkan hormon 
(MCF7), titisan sel karsinoma paru-paru (A549) serta titisan sel manusia bukan 
karsinoma (MRC-5). 
Ekstrak heksana dan etil asetat bagi kedua-dua spesies Pereskia secara 
umumnya menunjukkan aktiviti antioksidan yang lebih kuat daripada ekstrak lain. 
Ekstrak etil asetat bagi kedua-dua spesies Pereskia juga menunjukkan aktiviti 
antimikrob yang lemah pada bakteria yang dikaji. Bagi asei kesitotoksikan, ekstrak 
kedua-dua spesies Pereskia tidak aktif ke atas sel normal MRC-5. Ekstrak etil asetat 
kedua-dua spesies Pereskia secara umumnya menunjukkan nilai rintangan dan 
stimulasi yang lebih tinggi ke atas pelbagai titisan sel kanser berbanding dengan ekstrak 
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lain. Kematian kanser sel yang dirangsang oleh ekstrak aktif kedua-dua spesies 
Pereskia telah didapati mengaruh kematian sel secara apoptosis berdasarkan tanda 
fragmentasi DNA yang jelas. Fragmentasi DNA merupakan ciri utama apoptosis. 
Tambahan lagi, analisis LUX RT-qPCR [real-time reverse transcriptase–polymerase 
chain reaction (RT-qPCR) using LUX (Light Upon eXtension) primers] menunjukkan 
apoptosis yang dirangsang oleh ekstrak aktif ke atas sel kanser tertentu adalah menerusi 
pengaktifan p53, caspase-3 dan c-myc pada tahap ekspresi yang berbeza.  
Metil palmitat, metil linoleat, metil α-linolenat dan fitol telah dikenalpasti 
daripada ekstrak heksana Pereskia bleo melalui analisis GCMS manakala metil 
palmitat, metil linoleat, metil α-linolenat dan metil stearat telah dikenalpasti daripada 
ekstrak heksana Pereskia grandifolia. Daripada hasil penyaringan biologi, ekstrak etil 
asetat secara umumnya didapati mempunyai aktiviti biologi yang lebih kuat daripada 
ekstrak yang lain. Kajian kimia seterusnya ditumpukan kepada ekstrak etil asetat bagi 
kedua-dua spesies Pereskia.    
2,4-Di-tert-butilfenol (1), α-tokoferol (2), fitol (3), ß-sitosterol (4), 
dihidroaktinidiolid (5) dan satu campuran sterol yang mengandungi kampesterol (6), 
stigmasterol (7) and β-sitosterol (4) telah dipisahkan dan dikenalpasti daripada Pereskia 
bleo sementara 2,4-di-tert-butilfenol (1), α-tokoferol (2), ß-sitosterol (4) dan satu 
campuran sebatian yang mengandungi metil palmitat (9), metil oleate (10), metil stearat 
(11) dan 2,4-di-tert-butilfenol (1) telah dipisahkan dan dikenalpasti daripada Pereskia 
grandifolia. Perlu diambil perhatian bahawa 2,4-di-tert-butilfenol (1), α-tokoferol (2) 
dan ß-sitosterol (4) wujud dalam ekstrak etil asetat kedua-dua spesies Pereskia. Kajian 
aktiviti kesitotosikan sebatian ke atas titisan sel kanser dan penyelidikan selanjutnya ke 
atas mod tindakan, mencadangkan aktiviti sitotosik sebatian adalah berkaitan dengan 
induksi apoptosis.  
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Di samping itu, ketoksikan kedua-dua spesies Pereskia telah dikaji secara in 
vivo dan hasil eksperimen ketoksikan akut yang dijalankan ke atas tikus menunjukkan 
ekstrak tumbuhan adalah selamat. Penyaringan untuk Pereskia bleo dan Pereskia 
grandifolia tempatan menunjukkan kehadiran sejumlah kecil alkaloid sahaja.  
Hasil kajian terhadap Pereskia bleo dan Pereskia grandifolia ini memberi fakta 
saintifik yang sah dalam penggunaan daun kedua-dua Pereskia spesies untuk 
pengubatan kanser. Kajian mutagenik dan kesan ketoksikan pada organ penting untuk 
jangka yang lebih panjang perlu dijalankan untuk memastikan tumbuhan tersebut 
adalah selamat bagi penggunaan manusia.    
 
.  
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CHAPTER 1 
INTRODUCTION 
 
Today, naturally derived products play an important role as source of medicine. 
Many pharmaceutical agents have been discovered by screening natural products from 
plants and marine organisms. The structural diversity of compounds derived from 
natural products provides valuable sources of novel lead compounds against newly 
discovered therapeutic targets (Harvey, 1999).  
The statistics regarding the uses of natural products as drug are now well-known 
and have been repeatedly presented and discussed. Over the period 1981-2002, 1031 
new chemical entities (NCEs) have been discovered. Thus, in the area of cancer the 
percentage of new chemical entities that are non-synthetic has remained at 62 % 
averaged over the whole time frame. In the antihypertensive area, of the 74 formally 
known synthetic drugs, 48 can be traced to natural product structures/ mimics 
(Newman et al., 2003; Abas, 2005).  
There are around 250,000 plant species in the world and 60 % of them are 
located in the tropical rainforests. The plant resources of Malaysia comprise about 
15,000 species of higher plants. It was estimated that about 1,000 of these plants have 
undergone simple chemical screening and much less have been subjected to thorough 
chemical or pharmacological studies (Goh et al., 1993). The huge diversity of the 
Malaysian flora means that we can expect well diversed chemical structures from their 
secondary metabolites, and chemical diversity is one of the plus factors that makes 
natural products excellent candidates for any screening programme.  
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Ethnopharmacological data has been one of the common useful ways for the 
discovery of biological active compounds from plants, in which the selection of a plant 
is based on the prior information on the folk medicine use of the plant. It is generally 
known that ethnomedical data provides substantially increased chance of finding active 
plants relative to random approach (Chapuis et al., 1988; Cordell et al., 1991).  
Pereskia bleo (P. bleo) and Pereskia grandifolia (P. grandifolia), commonly 
known as the ‘Jarum Tujuh Bilah’ in Malay and ‘Cak Sing Cam’ in Chinese belong to 
the botanical family Cactaceae. P. bleo can be easily mistaken from P. grandifolia 
because they look similar vegetatively. However, they can be distinguished by the 
leaves, flowers and spines. P. bleo have thinner and corrugated leaves, orangish-red 
flowers with shorter spines compared to P. grandifolia. In contrast, P. grandifolia have 
thicker and uncorrugated leaves, pink to purple-pink flowers with longer and lesser 
spines. 
Both P. bleo and P. grandifolia have been used as natural remedy in cancer-
related diseases, either eaten raw or taken as a concoction brewed from fresh plant. The 
leaves are also taken as vegetables by some natives.  Both are believed to have anti-
cancer, anti-tumour, anti-rheumatic, anti-ulcer and anti-inflammatory properties. They 
are also used as remedy for the relief of headache, gastric pain, ulcers, haemorrhoids 
and atopic dermatitis; and refresh the body (Goh, 2000; Rahmat, 2004; Tan et al., 2005). 
The pounded leaf paste of P. bleo is also applied to the wound or cut for pain relief 
(Kehidupan Sihat, 2006).  In Panama, the locals use the whole plant of P. bleo to treat 
the gastrointestinal problems (Gupta et al., 1996). On the other hand, P. grandifolia is 
also used to reduce swellings (Sahu et al., 1974; Anon, 1969).  
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Although P. bleo and P. grandifolia are reported to be used in a large number of 
Malaysian traditional medicine preparations, there is not much recorded data on 
biological studies and chemical investigations of P. bleo and P. grandifolia. There is 
only one phytochemical report (Doetsch et al., 1980) and four biological studies 
(Matsuse et al., 1999; Tan et al., 2005; Ruegg et al., 2006; Er et al., 2007) reported for 
P. bleo. Similarly, very little phytochemical work (Doetsch et al., 1980; Sahu et al., 
1974) and biological study (Ooi et al., 2003) has been reported for P. grandifolia. 
The experimental approach in the present study is based on bioassay-guided 
fractionation. In this endeavour, the crude methanol and fractionated extracts of P. bleo 
and P. grandifolia were firstly prepared for the biological assessment. The extracts 
were subjected to antioxidant assays, antimicrobial assays and neutral red cytotoxicity 
assay to identify the bioactive extracts of both Pereskia species. The cytotoxic active 
extracts were further subjected to detection of DNA fragmentation (apoptosis) and 
determination of the expression level of apoptotic–related genes to verify the possible 
mechanisms of cell death elicited by the extracts on the cells.  
After identifying the bioactive extracts of P. bleo and P. grandifolia, the 
chemical constituents responsible for the bioactivities were identified. Thus, the 
bioactive extracts were subjected to isolation and purification procedures to obtain 
chemical constituents present in the extracts. The isolated chemical constituents were 
further tested for their cytotoxic activity against the selected human cell lines. The 
active cytotoxic chemical constituents were then subjected to detection of apoptosis and 
determination of the expression level of apoptotic–related genes.  
Acute oral toxicity was also undertaken in the present study to determine the 
safety parameters of the leaves of both Pereskia spp. as in vitro trials did not always 
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reflect the outcome of in vivo studies. In addition, the locally grown P. bleo and P. 
grandifolia were screened for alkaloids in the present study to confirm the presence of 
alkaloids as Doetsch et al. (1980) reported the isolation of alkaloids in both Pereskia 
spp. The general procedures in the present study are outlined in Figure 1.1.  
In the present study, the antioxidant activities of the extracts were determined 
by four different assays, namely scavenging activity of plant extracts on 1, 1-diphenyl-
2-picrylhydrazyl (DPPH) radicals, reducing power assay, ß-carotene method and Folin-
Ciocalteau’s method. To our knowledge, there is no antioxidant study reported for both 
P. bleo and P. grandifolia.  
The antimicrobial activities of the extracts were determined by agar diffusion 
and broth dilution method. The broth dilution method was used to determine the 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC). To our knowledge, there is only one report on the antimicrobial properties of P. 
bleo (Ruegg et al., 2006) and no such report on P. grandifolia. 
Determination of cytotoxic effect of Pereskia spp. extracts and isolated 
chemical constituents were investigated on six human cell lines, which were the human 
nasopharyngeal epidermoid carcinoma cell line (KB), human cervical carcinoma cell 
line (CasKi), human colon carcinoma cell line (HCT 116), hormone-dependent breast 
carcinoma cell line (MCF7), human lung carcinoma cell line (A549) and non-cancer 
human fibroblast cell line (MRC-5). To our knowledge, no report on the cytotoxicity of 
P. bleo and P. grandifolia against the above mentioned human cancer cell lines has 
ever been published. 
Apoptosis or programmed cell death plays important roles in many biological 
processes including carcinogenesis, tumorigenesis and cancer. Many chemotherapeutic 
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and chemopreventive agents have been found to induce apoptotic cell death (Kong et 
al., 2001). In the present study, DNA fragmentation (apoptosis) was detected using a 
modified TUNEL [terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick 
end labelling] assay.  
Subsequently, the protocol for the evaluation of mRNA expression levels of 
apoptosis-related genes by LUX RT-qPCR [real-time reverse transcriptase–polymerase 
chain reaction (RT-qPCR) using LUX (Light Upon eXtension) primers] analysis has 
been developed in the present study. This LUX RT-qPCR assay offers significant 
advantages with respect to the rapidity, sensitivity and reproducibility of quantification 
assay for gene expression.  
 
Objectives of study 
The main objectives of the present study were as follows:  
a. to screen for antioxidant, antimicrobial and in vitro cytotoxic activities of P. 
bleo and P. grandifolia extracts.  
b. to investigate the ability of cytotoxic active extracts of P. bleo and P. 
grandifolia to induce apoptosis and to determine the possible mechanisms of 
cell death elicited by the extracts on selected cancer cells. 
c. to isolate the chemical constituents from the identified bioactive extracts of P. 
bleo and P. grandifolia through the bioassay guided fractionation technique.  
d. to identify and elucidate the structures of the chemical constituents by using 
modern spectroscopic methods.  
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e. to evaluate the cytotoxic activities of the chemical constituents, their ability to 
induce apoptosis and possible mechanisms of cell death elicited by the chemical 
constituents on selected cancer cells. 
f. to develop a protocol for the evaluation of mRNA expression levels of 
apoptosis-related genes by LUX RT-qPCR assay [real-time reverse 
transcriptase–polymerase chain reaction (RT-qPCR) using LUX (Light Upon 
eXtension) primers]. 
g. to determine the safety parameters of P. bleo and P. grandifolia extracts by 
using acute oral toxicity assessment.   
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Figure 1.1, continued 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Natural products 
Natural products usually refer to secondary metabolites which has relatively 
complex structures. Secondary metabolites are usually characteristic of specific 
botanical sources in comparison to primary metabolites which occur in almost every 
plant. A general characteristic of natural products is that few of them have a clearly 
recognized function in the metabolic activities of the organisms in which they are found 
(Geissman et al., 1969).  
Natural products can be classified into various families, such as alkaloids, 
terpenoids and phenolics including flavonoids. Natural products perform various 
functions, and many of them have interesting and useful biological activities (Harvey, 
1999). The utility of natural products as a source of novel structures is still alive and 
well. The number of plants used as medicinal agents in commerce globally is unknown, 
but there are at least 1,000 species alone in China (Duke and Ayensu, 1985; Abas, 
2005).  
 
2.2 Cancer 
Cancer is the general term for a series of neoplastic diseases that are 
characterized by changes in a cell leading to abnormal (unordered and uncontrolled) 
cellular proliferation (Pettit, 1997). The disorder occurs in the normal processes of cell 
division, which are controlled by the genetic material (DNA) of the cell. Cancers may 
be caused in one of three ways, namely incorrect diet, genetic predisposition, and via 
the environment (Reddy et al., 2003).  
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To date, mortality that results from the common forms of cancer is still 
unacceptably high. The Second Report of the National Cancer Registry of Malaysia 
suggested a total of 23,746 cancer cases were diagnosed among Malaysians in the year 
2003, comprising 10,473 males and 13,273 females. The crude rate for males was 97.4 
per 100,000 population and 127.6 per 100,000 populations for females. The age 
standardized incidence rate (ASR) for all cancers was 134.3 per 100,000 males and 
154.2 per 100,000 females (The Second Report of National Cancer Registry, 2003).  
 
 
2.2.1 Carcinogens 
The majority of human cancers result from exposure to environmental 
carcinogens; these include both natural and manmade chemicals, radiation and viruses. 
Carcinogens may be divided into several classes, such as (i) genotoxic carcinogens, if 
they react with nucleic acids. These can be directly acting or primary carcinogens, if 
they are of such reactivity so as to directly affect cellular constituents; (ii) alternatively, 
they may be procarcinogens that require metabolic activation to induce carcinogenesis; 
(iii) epigenetic carcinogens are those that are not genotoxic (Reddy et al., 2003; 
Timbrell, 2000). It is also clear that genetic predisposition is one of the factors of 
human cancers apart from exposure to carcinogens. Thus, patients with the genetic 
xeroderma pigmentosum are more susceptible to skin cancer (Reddy et al., 2003).  
Carcinogens in the diet that trigger the initial stage include moulds and 
aflatoxins (for example, in peanuts and maize), nitrosamines (in smoked meats and 
other cured products), rancid fats and cooking oils, alcohol, and additives and 
preservatives. A combination of foods may have a cumulative effect, and when 
incorrect diet is added to a polluted environment, smoking, UV radiation, free radicals, 
11 
 
lack of exercise, and stress, the stage is set for DNA damage and cancer progression 
(Reddy et al., 2003).  
 
2.2.2 Cell cycle 
In cells that are dividing, the nuclear DNA molecules must be duplicated and 
then distributed in a way that ensures the two new cells receive a complete set of 
genetic instructions. The cells pass through a series of discrete stages called G1 phase, 
S phase, G2 phase and M phase in order to accomplish these tasks (Kleinsmith, 2006). 
These four phases are collectively referred to as the cell cycle.  
The cell cycle is commonly represented by a circular diagram (Figure 2.1). The 
G1, S and G2 phases are collectively referred as interphase. Besides providing the time 
needed for a cell to make copies of its DNA molecules, interphase is also a period of 
cell growth. Interphase occupies about 95 % of a typical cell cycle; whereas the actual 
process of cell division (M phase) only takes about 5 % (Kleinsmith, 2006). G1 is 
defined as the interval between M phase and S phase, and G2 is defined as the interval 
between S phase and M phase. S phase is defined as the time during the cell cycle when 
DNA synthesis is taking place, leading to a doubling of the amount of DNA per cell. M 
phase is the time when the amount of DNA per cell drops in half as cells divide. The 
restriction point is a control point near the end of G1 where the cell cycle can be halted 
until conditions are suitable for progression into S phase. Under normal conditions, the 
ability to pass through the restriction point is governed mainly by the presence of 
growth factors.  
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Figure 2.1: The cell cycle 
(Adapted from http://herb4cancer.files.wordpress.com/2007/11/cell-cycle2.jpg,  
19 August 2009) 
 
2.2.3 Carcinogenesis 
The transformation of a normal cell into a cancerous cell is believed to proceed 
through many stages over a number of years or even decades. Carcinogenesis is a 
multistep process that involves initiation, promotion and tumour progression. Initiation 
involves a reaction between the cancer-producing substance (carcinogen) and the DNA 
of tissue cells. There may be a genetic susceptibility. This stage may remain dormant, 
and the subject may only be at risk for developing cancer at a later stage. Promotion 
involves a prolonged period of proliferation of the initiated cells, occurs very slowly 
over a period ranging from several months to years. During this stage, a change in diet 
and lifestyle can have a beneficial effect so that the person may not develop cancer 
during his or her lifetime. The third and final stage involves progression and spread of 
the cancer, at which point diet may have less of an impact. Preventing initiation is an 
important anticancer strategy, as are the opportunities to inhibit cancer throughout the 
latter stages of malignancy (Reddy et al., 2003; Kleinsmith, 2006). 
Restriction 
point 
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2.3 Apoptosis in cancer 
Most of the cells from higher eukaryotes have the ability to self-destruct by 
activation of an intrinsic cellular suicide program referred to as programmed cell death 
or apoptosis (Ellis et al., 1991; Steller, 1995). Apoptosis is an intrinsic biological event 
that plays an essential role in development, homeostasis and in many disease process. 
Culling extra cells in a precise and systematic way is an important aspect of normal 
development. Hence, the other term for this process is programmed cell death. 
Occasionally, cell death program goes awry in several diseases. Degenerative diseases 
may result in (or be the result of) excessive apoptosis and some cancers appear to 
inhibit cell death cascades resulting in excessive and uncontrolled proliferation 
(O’Brien et al., 1998).  
Apoptosis is a unique type of cell death, different from what happens when cells 
are destroyed by physical injury or exposure to certain poisons. In response to such 
non-specific damage, cells undergo necrosis, a slow type of death in which cells swell 
and eventually burst, spewing their contents into surrounding tissues. Necrosis often 
results in a local inflammatory reaction that can cause further cell destruction, which 
makes it potentially dangerous (Kleinsmith, 2006; O’Brien et al., 1998).  
In contrast, apoptosis kills cells quickly and neatly, without causing damage to 
surrounding tissue. Apoptosis is characterized by certain morphological features, 
including reduction in cell volume, cell shrinkage, membrane blebbing, chromatin 
condensation and nuclear fragmentation (Kerr et al., 1972, 1994; Wyllie et al., 1980; 
O’Brien et al., 1998). The process involves a carefully orchestrated sequence of 
intracellular events that systematically dismantle the cell (Figure 2.2).  
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Figure 2.2: Main steps in apoptosis (Kleinsmith, 2006) 
 
As a cell begins to undergo apoptosis, the first observable change is cell 
shrinkage. Next, small bubble-like protrusions of cytoplasm form at the cell membrane 
as the nucleus and other cellular structures begin to disintegrate. The chromosomal 
DNA is then degraded into small pieces and the entire cell breaks apart, forming small 
fragments known as membrane-bound apoptotic bodies that are engulfed by 
macrophages or neighbouring phagocytic cells without generating an inflammatory 
response. Phagocytic cells are specialized for ingesting foreign matter and breaking it 
down into molecules that can be recycled for other purposes (Kleinsmith, 2006).  
The genetic basis for apoptosis implies that cell death, like any other metabolic 
or development program, can be disrupted by mutation. Elucidation of the core 
machinery of apoptosis has provided new insights into cancer biology, revealing novel 
strategies for cancer therapy (Reed, 2002).  In the last decade, basic cancer research has 
produced remarkable advances in the understanding of cancer biology and cancer 
genetics. Among the most important of these advances is the realization that apoptosis 
and the genes that control it have a profound effect on the malignant phenotype. For 
example, it is now clear that some oncogenic mutations disrupt apoptosis, leading to 
tumour initiation, progression or metastasis. Conversely, compelling evidence indicates 
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that other oncogenic changes promote apoptosis, thereby producing selective pressure 
to override apoptosis during multistage carcinogenesis (Scott and Athena, 2000).  
 
Review the process of apoptosis 
 Apoptosis involves a dynamic interplay of several molecules with up-regulatory 
and down-regulatory properties. Stimulation of pro-apoptotic molecules or inhibition of 
anti-apoptotic factors is dependent on the cell type and the form of insult. It is unlikely 
that the activation or inactivation of a single component will alter the ultimate fate of 
the cell and lead to apoptosis (Huerta et al., 2007).   
In the classical form of apoptosis, apoptosis is carried out by a series of protein- 
degrading enzymes known as cysteinyl aspartate-specific proteases (caspases). 
Caspases are grouped into initiator caspases (8 and 10) and execution caspases (3, 6 
and 7) (Kleinsmith, 2006; Huerta et al., 2007).   
Normally, caspase reside in cells in the form of inactive precursors called 
procaspases. When a cell receives a signal to commit suicide, an initiating member of 
the procaspase family is converted into an active caspase. The activated caspase 
catalyzes the conversion of another procaspase into an active caspase, which activates 
yet another procaspase and so forth (Kleinsmith, 2006). Hence, we can conclude that 
apoptosis is carried out by a caspase cascade.  
The presence of procaspase within a cell means that the cell is programmed 
with the seeds of its own destruction, ready to commit suicide quickly if required. It is 
therefore crucial that the mechanisms employed to control caspase activation are 
precisely and carefully regulated and are called into play only when there is a need to 
destroy unneeded or defective cells (Kleinsmith, 2006). Activation of caspase cascade 
occurs via two main routes, which are external pathway and/or internal pathway. Figure 
2.3 shows the two main routes for triggering apoptosis.  
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Generally, the external pathway is employed when a cell has been targeted for 
destruction by other cells in the surrounding tissue. In such cases, neighbouring cells 
produce molecules that transmit a ‘death signal’ by binding to death receptors present 
on the outer surface of the targeted cell. The activated death receptors then interact with, 
and trigger activation of, initiator procaspase molecules located inside the cell, thereby 
starting the caspase cascade (Figure 2.3) (Kleinsmith, 2006; Huerta et al., 2007).   
The internal pathway is a pathway particularly relevant to the field of cancer 
biology, which functions mainly in the destruction of cells that have sustained 
extensive DNA damage. In the internal pathway, damaged DNA triggers accumulation 
of the p53 protein, which stimulates the production of death-promoting proteins that 
alter the permeability of mitochondrial membranes. This event leads to the release of a 
group of mitochondrial proteins, including cytochrome c that activates the caspase 
cascade and thereby cause the cell to be destroyed by apoptosis.  
 
Figure 2.3: The two main routes for triggering apoptosis  
(Adapted from Kleinsmith, 2006) 
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(i) External pathway 
The external pathway is also known as extrinsic pathway or death receptor 
pathway. The detail mechanism of external pathway is shown in Figure 2.4. In Figure 
2.4, it is clearly shown that the external pathway is initiated by binding of: 1) the TNF- 
ligand (tumour necrosis factor ligand) to the TNF receptor, 2) the TRAIL-ligand (TNF-
related apoptosis inducing ligand) to the DR (death receptors), and 3) the FAS-ligand 
(apoptosis inducing receptor ligand) to the FAS receptors. This association leads to 
recruitment of adaptor molecules such as FADD [FAS (apoptosis inducing receptor) 
Associated Death Domain] or TRADD (Tumour Associated Death Domain) resulting 
in activation of initiator caspases (caspase 8 and 10), which in turn cleaves and 
activates executioner caspases (caspase 3, 6 and 7), culminating in apoptosis (Walczak 
and Krammer, 2000; Huerta et al., 2007).  
 
(ii) Internal pathway 
 The internal pathway is also known as intrinsic pathway or mitochondrial 
pathway. The internal pathway (Figure 2.4) is activated by release of cytochrome c 
from the mitochondrial inter-membrane into the cytosol. Once released, cytochrome c 
interacts with Apaf-1 (apoptosis activating factor-1), ATP and procaspase 9 to form 
apoptosome. The apoptosome cleaves and activates caspase 9, which leads to caspase 3, 
6 and 7 activity stimulating apoptosis (Adrain and Martin, 2001).  
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Figure 2.4: Mechanism of apoptosis (Huerta et al., 2007) 
 
In summary, apoptosis occurs in a sequential manner with the first 
morphological changes appearing at the membrane. Cell to cell adhesion decreases and 
either the cytosolic or mitochondrial proteins are altered resulting in nuclear changes. 
The ultimate determinant of apoptosis is an orderly form of intranucleosomal DNA 
fragmentation. As the biochemical hallmark of apoptosis is initiation of caspase 
cascade that leads to DNA fragmentation, both caspase activation and DNA 
fragmentation need to be demonstrated to establish if a cell has undergone the process 
of apoptosis (Huerta et al., 2007). 
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 2.4 Natural products and defence against carcinogenesis 
Researchers are increasingly turning their attention to folk medicine looking for 
new leads to develop better drugs against cancer, as well as viral and microbial 
infections (Galal et al., 1991; Hoffmann et al., 1993). Natural products have provided 
an endless supply of active compounds as source of medicine. A major group of these 
products are the powerful antioxidants, which are usually phenolic in nature, whilst 
some include reactive groups that confer protective properties (Reddy et al., 2003). 
Many pharmaceutical agents have been discovered by screening natural products from 
plants, animals, marine organisms and microorganisms.  
Plants are excellent sources of macronutrients (carbohydrates, proteins, fats and 
fibres) and micronutrients (antioxidants, vitamins and trace minerals). In addition, they 
are sources of an amazing diversity of secondary metabolites (phytochemicals), which 
are not essential for normal bodily function but are still biologically active and of 
medicinal value (Deorukhkar et al., 2007).  Although the mechanism of the protective 
effects of the natural products might not be clear, the fact that the consumption of fruits 
and vegetables lowers the incidence of carcinogenesis at a wide variety of sites is 
broadly supported. The epidemiological evidence suggests fruits and vegetables 
protection against a wide array of cancers, particularly those of the respiratory and 
digestive tracts to a lesser extent the hormone-related cancers (Reddy et al., 2003). 
The chemical diversity, structural complexity, affordability, lack of substantial 
toxic effects and inherent biologic activity of natural products makes them ideal 
candidates for new therapeutics. Natural products not only disrupt aberrant signalling 
pathways leading to cancer (i.e. proliferation, deregulation of apoptosis, angiogenesis, 
invasion and metastasis) but also synergize with chemotherapy and radiotherapy 
(Deorukhkar et al., 2007). About 25 % of the drugs prescribed worldwide come from 
plants, 121 such active compounds being in current use. Of the 252 drugs considered as 
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basic and essential by the World Health Organization (WHO). 11 % are exclusively of 
plant origin and a significant number are synthetic drugs obtained from natural 
precursors (Rates, 2001).  Vincristine, irinotecan, etoposide and paclitaxel are examples 
of plant-derived compounds that are being employed in cancer treatment (Rocha et al., 
2001). It is estimated that 60 % of anti-tumour and infectious drugs already on the 
market or under clinical trial are of natural origin (Shu, 1998).  
 
2.5 Natural products with conventional therapeutic modalities 
  Cancer therapy often involves a multi-pronged approach that incorporates 
surgical, chemotherapeutic and radiotherapeutic strategies. It is increasingly evident 
that the success of these interventions is hampered by development of resistance to 
these therapies and the inability to continue these therapies indefinitely due to their 
cumulative toxicities. One of the strategies that merit consideration in this battle against 
cancer is that of combining these traditional therapies with non-toxic agents that 
augment their effectiveness by selectively sensitizing cancer cells to the cytotoxic 
effects of chemotherapy and /or radiotherapy (Garg et al., 2005).  
According to Deorukhkar et al. (2007), natural products exert their anticancer 
effects at different levels, thereby modulating both the process of tumourigenesis and 
the efficacy of anticancer therapies. At level one, natural products inhibit the initial 
processes of tumourigenesis by inhibiting different steps that govern the transformation 
of an initiated cancer cell to a premalignant lesion. These are chiefly dietary 
phytochemicals and the role they play is chemopreventive. At level two, natural 
products exert their anticancer effects on multiple processes that result in the 
progression of premalignant lesions into overtly malignant tumours. At level three, 
natural products can be combined with conventional therapeutic modalities in order to 
achieve better tumour cell kill and to overcome the resistance of tumours to these 
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therapies. For example, (i) natural products enhance the apoptotic cell death and/or 
clonogenic death induced by chemotherapy and/or radiotherapy; (ii) natural products 
abrogate various pro-survival signalling pathways upregulated by tumours in an effort 
to overcome the cell triggered by chemotherapy and radiotherapy; (iii) natural products 
could minimize the toxicity of conventional therapies by inhibiting the physiologic 
processes induced by these therapies within normal tissues. The inherent lack of 
toxicity of natural products and the potential reduction of toxicity of cytotoxic therapies 
could improve the therapeutic ratio of cancer treatment. 
 
2.6 The Cactaceae family 
The cacti are well-known desert plants, widely recognized by their specialized 
growth form and essentially leafless condition. The Cactaceae is the only family of the 
order and contains from 50 to 150 genera and about 2000 species renowned for their 
remarkable morphological and physiological adaptations to drought (Barthlott & Hunt, 
1993). The plants are xerophytes and, possibly one exception, are all native to the 
Americas. They will not grow where there is virtually no rainfall, but thrive in deserts 
where there is a reasonable rainfall even if rain occurs very infrequently. Some cacti 
occur in rain forests, where they are often epiphytes (Evans, 1996).   
The leaves of the Cactaceae have evolved into spines, in order to allow less 
water to evaporate through transpiration than regular leaves, defend the cactus against 
water-seeking animals. Photosynthesis is carried out by enlarged stems, which also 
store water. Unlike many other succulents, the stem is the only part of a true cactus 
where this takes place. Very few members of the family have leaves, and when present 
these are usually rudimentary and soon fall off; they are typically awl-shaped and only 
1-3 mm long. Two genera, Pereskia and Pereskiopsis, do however retain large, non-
succulent leaves 5-25 cm long and also non-succulent stems. Pereskia, a genus that 
22 
 
consists of 17 species of leafy shrubs and trees, has now been determined to be the 
ancestral genus from which all other cacti evolved.  
(http://en.wikipedia.org/wiki/Cactaceae, 20 July 2008) 
Cacti come in a wide range of shapes and sizes. Some grow to great size. Some 
cacti produce beautiful flowers, which like spines and branches arise from areoles. The 
flowers are mostly bisexual and actinomorphic and commonly have many weakly 
differentiated perianth segments arising from an epigynous zone. The androecium 
typically consists of a very large number of stamens arising from the inner face of the 
epigynous zone. The gynoecium consists of a compound pistil of 3-many carpels, an 
equal number of stigmas, and an equal number of parietal placentae with numerous 
ovules in the single locule of the inferior ovary. Many cactus species are night-
blooming, as they are pollinated by nocturnal insects or small animals, principally 
moths and bats. Cacti range from small and round to pole-like and tall, such as the 
Saguaro. Some cacti bear edible fruit. The fruit is a berry, often with spines or bristles. 
A number of cactus species are cultivated for use as houseplants, as well as for 
ornamental gardens nowadays.  
(http://www.biologie.uni-hamburg.de/b-online/vascular/cact.htm, 06 July 2006 and 
http://en.wikipedia.org/wiki/Cactaceae, 20 July 2008). 
 
2.7 The Pereskia genus 
The genus Pereskia comprises of 25 tropical species and varieties of leafy cacti. 
They originate from the regions extending from Brazil in the South to Mexico in the 
North. The genus is named after Nicolas Fabre de Peiresc, a French botanist of the 16
th
 
century and has been given its own subfamily Pereskioideae. Members of this genus are 
usually referred to as lemon vines or rose cacti or leaf cacti, though this latter also 
refers to the genus Epiphyllum. 
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Species of Pereskia are very unusual cacti, resembling more wild roses than 
actual cacti. Pereskia species have large, bright green, privet-like leaves and long spiny 
stems. They are not always succulent plants; they can be classified as shrubs, climbing 
plants or slightly succulent trees. Unlike Pereskiopsis, Maihuenia, Quiabentia and 
Austrocylindropuntia (which possess succulent, persistent leaves), Pereskia is the only 
cactus genus that has persistent non-succulent leaves.  
The species of Pereskia are easy to grow. They grow fast and flower prolifically. 
Shrub species usually reach 1 m high, but climbing or arborescent species can even 
reach 5 to 20 m. Flowers may appear alone or in clusters. They generally resemble 
roses and reach a diameter of 1 to 5 cm. Colours of the flower depend on each species 
and vary from white, yellow to magenta or red. Fruits are ordinarily spherical, of 2 to 5 
cm diameter, and are wine red when ripe (http://en.wikipedia.org/wiki/Pereskia, 16 
April 2006). 
 
Scientific classification 
Kingdom    : Plantae 
Division     : Magnoliophyta 
Class          : Magnoliopsida 
Order         : Caryophyllales 
Family       : Cactaceae 
Subfamily : Pereskioideae 
Genus       : Pereskia Mill 
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2.7.1 The Pereskia bleo  
 Pereskia bleo (Kunth) DC., commonly known as the ‘Jarum Tujuh Bilah’ in 
Malay and ‘Cak Sing Cam’ in Chinese belongs to the botanical family Cactaceae. The 
appearance of P. bleo is shown in Figure 2.5-2.8.  
P. bleo has several synonyms, such as Pereskia corrugata, Pereskia cruenta, 
Pereskia panamensis, Rhodocactus corrugatus, Rhodocactus bleo, cactus bleo, wax 
rose cactus, orange rose cactus and Pereskia rose cactus (http://www.desert-
tropicals.com/Plants/Cactaceae/Pereskia_bleo.html, 07 July 2006). Although the plants 
resemble wild roses, they are actually primitive cacti with leaves. The stems are not 
succulent but woody, and have prominent spines.  
P. bleo can reach up to 12 feet (3 m) in height and a width of about half its 
height, but can also be kept pruned into a bushy shrub. The fleshy dark green leaves can 
reach 8 inches (20 cm) long by 2.5 inches (6.5 cm) wide. The 2 inch (5 cm) orangish-
red flowers open late in the afternoon and last only one day. They are very showy. If 
fertilized, they create a waxy hemispherical yellow fruit that is quite conspicuous. P. 
bleo likes full sun and dry conditions and propagation is by mean of cuttings.  
(http://toptropicals.com/cgi-bin/garden_catalog/cat.cgi?uid=pereskia_bleo, 16 April 
2006 and http://www.plantoftheweek.org/week219.shtml, 16 April 2006). 
P. bleo has been used as a natural remedy, either eaten raw (two fresh leaves per 
day) or taken as a concoction brewed from fresh plant (seven fresh flowers or leaves). 
The leaves were also taken as vegetable by some natives. P. bleo is believed to have 
anti-cancer, anti-tumour, anti-rheumatic, anti-ulcer and anti-inflammatory activities. It 
is also used as remedy for the relief of gastric pain and refreshment of the body (Goh, 
2000; Tan et al., 2005). In Panama, the locals use the whole plant of P. bleo to treat 
gastrointestinal problems (Gupta et al., 1996).  
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In Malaysia, the Chinese use P. bleo for the treatment of cancer and cancer-
related diseases, like breast carcinoma, brain and uterine tumours. A decoction of the 
leaves is drunk for relief of headache, gastric pain, ulcers, haemorrhoids and atopic 
dermatitis. The pounded leaf paste may be applied to the wound or cut for pain relief 
(Kehidupan Sihat, 2006).  
                 
 
                                                                                                                       
 
 
 
 
Figure 2.5: The appearance of P. bleo in Seksyen 17, Petaling Jaya, Selangor, 
Malaysia 
 
 
 
 
 
 
 
 
Figure 2.6: The stem of P. bleo 
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Figure 2.7: The hemispherical fruit of P. bleo 
 
 
 
 
 
 
 
 
Figure 2.8: The orangish-red flowers of P. bleo 
 
Previous work on P. bleo 
Although the P. bleo is reported to be used in a large number of Malaysian 
traditional medicine preparations, there is not much recorded data on biological studies 
or cytotoxic activity against various cancer cell lines. Chemical investigations on P. 
bleo are also rare in comparison to other Pereskia species, as there were only one 
phytochemical report and four biological studies reported for this plant.  
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The earliest phytochemical study was by Doetsch et al. (1980), who reported 
the isolation of four alkaloids, namely 3,4-dimethoxy-β-phenethylamine, mescaline, 3-
methoxytyramine and tyramine (Figure 2.12).  
A later report by Matsuse et al. (1999) tested the water and methanol extracts of 
P. bleo for anti-human immunodeficiency virus (HIV) effects by determining the 
inhibition of HIV-1 induced cytopathic effect (CPE) on MT-4 cells. However, the P. 
bleo extracts did not show any positive anti-HIV effects in the screening.  
An investigation by Tan et al. (2005) reported that the methanol extract of P. 
bleo possessed cytotoxic effects against T-47D (human breast carcinoma cell line) cells 
and the cell death was found to be apoptotic in nature, mainly via the activation of the 
caspase-3 and c-myc pathways. Ruegg et al. (2006) reported that the methanol and 
dichloromethane extracts of the aerial part of P. bleo did not show active antimicrobial 
activity against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, 
Mycobacterium smegmatis, Candida albicans, Pseudomonas aeruginosa and 
Helicobacter pylori.    
A more recent investigation by Er et al. (2007) indicated the anti-proliferative 
and mutagenic activities of aqueous and methanol extracts of P. bleo leaves against 4T1 
(mouse mammary cancer cell line) cells or NIH/3T3 (normal mouse fibroblast cell line) 
cells. The authors also reported that there was an increase in the level of apoptosis in 
4T1 and NIH/3T3 cells treated with increasing concentrations of the aqueous extract of 
P. bleo. This suggested that cell death occurred via apoptosis to some degree in the 
aqueous extract-treated cells.  
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2.7.2 The Pereskia grandifolia  
 Pereskia grandifolia Haw. is a shrub or small tree that can grow up to 10 m tall. 
The trunk is very spiny and measures up to 20 cm in diameter. Unlike most cacti, 
Pereskia species have persistent leaves and also have spines (modified leaves); 
however, they lack glochids. P. grandifolia has one leaf below each areole, and 
(uniquely) some leaves are among the spines within the areole. The leaves are ovate or 
obovate-lanceolate; usually 9-23 cm long and 4-6 cm broad, rather thin, venation 
pinnate. The spines are 0-8, 1-4 cm long, brown-black, straight, slender. The 
appearance of P. grandifolia is shown in Figure 2.9-2.11. 
 In contrast to P. bleo, P. grandifolia has beautiful pink to purple-pink flowers. 
The flowers are few to many, diurnal, 3-7 cm in diameter; the floral cup and fruit 
combine into a fleshy structure with an inferior ovary. The fruit is pear-shaped, 
irregularly angled, to 10 cm long, and to 7 cm in diameter, fleshy. Oddly, the fruit have 
floral areoles which are bracteate and short woolly hairs; usually the bracts fall before 
the fruit is mature. P. grandifolia is cultivated widely in tropical countries and is native 
to Brazil (http://www.doacs.state.fl.us/pi/enpp/94-7&8all.htm, 07 July 2006; Benson, 
1982; Huxley, 1992).  
In Malay, P. grandifolia is known as ‘Jarum Tujuh Bilah’, ‘Duri Bintang Tujuh’, 
‘Jarum Bilah’ or ‘Pokok 1001 Khasiat’.  In Chinese, it is known as ‘Cak Sing Cam’ 
(Chen, 2002). P. grandifolia has several synonyms or other Latin names, such as 
Rhodocactus grandifolius (Haw.) Kunth., Rhodocactus tampicanus (Weber.) Backeb., 
Pereskia ochnacarpa Miq. and Pereskia tampicana F.A.C.Weber. It is also known as 
large flowered Barbados gooseberry, large leaved Barbados gooseberry, rose cactus, 
grootblaar and Barbadosstekelbessie  
(http://www.hear.org/gcw/html/autogend/species/14349.HTM, 07 July 2006).  
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P. grandifolia can either be eaten raw (two fresh leaves per day) or taken as a 
concoction brewed from fresh plant (seven fresh flowers or leaves). P. grandifolia is 
believed to have anti-cancer, anti-tumor, anti-rheumatic, anti-ulcer and anti-
inflammatory activities. It is also used as remedy for the relief of gastric pain and 
refreshes the body (Goh, 2000). P. grandifolia is also used to reduce swellings (Sahu et 
al., 1974 and Anon, 1969). 
Rahmat (2004) reported that P. grandifolia is used by the locals to give relief to 
headaches, besides its use in preventing cancer and refreshing the body. Chen (2002) 
reported that the Chinese boil the leaves alone or together with meat to be eaten as soup. 
It can fight any type of cancer from head to toe and also help in curing high blood 
pressure, diabetes, gastric problems, headaches and pain relief. In Brazil, the translation 
of P. grandifolia is ‘Pray-For-Us’, and the leaves can either be used in green salads, or 
be cooked (http://davesgarden.com/pf/go/57249/index.html, 26 June 2006).  
 
 
 
 
 
 
 
 
 
Figure 2.9: The appearance of P. grandifolia in Seksyen 17, Petaling Jaya, 
Selangor 
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Figure 2.10: The stem of P. grandifolia 
                                              
 
 
 
 
 
 
 
 
Figure 2.11: The pink flowers of P. grandifolia 
 
Previous work on P. grandifolia 
 As for P. bleo, very little phytochemical work and biological study has been 
reported for P. grandifolia. Doetsch et al. (1980) isolated three alkaloids, p-methoxy-β-
hydroxy-β-phenethylamine, 3-methoxytyramine and tyramine from P. grandifolia 
(Figure 2.12). Investigation by Sahu et al. (1974) yielded the dimethyl ester (1a) from 
dried powdered fruits of P. grandifolia (Figure 2.13). The only biological report on P. 
grandifolia by Ooi et al. (2003) stated that the leaves extract was found to inhibit the 
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cell growth of NCI-II23 (human non-small lung adenocarcinoma cell line) and Caov-3 
(human ovarian carcinoma cell line) cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12: Alkaloids isolated from P. bleo and P. grandifolia (Doetsch et al., 1980) 
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Figure 2.13: Compounds isolated from dried powdered fruits of P. grandifolia 
(Sahu et al., 1974) 
 
2.8 Bioactivity assays 
 Bioassay-guided fractionation is regarded as the most practical experimental 
approach for natural product drug discovery. In this endeavour, the plant materials are 
selected and extracts are prepared for biological assessment. The extracts are then 
subjected to a suitable bioassay system. The active extracts are identified and chose for 
isolation and purification of pure compound. This process continues until a pure active 
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substance is obtained. The resulting substance is then subjected to structure elucidation 
and biological assessment. 
  
2.9 Antioxidant activity  
2.9.1 Oxygen and singlet oxygen 
Oxygen is an indispensable element throughout the lifetime of aerobic living 
organisms such as prokaryotes, fungi, eukaryotes, plants and animals. Nevertheless, 
oxygen is undeniably a double sword as it is also a lethal toxin for living organisms 
(Benzie, 2000). When we breathe oxygen in its natural state of two atoms, it poses no 
problems. However, approximately 1 to 3 % of the oxygen (O2) consumed is 
incompletely metabolized in the mitochondria and thereby diverted into superoxide ion 
(O2
-
·) generation. The mitochondrial respiratory chain produces ROS (reactive oxygen 
species) as by-products of electron transport (Ahmad, 1995).  
Oxygen is easily broken down to singlet oxygen (
1
O2) by heat, UV and 
photochemical reactions of many compounds. Singlet oxygen molecules are incomplete, 
energetically unstable, highly reactive and short-lived. Stability is achieved by the 
removal of electrons (i.e. oxidation of) from surrounding molecules to claim their lost 
electron, thus creating other new ROS with unpaired electrons in the process. These 
ROS attack other molecules, leading to the propagation of a free radical chain reaction 
(Ramarathnam et al., 1995).  
 
2.9.2 Free radicals and Reactive Oxygen Species (ROS) 
A free radical is defined as any atomic or molecular species capable of 
independent existence that contains one or more unpaired electrons in one of its 
molecular orbital (Halliwell et al., 1992).  Free radicals are also termed as ROS with 
one or more unpaired electrons, to describe both radical and non-radical oxidants. The 
34 
 
radical ROS included superoxide (O2
-
·), hydroxyl (·OH), nitric oxide (NO·) and 
peroxyl (ROO·). Non-radical ROS are hydrogen peroxide (H2O2), ozone (O3), singlet 
oxygen (
1
O2) and hypochlorous acid (HOCl) (Aruoma, 1994).  
Free radicals are generated constantly in the body due either to physiological 
metabolism or pathological alterations (Gate et al., 1999; Benzie, 2000). When an 
imbalance occurs between oxidants and antioxidants in favour of oxidants, excess ROS 
are formed; these may contribute to the aging process as well as to chronic disease such 
as cancer and coronary heart disease (Ames and Shigenaga, 1992; Stocker, 1999; Liu et 
al., 2000; Benzie, 2000). Among the major cellular and extra-cellular components, 
proteins, enzymes, lipids, DNA and RNA form the primary targets for the ROS. 
However, oxidation of the unsaturated fatty acid components of cell membrane is the 
oxidative event that occurs most frequently inside the human body (Ramarathnam et al., 
1995).  
 
2.9.3 Cellular effects of oxidative stress and related diseases 
Oxidative stress occurs in most human diseases (Halliwell and Gutteridge, 
1999). However, this is not to say oxidative stress is the cause of most diseases. The 
increment of free radicals may be secondary to the disease process. Oxidative stress 
causes three major cellular effects: (i) lipoperoxidation (ii) DNA oxidation, and (iii) 
protein oxidation.  
Lipid peroxidation occurs in polyunsaturated fatty acids. The peroxidation of 
unsaturated fatty acids can induce the conversion of several fatty acid side chains in 
lipid hydroperoxides, which in turn leads to the formation of a reaction chain (Gate et 
al., 1999). Previous researches indicated that lipid peroxidation increased significantly 
in several pathologies such as diabetes (Sato et al., 1979), hyperglycemia (Esterbauer et 
al., 1990), atherosclerosis (Plachta et al., 1992) and liver diseases (Rouach et al., 1997). 
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The cholesterol or fatty acid of the plasma low-density lipoprotein (LDL) can also be 
oxidized during oxidative stress. Oxidized LDL is considered to be the major factor in 
the development of atherosclerosis (Steinberg et al., 1989; Galle et al., 1995; Gate et al., 
1999).   
   Damage to DNA strands can occur directly by ROS in close proximity to the 
DNA or indirectly, for example, by impairing production of protein needed to repair 
DNA. Alteration in DNA leads to mutagenesis and carcinogenesis (Ames, 1983; Floyd, 
1990). Moreover, alteration in DNA has been suggested to be responsible in part on the 
processes of aging (Fraga et al., 1990), diabetes mellitus (Dandona et al., 1996), 
inflammatory diseases (Ames, 1983) and liver disease (Sipowicz et al., 1997). 
Furthermore, lipid peroxidation is also a major cause of food deterioration, affecting 
colour, flavour, texture and nutritional value (Halliwell and Gutteridge, 1999).   
Proteins are also target for free radicals. Protein oxidation alters signal 
transduction mechanism, transport system or enzyme activities and triggers antibody 
formation and autoimmune processes (Halliwell and Gutteridge, 1999; Wiseman and 
Halliwell, 1996). Oxidized proteins may be also associated in atherosclerosis and aging 
(Berliner and Heinecke, 1996; Stadtman, 1992). 
  
2.9.4 Biological antioxidant defence mechanisms 
Excess production of ROS such as hydrogen peroxide, superoxide anion, 
hydroxyl and other radicals is known to damage cells. However, most living organisms 
have efficient defences and protective systems in the cells that are essential for 
defending the organism against the oxidative stress caused by ROS (Osawa, 1995). A 
biological antioxidant has been defined as ‘any substance that, when present at low 
concentrations compared to those of oxidisable substrate, significantly delays or 
prevents oxidation of that substrates’ (Benzie and Strain, 1999).  
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Antioxidants are characterized by their origins. Antioxidants that are present in 
human cells are of two main categories, which are enzymatic antioxidants and non-
enzymatic antioxidants. Cells have developed several enzymatic antioxidant systems 
which convert oxidants into non-toxic molecules, thus protecting the organisms from 
potentially damaging effects of ROS (Gate et al., 1999). Enzymatic antioxidants are 
generated in situ by cellular metabolism to stabilize the reactive free radicals by 
converting them to more stable state. Thus the intracellular environment contains 
enzymes such as superoxide dismutase (SOD), catalase and glutathione peroxidase.  
There are a variety of non-enzymatic antioxidants and low molecular mass 
molecules which are important in scavenging ROS, such as Vitamin E, Vitamin C, ß-
carotene, selenium, ascorbate, carotenoids and Vitamin A (Gate et al., 1999). 
Epidemiological evidence indicates that the consumption of food stuffs containing 
antioxidant phytonutrients, such as flavonoids and polyphenolics, is advantageous for 
health although the human body has defence mechanisms to combat and reduce 
oxidative damage (Cao et al, 1998; Pulido et al., 2000).  
 
2.9.5 Synthetic and natural antioxidants 
 A number of synthetic antioxidants, such as 2- and 3-tert-butyl-4-
methoxyphenol (i.e. butylated hydroxyanisole, BHA), 2,6-di-tert-butyl-4-methylphenol 
(i.e. butylated hydroxytoluene, BHT) and tert-butylhydroquinone (TBHQ) have been 
added to foodstuffs to prevent the oxidation of food, but their safety has been 
questioned due to toxicity issue (Valentao et al., 2002). BHA and BHT were found to 
be anticarcinogenic as well as carcinogenic in experimental animals. Originally, BHA 
appeared to have tumour-initiating as well as tumour-promoting action. However, later 
research reported that BHA and BHT also caused tumour promotion (Botterweck et al., 
2000). 
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 Therefore, there has been considerable interest in the development and isolation 
of natural antioxidants from botanical sources, especially edible plants to replace 
synthetic antioxidants. Natural antioxidants are presumed to be safe since they occur in 
plant foods and are seen as more desirable than their synthetic counter-parts 
(Amarowicz et al, 2004; Sakanaka et al., 2004). According to Pokorny (1991) when 
compared to synthetic antioxidants, natural antioxidants have the following advantages: 
(i) they are readily acceptable by the consumers (ii) they are considered to be safe (iii) 
no safety tests are required by legislation (iv) this natural antioxidant (not as a synthetic 
chemical antioxidant) is identical to the food which people have taken over a hundred 
years or have been mixing with food (Bera et al., 2006).  
Unlike synthetic antioxidants, which are phenolic compounds with varying 
degrees of alkyl substitution, natural antioxidants can be phenolic compounds 
(flavonoids, phenolic acids and tannins), nitrogen-containing compounds (alkaloids, 
chlorophyll derivatives, amino acids, peptides and amines), carotenoids, tocopherols or 
ascorbic acid and its derivatives (Velioglu et al., 1998). The roles of these compounds 
as potential antioxidants can be inferred by their similarity to synthetic antioxidants, of 
related structures (Larson, 1988).  
Flavonoids and other plant phenolics, such as phenolic acids, tannins, lignans 
and lignin, are especially common in the leaves, flowering tissues, and woody parts, 
such as stems, bark and roots of plants. The antioxidant activity of these phenolics is 
mainly due to their redox properties, which allow them to act as reducing agents or 
hydrogen-atom donors. The natural antioxidants are functioning as free radical 
scavengers and chain breakers, complexes of pro-oxidant metal ions and quenchers of 
singlet-oxygen formation (Pratt, 1992).  
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2.9.6 Methods to determine antioxidant activities 
Ever since the epidemiological consequences of free radicals with certain 
diseases were disclosed, there is a growing interest in searching for the beneficial health 
effects of certain foods and plants (Lee and Halliwell, 2001). It is therefore of great 
interest to measure the antioxidant capacity using various radicals and antioxidant 
systems properly. Thus, convenient methods for quick and simple quantification of the 
antioxidant capacity are needed.  
 There are two major groups of commonly used methods for total antioxidant 
activity determination, which are (i) assays based on a single electron transfer reaction, 
monitored through changes in colour as the oxidant is reduced, and (ii) assays based on 
a hydrogen atom transfer reaction, where the antioxidant and the substrate (probe) 
compete for free radicals (Huang et al., 2005; Tabart et al., 2009).  
Electron transfer reaction assays include the trolox equivalent antioxidant 
capacity (TEAC) assay, ferric reducing ability of plasma (FRAP) assay, copper 
reduction (CUPRAC) assay, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging 
capacity assay and Folin-Ciocalteau method. Hydrogen atom transfer reaction assays 
include the crocin bleaching assay, total peroxyl radical-trapping antioxidant parameter 
(TRAP) assay and oxygen radical absorbance capacity (ORAC) assay. Other methods 
not included in these two groups have been developed, such as the total oxidant 
scavenging capacity (TOSC) assay, the chemiluminescence assay and the 
electrochemiluminescence assay (Huang et al., 2005; Prior et al., 2005; Tabart et al., 
2009).   
As stressed by Frankel and Meyer (2000) and Huang et al. (2005), no single 
method is adequate for evaluating the antioxidant capacity since different methods can 
yield widely diverging results. Tabart et al. (2009) suggested various methods based on 
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different mechanisms, must be used in parallel to evaluate the antioxidant capacity of 
compounds or foods, since different methods can give very different results.  
 
2.10 Antimicrobial activity  
 A large number of human, animal and plant disease are caused by pathogenic 
microbes (fungi, bacteria and algae). Within the recent years, infections have increased 
to a great extent. Infections due to fungi and bacteria have been a major cause of death 
in higher organisms. Infectious diseases, particularly skin and mucosal infections, are 
common in most of the tribal inhabitants due to lack of sanitation, potable water and 
awareness of hygienic food habits (Ahmad and Beg, 2001).  
Foodborne illness resulting from consumption of food contaminated with 
pathogenic bacteria has been of vital concern to public health. Foodborne illness is a 
serious health threat and has significant economic consequences for people in both the 
developing and developed world. Foodbourne illness can be defined as ‘any illness of 
an infectious or toxic nature caused by or thought to be caused by the consumption of 
food or water’. The illness caused by foodborne microorganisms, principally bacteria, 
are associated with gastrointestinal symptoms of nausea, vomiting, stomach pains and 
diarrhoea. Since diarrhoea is a common clinical symptom in foodborne illness, many of 
these illnesses are referred to as ‘diarrhoeal illnesses’ (Lin et al., 2005).  
An estimated 76 million cases occur annually in the United States, resulting in 
300,000 hospitalizations and 5,000 deaths (Mead et al., 1999). Among the reported 
outbreaks in the United States during 1993-1997 periods for which the aetiology was 
determined, bacterial pathogens caused the largest outbreaks (75 %) and the largest 
percentage of cases (86 %). Salmonella spp., Listeria monocytogenes and Escherichia 
coli accounted for the largest number of breakfasts, cases and deaths (Todd, 1989).   
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Gram-positive bacteria are common pathogens responsible for skin disease 
conditions. These include Staphylococcus aureus for skin infections (Darmstadt and 
Lane, 1994; Trilla and Miro, 1995; Noble, 1998), Staphylococus pyogenes for 
pharyngitis, tonsillitis and impetigo (Cappelletty, 1998; Cunningham, 2000) and both 
organisms for otitis media (Brook, 1994; Brook and Gober, 1998).  
The treatment of these infections is mainly based on the use of antibiotics. 
Historically many of the new antibiotics were isolated from natural sources (i.e. soil 
microbes, plants). Many more were later synthesized and introduced in clinical 
practices. The discovery of antibiotic penicillin by Fleming is therefore considered to 
be one of the most important discoveries in the world. 
  However, in recent years, a number of antibiotics have lost their effectiveness 
due to the development of resistant strains, mostly through the expression of resistance 
genes (Davis, 1994; Service, 1995). In addition, antibiotics are sometimes associated 
with adverse effects including hypersensitivity, immune-suppression and allergic 
reaction (Ahmad et al., 1998).  
The discovery and development of new antimicrobial agent is therefore an 
ongoing process. Remarkable diversity of chemicals present in natural medicinal plant 
has tremendous potential in the searching of new antimicrobial agents with possibly 
novel mechanisms of actions (Ramzi and Ulrike, 2005). The compounds that can either 
inhibit the growth of pathogens or kill them and have no or least toxicity to host cells 
are considered candidates for developing new antimicrobial drugs. In recent years, 
antimicrobial properties of natural products are being increasingly reported from 
different parts of the world.  
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Disease burden, infection and foodbourne illness caused by microorganisms tested 
in present study 
 
(i) Gram negative bacteria 
Escherichia coli 
Escherichia coli, Shigellas, Salmonellas and Vibrio cholerae are the common 
pathogens and major cause of foodbourne illness in worldwide. Diarrhoea caused by a 
variety of E. coli strains is a major problem in developing countries, especially children 
living in the developing world (Girard et al., 2006). Disease caused by E. coli follows 
ingestion of contaminated food or water and is characterized by profuse watery 
diarrhoea lasting for several days. It may lead to dehydration and malnutrition in young 
children in developing countries. Infection by E .coli strain O157:H7 is accompanied 
by a watery diarrhoea rapidly progressing to frank haemorrhagic colitis, and leads in up 
to 20 % of paediatric patients to serious sequelae, including the haemolytic uremic 
syndrome (HUS) characterized by thrombocytopenia, haemolytic anaemia and renal 
failure which can lead to permanent loss of kidney function (Karmali, 2004).  
 
Pseudomonas aeruginosa 
 Infections caused by P. aeruginosa are among the most difficult to treat with 
conventional antibiotics (Levison and Jawetz, 1992). P. aeruginosa is an opportunistic 
pathogen that causes urinary tract infections, respiratory system infections, dermatitis, 
soft tissue infections, bacteremia and a variety of systemic infections, particularly in 
victims of severe burns, and in cancer and AIDS patients who are immunosuppressed 
(Trafny, 1998; Yau et al., 2001). The bacterium almost never infects uncompromised 
tissues, yet there is hardly any tissue that it cannot infect, if the tissue defences are 
compromised in some manner (Levison and Jawetz, 1992). 
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(ii) Gram positive bacteria 
Staphylococcus aureus 
 S. aureus is a gram positive bacterium known to play a significant role in 
invasive skin diseases including superficial and deep follicular lesions. Skin and skin 
structure infections (SSSIs) are among the most common infectious encountered in 
medical practice. Skin and skin structure infections are defined by the United States 
Food and Drug Administration (FDA) as uncomplicated and complicated. 
Uncomplicated SSSIs include simple abscesses, impetiginous lesions, furuncles and 
cellulitis. Complicated SSSIs (cSSSIs) include deeper soft-tissue infections requiring 
significant surgical intervention such as infected ulcers, burns, and major abscesses or 
an infection occurring in the setting of a significant underlying diseases state that 
complicates the response to treatment (Yang and Kerdel, 2006). 
 
Bacillus subtilis 
 Bacillus spp. is commonly microbes found in natural environmental including 
soil, plant, water and animal tissues. Most Bacillus spp. are regarded as having little 
pathogenic potential. B. subtilis has been known to act as invaders or secondary 
infectious agents in a number of diseases and has been implicated in some cases of food 
poisoning (Turnbull and Kramer, 1991).        
 
2.11 In vitro cytotoxic activity tests 
2.11.1 In vitro testing system 
The application of in vitro assay systems for the search of potential 
chemopreventive and anticancer agents has been common since the beginnings of 
cancer chemotherapy in 1946 (Wilson, 2000). The use of cell culture systems basically 
offer numerous advantages over whole animal models (in vivo system), being 
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inexpensive, sensitive, with reproducibility of test conditions, rapid and most 
importantly no ethical constraints associated with using animal experimentation for 
screening of cytotoxic activity (Borenfreund and Puerner, 1985; Stark et al., 1986; 
Cordell et al., 1991).   
 In general, the in vitro test systems can be divided into two groups; one 
consisting of chemically-induced cell transformation system, which are used to detect 
changes in initiation versus promotion process, and the other comprising of cells with 
identified oncogenes or transforming growth factors. The endpoint of these assays is to 
observe inhibition effects of cell proliferation, transformation or differentiation 
(Greenwald et al., 1990). Table 2.1 outlines several endpoints used to identify cytotoxic 
effects of chemopreventive or anticancer agents using in vitro test system (Knox et al., 
1986).  
 
Table 2.1: Endpoints used to identify cytotoxic effects using in vitro test system 
(Knox et al., 1986) 
 
Class Endpoint 
Cell viability 
Vital dye uptake; dye exclusion; detachment from culture  
dish surface; fall in cell number; replating efficiency 
Cell morphology 
Cell size and shape; cell-cell contacts; nuclear size, shape 
and inclusions; nucleolar number, size, shape and 
inclusions; cytoplasmic vacuolation.  
Cell proliferation 
Increase in cell number, total DNA, total RNA, total 
protein; colony formation on culture dish surface. 
Membrane damage 
Loss of enzymes, ions or cofactors; leakage from 
prelabelled cells.  
Uptake or incorporation 
of radioactive precursors 
Uridine and RNA synthesis; thymidine and DNA 
synthesis; amino acids and protein synthesis 
Metabolic effects Inhibition of metabolic co-operation; cofactor depletion 
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2.11.2 In vitro cytotoxic activity testing 
The discipline of cell toxicology (cytotoxic activity) is defined as quantitative 
and qualitative investigations of adverse effects of chemical and physical factors on 
cells, including toxicity ranking, extrapolation to the organism level and risk evaluation. 
Cell toxicology can be said to link together the disciplines of cell biology and 
toxicology (Walum et al., 1990).  
It is important to distinguish between the terms ‘cytotoxic’, ‘antitumor’ and 
‘anticancer’. ‘Cytotoxic’ compounds are toxic to cells in culture and maybe cytostatic 
(i.e. stop cell growth, reversibly or irreversibly) or cytocidal (kill cells). ‘Antitumor’ 
compounds are those which are active in an in vivo tumour system. Such compounds 
would therefore show selectivity against tumour cells. ‘Anticancer’ compounds are 
those which are effective in cancers in humans. Hence it requires human clinical trials 
to determine if any antitumor compound has anticancer activity (Rahman et al., 2001).  
In vitro cytotoxicity assays can be used to predict human toxicity and for the 
general screenings of chemicals (Clemedson and Ekwall, 1999; Scheers et al., 2001). 
Cytotoxicity screening models provide important preliminary data to help select plant 
extracts with potential antineoplastic properties for future work (Cardellina et al., 1999). 
In past years, a number of methods have been developed to study cell viability and 
proliferation in cell culture (Cook and Mitchell, 1989). The most convenient, modern 
assays have been optimized for the use of microtiterplates (96- well format). Each well 
requires only a small amount of test sample so that several replicates can be performed 
and a range of concentrations tested. This allows many samples to be analyzed rapidly 
and simultaneously. Colorimetric and luminescence based assays allow samples to be 
measured directly in the plate by using a microtiterplate reader or ELISA plate reader. 
Cytotoxicity assays have been developed which use different parameters associated 
with cell death and proliferation (Weyermann et al., 2005). 
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2.11.3 Methods to determine cytotoxic activity 
Cytotoxicity assays are widely used in in vitro toxicology studies. It has been 
previously reported that different cytotoxicity assays can give different results 
depending on the test agent used and the cytotoxicity assay employed. For this reason, 
it is important to consider what effect is expected, respective of what cell death 
mechanism is predicted when choosing a suitable cytotoxicity assay for the studies 
(Weyermann et al., 2005).  
The lactate dehydrogenase leakage (LDH) assay, a protein assay, the neutral red 
assay, the methyl tetrazolium (MTT) assay and ATP content assay are the most 
common employed assays for the detection of cytotoxicity or cell viability following 
exposure to toxic substances (Fotakis and Timbrell, 2006; Weyermann et al., 2005). 
These assays are based on different modes of detection like LDH release which is based 
on the release of enzyme into the culture medium after cell membrane damage; protein 
content of viable cells that are left after washing of the treated plates; neutral red uptake 
by functional lysosomes; MTT metabolism which is based on the enzymatic conversion 
of MTT in mitochondria and ATP content of treated cells (Fotakis and Timbrell, 2006). 
Thus, one has to be careful with the suitability of the assay used to prevent false-
positive or false-negative results.  
 
2.12 Apoptosis screening and detection 
There are several typical methods for apoptosis screening and detection (Table 
2.2). However, each method to detect and verify apoptosis has advantages and 
disadvantages. It is suggested to use multiple complementary techniques to confirm 
apoptosis.  
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Table 2.2: Typical methods to study different aspect of apoptosis  
(Huerta et al., 2007) 
 
Detection aspects Methods / assay 
Morphological changes  Microscopic techniques 
 Electron microscopy (EM) 
 Light microscopy (LM) 
 Fluorescence microscopy (FM) 
 DNA staining assay 
 Dye exclusion 
 DNA binding dyes 
 Annexin V 
DNA fragmentation  TUNEL (terminal deoxynucleotidyl transferase 
(TdT)-mediated dUTP nick end labelling) 
 ISEL (In situ end labelling technique) 
 FIGE (Field inversion gel electrophoresis) 
 Flow cytometry and ELISA (enzyme-linked 
immunosorbent assay) 
 DNA laddering 
 DNA fragmentation measurement 
 APO ssDNA 
 
 
2.12.1 Detection of morphological changes 
Microscopic techniques 
One of the methods to detect apoptosis by observation of morphological 
changes is microscopic techniques, which include electron microscopy (EM), light 
microscopy (LM) and fluorescence microscopy (FM). EM is time consuming and 
requires expensive equipment and specialized training (White and Cinti, 2004) while 
LM and FM can only be used to detect the late events of apoptosis (Huerta et al., 2007). 
All these microscopic techniques can detect apoptosis in vitro but are limited by the 
fact that they can only detect apoptosis at a single point in time and inability to screen a 
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large number of samples. Thus, it is possible to miss the characteristic apoptosis bodies 
by microscopy to establish apoptosis.  
 
DNA staining assay 
 Dye exclusion, DNA binding dyes and Annexin V are some of the techniques 
for DNA staining assays. Generally, the cell membrane of dead cells becomes 
permeable to dyes and can be stained. In contrast, viable cells can be excluded by dyes 
that will not penetrate the intact plasma membrane.  Trypan blue is a typical exclusion 
dye that can be used to differentiate viable and dead cells by light microscopy such that 
blue-stained cells can be distinguished from the viable non-stained cells. In the present 
study, the density of the viable cells in neutral red cytotoxicity assay was counted by 
0.4 % of trypan blue exclusion in a haemocytometer.  
The fluorescent dyes, such as propidium iodide (PI), Hoechst 33342, 4’,6-
diamidino-2-phenylindole (DAPI) and YOPRO-1, become highly fluorescent upon 
binding of DNA in viable cells. These DNA markers make the chromatin condensation 
readily visible by fluorescence microscopy and simplify the detection of morphological 
changes during apoptosis. Thus, this is not a very specific test for apoptosis, but this 
can be compensated by using other detection methods.  
 
2.12.2 Detection of DNA fragmentation 
DNA fragmentation is one hallmark of apoptosis. The morphological changes 
observed in the nucleus of apoptotic cells are, in part, due to the generation of DNA 
fragments through the action of endogenous endonucleases, including the caspase-
dependent DNase (Arends et al., 1990; Gavrieli et al., 1992). Typically, the DNA of 
apoptotic cells is cleaved to a population of multimers of 180-200bp fragments, readily 
observed as a ‘ladder’ on agarose gels.  
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There are several established assays that are used for the detection of DNA 
fragmentation as listed in Table 2.2 and TUNEL [terminal deoxynucleotidyl transferase 
(TdT)-mediated dUTP nick end labelling] assay is the most widely used in situ test 
among all the techniques.  
 
2.12.3 TUNEL assay 
The TUNEL assay was introduced by Gavrieli et al. (1992). TUNEL assay is 
based on the specific binding of terminal deoxynuclotidyl transferase (TdT) to 3’-OH 
ends of fragmented DNA (nicks). Following proteolytic treatment of histological 
sections, TdT incorporates X-dUTP (X=biotin, DIG or fluorescein) at sites of DNA 
breaks. Termini modified nucleotides Avidin-peroxidase amplifies the signal and 
allows for examination of labelled cells under light or fluorescent microscopy, flow 
cytometry or immunohistochemistry (Gavrieli et al., 1992).     
 
Limitations of TUNEL assay 
The sensitivity and specificity of the TUNEL assay has been criticized, and it 
has been reported that several factors can produce a false-positive signal in TUNEL 
assay (Pulkkanen et al., 2000). The following are some limitations of the TUNEL assay: 
i. Fixation and handling of cells can significantly alter the results of TUNEL assay 
(Charriaut-Marlangue and Ben Ari, 1995; Ichimura et al., 1995; Lucassen et al., 
1995). 
ii. The rates of apoptosis might be inaccurate if fixation is prolonged (Davison et 
al., 1995).  
iii. Measurement of apoptosis at a single time point in cell or tissue sections may be 
an inaccurate representation of the true rate of programmed cell death. 
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iv. TUNEL assay is not specific for apoptosis. It indicates DNA cleavage from any 
form of cell death and necrotic cells may also be labeled by this technique 
(Grasl-Kraupp et al., 1995).  
Hence, TUNEL is an accepted assay to establish apoptosis in vitro and in situ 
and when confirmed with other methods, it is a reliable test for apoptosis (Huerta et al., 
2007). It is advisable to employ two independent methods (e.g. DNA fragmentation and 
caspase-3 activation) to confirm that cell death is occurring by apoptosis. Thus, the 
detection of DNA fragmentation by using DeadEnd
TM 
Colorimetric TUNEL System 
had been carried out with determination of expression level of apoptotic related genes 
in the present study.   
 
2.13 Determination of expression level of apoptotic-related genes  
The therapeutic application of apoptosis is currently being considered as a 
model for the development of anti-tumour drugs (Hong et al., 2003). It is therefore 
essential to identify apoptosis-inducing compounds that are candidate anti-cancer agent. 
Thus, the importance of investigating the role of gene expression in the identification of 
potential chemotherapeutic agents using mechanism-based studies holds great promise 
for elucidating mechanisms and devising more specific and effective treatments for 
cancer-related diseases.  
 
2.13.1 Introduction to gene expression 
 Gene expression is the process by which information from a gene is used in the 
synthesis of a functional gene product. There are several steps in the gene expression 
process, including the transcription step and translation step. Genes are expressed by 
being transcribed into RNA, and this transcript may then be translated into protein 
(Figure 2.14).  
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Figure 2.14: Steps in gene expression process 
(Adapted from http://en.wikipedia.org/wiki/Gene_expression,  
20 April 2009) 
 
The gene itself is typically a long stretch of DNA and does not perform an 
active role. It is a blue print for the production of RNA. The production of RNA copies 
of the DNA is called transcription and is performed by RNA polymerase. RNA is 
central to the synthesis of proteins while mRNA is the RNA that carries information 
from DNA (protein sequence) to the ribosome (the protein synthesis [translation] in the 
cell).  The coding sequence of the mRNA determines the amino acid sequence in the 
protein that is produced.   Non-protein coding genes (e.g. rRNA genes, tRNA genes) 
are transcribed and involved in the process of translation, but not translated into protein. 
The mRNA is then exported from the nucleus to the cytoplasm, where it is bound to the 
ribosome and translated into its corresponding protein form with the help of tRNA. 
While the genes of an organism are relatively fixed, the mRNA population represents 
how genes are expressed under any set of conditions. 
 
2.13.2 Importance of gene expression measurement  
Understanding the process of cell death associated with numerous disease 
conditions is essential in resolving the pathogenesis and identifying possible therapeutic 
approaches. For many years, the cytotoxic actions of the chemotherapeutic drugs were 
ascribed solely to their ability to induce genotoxic death (Kamesaki, 1998). However, 
there were accumulating evidences that these agents exert their cytotoxic effects mainly 
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by inducing apoptosis in tumour cells. Impairment of apoptosis is known to be related 
to cell immortality and carcinogenesis; the induction of apoptosis in neoplastic cells, 
therefore, is vital in cancer treatment.  
The chemotherapeutic drugs that have been observed to induce apoptosis in 
vitro include etoposide, camptothecin, VM26, vincristine, cis-platinum, 
cyclophosphamide, paclitaxel, 5-fluorouracil and doxorubicin (Kaufman, 1989; Walker 
et al., 1991; Shinomiya et al., 1994; Havrilesky et al., 1995; Huschtscha et al., 1996). 
In accordance with these in vitro studies, other studies also provide evidences that 
chemotherapeutic agents induce apoptotic tumour cell death in vivo. Experimental 
studies of murine tumours have demonstrated that cis-platinum, cyclophosphamide and 
other chemotherapeutic agents induced apoptosis in various tumours in vivo (Meyn et 
al., 1995). Several clinical studies have also shown that chemotherapy triggers 
apoptotic cell death in patients undergoing chemotherapy (Gorczyca et al., 1993; 
Moreira et al., 1995).  
Therefore, it is important to determine the expression level of apoptotic-related 
genes in order to determine the possible mechanisms of cell death elicited by the active 
extracts and isolated compounds on the selected cell lines. 
 
2.13.3 Apoptotic-related genes 
Apoptosis is a complex process that involves a variety of different signalling 
pathways that lead to a multitude of changes in the dying cells. Three apoptotic-related 
genes used in the present study were p53, caspase-3 and c-myc.  
 
p53 
 The p53 is the first tumour suppression gene linked to apoptosis which is 
expressed in a variety of malignancies (Kaabinejadian et al., 2008). Tumour 
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suppression gene is a gene that protects a cell from becoming cancer one. p53 has 
appeared as a key tumour suppressor and important target for novel cancer therapy. It 
plays a major role in preventing tumour development (Mills, 2006).  
 Cellular tumour antigen p53 is a transcription factor with multiple functions 
including regulation of the cell cycle, inhibition of angiogenesis, DNA repair and 
apoptosis (Lacroix et al., 2006). p53 is a nuclear protein and also known as tumour 
protein 53 (TP53), tumour suppressor p53, phosphoprotein p53 and antigen NY-CO-13. 
It has been described as ‘the guardian of the genome’, which referred to its role in 
conserving stability by prevent genome mutation and selectively inhibit the growth of 
eradicate damaged cells (Lane, 1992). p53 plays an important role in cellular responses 
to a variety of environmental and intracellular stresses including DNA damage, UV 
radiation, hypoxia and hyper-proliferation (Vousden and Lu, 2002; Meek, 2004). It has 
been implicated as an important determinant of tumour cell sensitivity to cytotoxic 
agents (Kaabinejadian et al., 2008). Tumours that lack p53 function often respond 
poorly to radiation and chemotherapy (Michalak et al., 2005).  
The p53 signalling pathway is in standby mode under normal cellular conditions. 
Activation occurs in response to cellular stresses and leads to an increase in the level of 
p53 protein due to reduced MDM2-dependant proteolytic degradation and increased 
affinity of p53 for DNA. Since p53 exerts its anti-proliferative action by inducing cell 
cycle arrest or apoptosis, loss of p53 activity, which often occurs in cancer, disrupts 
apoptosis and accelerates the appearance of tumours (Kaabinejadian et al., 2008).  
 
Caspase-3 
Caspase-3 was used as one of the apoptotic markers in the present study. Many 
of the events that occur during apoptosis are mediated by caspases, a family of cysteine 
proteases (Alnemri et al., 1996; Cardone et al., 1988; Chen et al., 2001). The family of 
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caspases formed an executionary arm that implements the apoptotic cell death 
processes. Caspases are normally present in the cell as proenzymes that require limited 
proteolysis for activation of enzymatic activity (Nunez et al., 1998). It was well 
documented that once activated, caspases cleave a variety of intracellular polypeptides, 
including major structural elements of the cytoplasm and nucleus, components of the 
DNA repair machinery and a number of protein kinases. Collectively, these scissions 
disrupt survival pathways and disassemble important architectural components of the 
cells, contributing to the stereotypic morphological and biochemical changes that 
characterize apoptosis cell death (Earnshaw et al., 1999).   
Caspases are divided into pro-apoptotic (caspase 2, 3, 6, 8, 9 and 10) and pro-
inflammatory (caspase 1, 4 and 5) members. Among the caspases, caspase-3, which is 
recognized as a central player in mediating cellular apoptosis, is the most commonly 
activated caspases in the apoptosis process (Janicke et al., 1998). The activation of 
caspase-3 is an important downstream event in apoptosis. Caspase-3 has been widely 
shown to mediate the limited proteolysis of the structural protein gelsolin, p21-
activated kinase 2 (PAK2), focal adhesion kinase (FAK) and rabaptin 5 (Cosulich et al., 
1997; Kothakota et al., 1997; Rudel and Bokoch, 1997; Wen et al., 1997) and cleavage 
inactivation of DNA fragmentation factor such as DFF45 and ICAD (Liu et al., 1997; 
Enari et al., 1998; Sakahira et al., 1998). Evidences of caspase 3 involvements in the 
apoptosis process are well documented, for example, caspase-3
-/-
 mice (caspase-3-
knockout mice) can survive to birth, but they exhibit perinatal mortality as a result of 
defects in brain development that correlate with a decrease in levels of apoptosis 
(Kuida et al., 1996; Woo et al., 1998). Caspase-3 was also reported to be required for 
apoptosis in neutrophils and activated T-cells (Woo et al., 1998).  
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C-myc 
 The c-myc gene is the main member of Myc-family that also includes N-myc, 
L-myc, S-myc and B-myc. Like other Myc proteins, c-myc is important in organization, 
with the crucial regions needed for proliferation, apoptosis and transcriptional activities 
located in its terminal domains (Prendergast, 1999). It is a regulator of cell cycle 
progression and can cause cells to undergo apoptosis (Askew et al., 1991; Evan et al., 
1992). C-myc is also an enhancer of apoptosis (McCarthy et al., 1994), which was 
shown to enhance activation-induced cell death in T-cell hybridomas (Shi et al., 1992). 
An increased expression of c-myc has been demonstrated to lead cells into apoptotic 
route (Wurm et al., 1986; Wyllie et al., 1987; Askew et al., 1991; Evan et al., 1992).  
 
2.13.4 Methods of mRNA quantification 
There are four methods in common use for the quantification of mRNA: (i) 
northern blotting (Parker and Barnes, 1999), (ii) ribonuclease protection assay (Hod, 
1992; Saccomanno et al., 1992), (iii) in situ hybridization (Parker and Barnes, 1999) 
and (iv) competitive reverse transcriptation-polymerase chain reaction (RT-PCR) (Weis 
et al., 1992). These methods are time consuming and require considerable effort. 
Northern analysis is the only method providing information about mRNA size, 
alternative splicing and the integrity of RNA samples. The ribonuclease protection 
assay is most useful for mapping transcript initiation and termination sites and 
intron/exon boundaries, and for discriminating between related mRNA of similar size, 
which would migrate at similar positions on a northern blot.  There is no amplification 
involved in northern blotting and ribonuclease protection assay. In situ hybridization is 
the most complex method of all, but is the only one that allows localization of 
transcripts to specific cells within a tissue (Bustin, 2000). Techniques such as Northern 
blotting and ribonuclease protection assays work very well, but time consuming and 
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require more RNA than is sometimes available. Thus, the main limitation of these three 
techniques is their comparatively low sensitivity (Melton et al., 1984).    
RT-PCR is an in vitro method for enzymatically amplifying defined sequences 
of RNA (Rappolee et al., 1988) and permits the analysis of different samples when 
amounts of RNA are low. It is the most sensitive and the most flexible of the 
quantification methods (Wang and Brown, 1999) and can be used to compare the levels 
of mRNAs in different sample populations, to characterize patterns of mRNA 
expression, to discriminate between closely related mRNAs, and to analyse RNA 
structure (Bustin, 2000).  
 
2.13.5 RT-PCR quantification  
It is important to review the nature of the PCR in order to understand RT-PCR 
quantification. The advantages of PCR, accounting for its success in gene expression, 
have been its sensitivity, specificity and rapidity. PCR is conceptually simple and 
amenable to full automation. PCR techniques allow for the in vitro synthesis of millions 
of copies of a specific gene segment of interest, allowing the rapid detection of as few 
as 1 to 10 copies of target DNA from the original sample (Figure 2.15) (DeBiasi and 
Tyler, 2004).  
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Figure 2.15: General PCR schema (DeBiasi and Tyler, 2004) 
 
(i) Conventional RT-PCR quantification 
 Conventional RT-PCR is a complex assay (Figure 2.16A) and all physical and 
chemical components of the reaction are interdependent. The conventional RT-PCR 
assay measures the end-product of PCR amplification after a given number of cycles 
and involves some methods for quantitating the bands on the gel (end-point quantitative 
RT-PCR) (Yuan et al., 2000). Conventional RT-PCR is only semi-quantitative at best, 
in part because of the insensitivity of ethidium bromide stain and also the difficulties of 
observing the reaction during the truly linear part of the amplification process and get 
truly quantitative results. Various competitive PCR protocols have been designed to 
overcome this problem but they tend to be cumbersome and time consuming to perform. 
DNA sequencing may be required to confirm the identity of the amplicon. Thus, real-
time RT-PCR (RT-qPCR) has been developed so that more accurate results can be 
obtained to quantitate differences in mRNA expression.  
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Figure 2.16: RT-PCR quantification  
(A) Conventional RT-PCR (B) Real-time RT-PCR (RT-qPCR) (Bustin, 2000) 
 
(ii) The RT-qPCR quantification 
Real-time PCR (qPCR) uses fluorescent reporter dyes to combine the 
amplification and detection steps of the PCR reaction in a single tube format (Higuchi 
et al., 1992; Higuchi et al., 1993). The real-time reverse transcription-polymerase chain 
reaction (RT-qPCR) involves of three steps: (i) the reverse transcriptase (RT)-
dependent conversion of RNA into cDNA, (ii) the amplification of the cDNA using the 
PCR and (iii) the detection and quantification of amplified fluorescence products in 
real-time (Nolan et al., 2006).  RT-qPCR schema is shown in Figure 2.16B.  
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qPCR is proven to be a sensitive, reliable and convenient alternative for 
quantifying the changes in expression of multiple genes (Bustin, 2000; Heid et al., 1996; 
Freeman et al., 1999). At the start of a PCR reaction, reagents are in excess while 
template and product are at low enough concentrations. This is to prevent product re-
naturation compete with primer-binding and allows amplification to proceed at a 
constant and exponential rate. The amount of DNA theoretically doubles with every 
cycle of PCR. After certain cycles, the reaction rate ceases to be exponential and enters 
a linear phase of amplification, which primarily due to product re-naturation competing 
with primer binding. However, the reaction cannot go on forever. The amplification 
rate eventually drops to near zero and reaches a plateau phase with little product is 
made (Figure 2.17).  
The amplification curve of qPCR is shown in Figure 2.17. The assay relies on 
measuring the increase in fluorescent signal, which is proportional to the amount of 
DNA produced during each PCR cycle and so the progress of the reaction can be 
viewed. Furthermore, the use of probes labelled with different reporter dyes allows the 
detection and quantification of multiple target genes in a single (multiplex) reaction. 
Individual reactions are characterized by the PCR cycle number at which fluorescence 
first rises above a defined or threshold background fluorescence, a parameter known as 
the threshold cycle (Ct) or crossing point (Cp). A fixed fluorescence threshold is set 
significantly above the baseline by the operator. The higher the starting copy number of 
the nucleic acid target, the sooner the significant increase in fluorescence is observed 
and the lower the Ct. This correlation between fluorescence and amount of amplified 
product permits accurate quantification of target molecules over a wide dynamic range, 
while retaining the sensitivity and specificity of conventional end-point PCR assays. 
The closed-tube (homogenous) format eliminates the need for post-amplification 
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manipulation and significantly reduces hands-on time and the risk of carry-over 
contamination (Nolan et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17: The qPCR amplification curve. A typical qPCR amplification curve is 
a sigmoid curve which defines by baseline, log-linear phase and plateau phase. 
The parameter Ct (threshold cycle) is defined as the cycle number at which the 
fluorescence emission exceeds the fixed threshold. 
 
Several factors have contributed to the transformation of RT-qPCR technology 
into a mainstream research tool: (i) as a closed-tube format (homogenous) assay, it 
avoids the need for post-PCR processing (i.e. agarose gel electrophoresis) which can be 
time consuming and does not quantify the amount of nucleic acid within the samples, 
(ii) it offers a much wider dynamic range of up to > 10
7
-fold (compared to 10
3
-fold in 
conventional RT-PCR) and (iii) the assay realizes the inherent quantitative potential of 
the PCR, making it a quantitative as well as qualitative assay (Ginzinger, 2002).  
 
 
 
Log-linear 
phase 
Plateau phase 
 
Baseline 
Threshold 
Ct 
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Chemistry options for real-time amplification 
 There are three chemistry options for real-time amplification, which are (i) 
dsDNA (double-stranded DNA) intercalator dye based, (ii) probe based (i.e. 
hybridization probes and hydrolysis probes) and (iii) primer based. The dsDNA 
intercalator dye based techniques involves detection of the binding of a fluorescent dye 
(e.g. SYBR Green) to DNA (Morrison et al., 1998). TaqMan probe is a typical 
hydrolysis probe (Heid et al., 1996) which utilized the 5’ exonuclease activity of Taq 
polymerase while hybridization probes include molecular beacons (Abravaya et al., 
2003) and scorpions (Solinas et al., 2001; Terry et al., 2002).  In present study, 
fluorogenic LUX primer, which is one of the primer-based chemistries, is utilized for 
RT-qPCR quantification. This fluorogenic LUX primer method, however, has some 
advantages over some methods that include the ease of design and synthesis of the 
fluorogenic primers (Lowe et al., 2003).  
 
2.13.6 Fluorogenic LUX primer RT-qPCR assay 
 The use of LUX (Light Upon eXtension) primers for detection and 
quantification of genes on real-time platforms represents the most recent advance in 
real-time design (Sharkey et al., 2004). This technology was established in 2002 by 
scientists in the Invitrogen Corporation. LUX primers are easy to use, highly sensitive 
and efficient for performing qPCR and RT-qPCR to quantify 100 or fewer copies of a 
target gene in as little as 1 pg of template DNA or RNA. This detection format includes 
one single-labeled, self-quenched primer and an unlabeled counterpart (Rekhviashvili 
et al., 2006). The fluorogenic LUX primer is designed to be ‘self-quenched’ until it is 
incorporated into a double-stranded PCR product, whereupon its fluorescence increases, 
i.e., is ‘dequenched’. The counterpart PCR primer used in conjunction with the 
fluorogenic primer is a standard, unlabeled oligonucleotide (Lowe et al., 2003).    
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 As such primers are at an early stage of development, little on them is available. 
They do, however, appear to represent a more economical option than other detection 
chemistries that are relatively easy to design (Sharkey et al., 2004).  
 
LUX primer reaction 
Changes in emission of fluorescence are affected by the primary and secondary 
structure of a LUX primer. The 3’-end of a LUX primer requires guanosine bases near 
the conjugated tag. The 5’-end of this fluorogenic primer is modified by the addition of 
a short sequence that is complementary to the labeled 3’-end of the primer. This 5’ tail 
enables the LUX primer to assume a hairpin configuration at temperature below the 
melting point of the hairpin, which causes a fluorescence-quenching effect (Figure 
2.18). During PCR, when a fluorogenic LUX primer binds to the complementary 
sequence and becomes linear, the fluorophore is dequenched and the levels of 
fluorescence increase by 10-fold (Figure 2.18) (Nazarenko et al., 2002a; Nazarenko et 
al., 2002b; Chen et al., 2004; Lowe et al., 2003; Sharkey et al., 2004).   
The above characteristics and other standard characteristics of the primers, such 
as length and Tm, are included in the primer design by proprietary software called LUX 
Designer (Invitrogen, http:// www.invitrogen.com/lux). These design rules enable the 
software to output numerous primer pairs that are located throughout the target (input) 
sequence.   
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Figure 2.18: LUX primer reaction (www.invitrogen.com/lux) 
 
Labelling  
 Each fluorogenic LUX primer is labelled with one of two reporter dyes, either 
FAM (6-carboxy-fluorescein) or JOE (6-carboxy-4’,5’-dichloro-2’,7’-dimethoxy-
flurescein). Typically, a FAM-labelled primer set is used to detect gene of interest 
while a JOE-labelled primer set is used to detect a housekeeping gene as an internal 
control.  
 
Melting curve analysis 
 Melting curve analysis during qPCR is important to identify the presence of 
primer dimmers and analyze the specificity of the reaction. Thus, it is encouraged to 
program the real-time instrument to perform melting curve analysis after thermo 
cycling, in which the temperature is raised by a fraction of a degree and the change in 
fluorescence is measured.  
Melting curve analysis identifies the change in fluorescent signal that occurs 
when dsDNA dissociates or ‘melts’ into ssDNA (single-stranded DNA). The software 
plots the rate of change of the relative fluorescence units (RFU) with time (T) [-
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d(RFU)/dT] on the Y-axis versus the temperature on the X-axis, and this will peak at 
the melting temperature (Tm) (Figure 2.19).  
Melt curves are a powerful means of providing accurate identification of 
amplified products and distinguishing them from primer dimmers and other small 
amplification artefacts. The Tm of a DNA molecule depends on both its size and its 
nucleotide composition; hence GC-rich amplicons have a higher Tm than those having 
abundance of AT base pairs (Nolan et al., 2006).  
All amplicon for a particular primer pair should have the same melting 
temperature, unless there are contamination, mispriming or primer dimmers artifacts. 
The presence of primer dimmers in samples containing template decreases PCR 
efficiency and obscures analysis and determination of Ct (threshold cycle). By 
identifying the temperature at which the dsDNA dissociates, small artifacts such as 
primer dimmers with lower annealing temperature can be distinguished from larger 
amplicon with higher annealing temperature.  
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Figure 2.19: Melting curve analysis confirming specific amplification with LUX 
primers. The melting curve shows the changing rate of relative fluorescence [-
d(RFU)/dT] over temperature (°C). qPCR was performed on 10-fold serial 
dilutions (10
6
 to 10
3
 copies) of human ß-actin plasmid using 200 nM FAM-labeled 
LUX™ Primer. Reactions were amplified by 50 cycles of PCR using a Corbett 
Research Rotor-Gene™. Melting curve analysis was performed after 
amplification using a temperature ramp of 1 °C/5 sec. between 65 °C and 95 °C. 
Colored lines indicate template-specific reactions. Black lines indicate no-template 
controls. Figure adapted from www.invitrogen.com/lux. 
 
2.14 Acute oral toxicity assessment  
The acute oral toxicity test is the simplest, and often the first toxicity test to be 
conducted on a sample. A single, high dose of the test sample is given to each 
experimental animal and the mortality is observed; death within the observation period 
(usually of 14 days duration) whether caused by natural death or humane killing is 
studied (Stallard, 2006).  
Acute oral toxicity testing is required prior to clinical trials and results in 
relevant information for: (i) basic characterization of the toxic potential, (ii) early 
selection of suitable pharmacological substances, (iii) dose range finding, (iv) first 
evidence on target organs (Ukelis et al., 2008). Although the result does not explain the 
exact mechanism of toxicity observed, it does provide vital parameters for subsequent 
non-clinical and clinical studies.  
Specific PCR 
product 
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Animal models have overall a good predictability for human toxicities of 
around 70-80 %. However, they are still only a model and can lead to misleading 
results and not predictive of human toxicity in particular if species-species 
biotransformation determines toxicity (Kola and Landis, 2004; Olson et al., 2000). 
Toxic manifestations that affect the entire organism such as pain, distress, vital 
functions (cardiovascular, central nervous and respiratory system), allergic reactions, 
changes of outer appearance, behavioral alterations and general stimulation or sedation 
can be detected by in vivo assays. However, detection of effects on vital functions is 
usually not assessed in acute toxicity studies. Generally, it is possible to get first hints 
on these complex toxicities by applying in vivo methods, whereas information on vital 
functions cannot be assessed by in vitro cytotoxicity methods (Ukelis et al., 2008).   
The findings of this study corroborated the need for safety study on both 
Pereskia spp. used for primary health care in Malaysia. Such studies need to be carried 
out before continued widespread use of some species provokes long term and 
irreversible damages.  
 
LD50  
Traditionally, the aim of the acute oral toxicity study has been the estimation of 
the LD50. The LD50 value, defined as the statistically derived dose that, when 
administered in an acute toxicity test, is expected to cause death in 50 % of the treated 
animals in a given period, is currently the basis for toxicologic classification of 
chemicals. For a classical LD50 study, laboratory mice and rats are the species typically 
selected. Often both sexes must be used for regulatory purposes (Walum, 1998).   
Under the globally harmonized system of classification (GHS) (OECD, 1998), 
substances are assigned to classes 1-5, with substances in class 1 being the most toxic, 
according to their estimated LD50 values as shown in Table 2.3. Substances in class 5 
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are sometimes termed unclassified. The classification given affects restrictions on 
transportation and use of the substances, as well as how it must be labelled. Substances 
assigned to classes 1 and 2 are labelled fatal if swallowed, substances assigned to class 
3 are labelled toxic if swallowed and substances assigned to class 4 are labelled harmful 
if swallowed.  
Table 2.3: GHS acute oral toxicity classifications 
Class Range for estimated LD50 (mg/kg) 
1 LD50  ≤ 5 
2 5 < LD50 ≤ 50 
3 50 < LD50 ≤ 300 
4 300 < LD50 ≤ 2000 
5 2000 < LD50 
  
The absolute LD50 value for a compound varies among different laboratories, 
and these variations have been attributed to differences in e.g. protocols details, animal 
strains, caging and test-chemical source (Walum, 1998).  In particular, the necessity to 
determine a high statistical accuracy in the LD50 value has been questioned. Oliver 
(1986) made the points that (i) the LD50 value is not an absolute value but is an 
inherently variable biologic parameter that cannot be described in terms of accuracy but 
only of precision, (ii) the LD50 value refers only to mortality and is illustrative of no 
other clinical expression of toxicity.  
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Plant materials 
The fresh leaves of P. bleo and P. grandifolia were collected from Petaling Jaya, 
Selangor, Malaysia in September 2006 and February 2007 respectively. They were 
identified by Professor Dr. Halijah Ibrahim of Institute of Biological Sciences, Faculty 
of Science, University of Malaya, Malaysia and deposited in the herbarium of the 
Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala 
Lumpur, Malaysia with voucher numbers of SN01-06 (P. bleo) and SN01-07 (P. 
grandifolia).  
 
3.2 Extraction and fractionation of methanol extract of plant samples 
The fresh leaves of plant samples were washed, dried and ground using a 
blender to a fine powder. The dried, ground leaves were then soaked in methanol (1.5 L) 
for 3 days at room temperature. The solvent-containing extract was then decantered, 
dried with anhydrous sodium sulphate and filtered. The extraction of the ground leaves 
was further repeated (2x) with methanol (1.5 L each time). The filtrate from each 
extraction was combined and the excess solvent was evaporated under reduced pressure 
using a rotary evaporator to give a dark green crude methanol extract. Part of the 
methanol extract was further extracted with hexane to give a hexane-soluble extract and 
a hexane insoluble residue. The hexane-insoluble residue was further partitioned 
between ethyl acetate–water (1:1, 100 ml: 100 ml) to give an ethyl acetate-soluble 
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extract. The water layer was then freeze-dried to give a brown coloured water extract. 
The crude methanol extract and resulting extracts were then evaluated for their 
biological activities. The concentrations of extracts were prepared according to the 
requirements for each assay. 
  
3.3 Antioxidant activity  
3.3.1 Folin-Ciocalteu method 
 The reducing capacity of P. bleo and P. grandifolia extracts, expressed as gallic 
acid equivalents (GAEs), were measured according to the Folin-Ciocalteu method 
(Cheung et al., 2003; Singleton and Rossi, 1965).  
 
Preparation of gallic acid calibration plot 
  A calibration plot, using gallic acid with concentrations ranging from 25 to 
1000 mg/l was prepared. Gallic acid stock solutions in volumes ranging from 0.005 ml 
to 0.2 ml were pipetted out into test tubes. The final volume was made to 1 ml with 
methanol in each test tube. 0.02 ml of different concentrations of gallic acid solution 
and negative control (methanol was used instead of gallic acid) were mixed with 1.58 
ml of distilled water. 0.1 ml of Folin-Ciocalteu’s phenol reagent was added to each test 
tube. After 3 min, 0.3 ml of saturated sodium carbonate (Na2CO3) solution (~35 %) was 
added to the mixture. The reaction mixtures were incubated at 40 °C for 30 min. The 
blank contained only methanol. The absorbance was determined at 765 nm with a 
spectrophotometer. The gallic acid calibration plot was obtained by plotting the 
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absorbance against concentration of gallic acid (mg/l). Table 3.1 summarizes the 
preparation of different concentrations of gallic acid solution for calibration plot.  
 
Table 3.1: The preparation of different concentrations of gallic acid solution for 
calibration plot 
 
Gallic acid (mg/l) Gallic acid stock solution (ml) Methanol (ml) 
0 0.000 1.000 
25 0.005 0.995 
50 0.010 0.990 
75 0.015 0.985 
100 0.020 0.980 
150 0.030 0.970 
200 0.040 0.960 
250 0.050 0.950 
500 0.100 0.900 
1000 0.200 0.800 
 
Determination of reducing capacity in test extracts 
A stock extract in methanol was prepared at a concentration of 20 mg/ml. 0.02 
ml of extract with different concentrations (4, 8, 12, 16 and 20 mg/ml) and control 
(methanol was used instead of extract) were mixed with 1.58 ml of distilled water. The 
test extract was assayed according to the method described above. The blank contained 
only methanol. All extracts were assayed in triplicate. BHA (butylated hydroxyanisole) 
was used as positive reference standard in the study. 
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3.3.2 Scavenging activity on 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals 
The scavenging activity of the extracts of P. bleo and P. grandifolia on DPPH 
radicals was measured according to the method of Cheung et al. (2003) with some 
modification. Extracts with different concentrations and control (methanol was used 
instead of extract) were mixed with 0.8 % of DPPH solution. The reaction mixtures 
were incubated at room temperature and allowed to react for 30 min in the dark. All 
measurements were done in dim light. The optical density was measured at 520 nm 
with a spectrophotometer. Methanol was used as blank.  
The extracts were pre-screened for scavenging activity towards the stable DPPH 
radicals at concentrations of 1-5 mg/ml. Reaction mixtures of test extracts; DPPH and 
methanol for the assay were prepared according to the Table 3.2. For the IC50 value less 
than 1.0 mg/ml which was the lowest concentration in pre-screening test, the extract 
was subjected to further examinations on more intensive concentration (100-1000 
g/ml) by DPPH assay according to the Table 3.3.  
Ascorbic acid and BHA were used as positive reference standards. The standard 
plot, using positive reference standards with concentrations ranging from 1.56 to 
200.00 g/ml was prepared. Reaction mixtures of positive reference standards, DPPH 
and methanol for the assay were prepared according to the Table 3.4.  
The scavenging activity (%) on DPPH radical was calculated according to the 
following equation: 
 
 
Scavenging activity (%) = OD control – OD sample x 100 % 
     OD control  
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OD control was the absorbance of the control, and OD sample was the absorbance of 
the extract/standard. In this study, the scavenging activity was stated in the value of 
IC50. The IC50 value is the effective concentration of which DPPH radical was 
scavenged by 50 %. The IC50 values were estimated by a non linear regression 
algorithm and presented as the mean of triplicate analysis. Low IC50 value indicates 
strong ability of the extract to act as DPPH scavenger.  The higher the IC50 value 
indicates the lower the scavenging activity of the scavengers as more amount of the 
scavengers were required to achieve 50 % scavenging reaction and thus the scavengers 
are less effective in scavenging the DPPH radicals.  
 
Table 3.2: Preparation of reaction mixture of selected extracts or fractions, DPPH 
and methanol 
 
Concentration of 
extract (mg/ml) 
Volume of 
methanol (l) 
Volume of extract 
stock solution(l) 
Volume of DPPH 
solution (l) 
5 725 250 25.0 
4 775 200 25.0 
3 825 150 25.0 
2 875 100 25.0 
1 925 50 25.0 
Control 975 - 25.0 
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Table 3.3: Preparation of reaction mixture of selected extracts, DPPH and 
methanol 
 
Concentration of 
extract (g/ml) 
Volume of 
methanol (l) 
Volume of extract  
stock solution (l) 
Volume of DPPH 
solution (l) 
1000 925 50 25.0 
900 930 45 25.0 
800 935 40 25.0 
700 940 35 25.0 
600 945 30 25.0 
500 950 25 25.0 
400 955 20 25.0 
300 960 15 25.0 
200 965 10 25.0 
100 970 5 25.0 
Control 975 - 25.0 
 
 
Table 3.4: Reaction mixture of positive reference standards, DPPH and methanol 
for DPPH assay 
 
Concentration of 
positive reference 
standard (g/ml) 
Volume of 
methanol (l) 
Volume of 
positive reference 
standard  stock 
solution (l) 
Volume of DPPH 
solution (l) 
200.00 475.00 500.00 25.0 
100.00 725.00 250.00 25.0 
50.00 850.00 125.00 25.0 
25.00 912.50 62.50 25.0 
12.50 943.75 31.25 25.0 
6.25 959.38 15.63 25.0 
3.12 967.19 7.81 25.0 
1.56 971.09 3.91 25.0 
Control 975.00 - 25.0 
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3.3.3 Reducing power assay 
The reducing power of the prepared extracts was determined according to 
method of Oyaizu (1986). Briefly, each extract in varying amounts of 5 mg, 10 mg and 
20 mg was dissolved in 1.0 ml of distilled water to which was added 2.5 ml of 0.2 M 
phosphate buffer (pH 6.6) and 2.5 ml of 1 % (w/v) solution of potassium ferricyanide 
(Sigma). The mixture was incubated in a water bath at 50
0
C for 20 min. Following this, 
2.5 ml of 10 % (w/v) trichloroacetic acid solution was added and the mixture was then 
centrifuged at 1000 rpm for 10 min. A 2.5 ml aliquot of the upper layer was combined 
with 2.5 ml of distilled water and 0.5 ml of a 0.1 % (w/v) solution of ferric chloride. 
Absorbance of the reaction mixture was read spectrophotometrically at 700 nm. 
Increased absorbance of the reaction mixture indicates greater reducing power. Mean 
values from three independent samples were calculated for each extract. Ascorbic acid 
and BHA were used as positive reference standards. The higher absorbance of the 
reaction mixture indicates greater reducing power. The extracts that showed 
comparable absorbance readings with ascorbic acid and BHA are considered having 
high reducing power.  
 
3.3.4 ß-Carotene bleaching method  
The antioxidant activity of the prepared extracts was determined according to 
the ß-carotene bleaching method described by Cheung et al. (2003). A reagent mixture, 
containing 1 ml of ß-carotene solution (0.2 mg/ml in chloroform), 0.02 ml of linoleic 
acid and 0.2 ml of Tween 80 was pipette into a round-bottom flask. After removing the 
chloroform by using a rotary evaporator, 50 ml of oxygenated distilled water was then 
added to the flask. The mixture was stirred vigorously to form a liposome solution. 
74 
 
Aliquots (5 ml) of the liposome solution were transferred to a series of test tubes 
containing 0.2 ml of extract with different concentrations (4 to 20 mg/ml). Methanol or 
water (instead of extract) was used as control while the blank contained all the earlier 
chemicals (0.02 ml of linoleic acid and 0.2 ml of Tween 80 in 50 ml of oxygenated 
distilled water) except ß-carotene solution. The absorbance of each extract was 
measured immediately (t = 0 min) at 470 nm using a spectrophotometer. Subsequently, 
the reaction mixtures were incubated at 50°C. The absorbance was measured again at 
time intervals of 20 min for 2 h (t = 120 min). All samples were assayed in triplicate. 
BHA was used as positive reference standard in this assay.  
The rate of ß-carotene bleaching (R) was calculated according to equation as 
below:  
       
where: ln = natural log; a = absorbance at time 0; b = absorbance at time t, which t = 20, 
40, 60, 80, 100 or 120 min. The antioxidant activity (%) was calculated in terms of 
percent inhibition relative to the control, using the equation as below: 
 
 
 
3.3.5 Statistical analysis 
The antioxidant data were subjected to one-way analysis of variance (ANOVA) 
and the significance of the difference between the means was determined by the 
Duncan’s multiple range tests at 95 % least significant difference (p < 0.05).  
R = ln (a/b) 
 t 
Antioxidant activity (%) =        Rcontrol - Rsample   
     Rcontrol 
x 100 % 
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3.4 Antimicrobial activity 
3.4.1 Preparation of agar and broth  
Mueller Hinton agar  
38 g of Mueller Hinton agar was suspended in 1 litre of distilled water. The 
solution was boiled to dissolve the medium completely and sterilized by autoclaving for 
15 min at 15 psi, 121 °C. Subsequently, the medium was cooled to 45-50 °C and 
dispensed into petri dishes. Final pH should be 7.4 ± 0.2 at 37 °C. 
 
Mueller Hinton broth  
23 g of Mueller Hinton broth was suspended in 1 litre of distilled water. The 
solution was sterilized by autoclaving for 15 min at 15 psi, 121 °C. Final pH should be 
7.4 ± 0.2 at 37°C. 
 
3.4.2 Test microorganisms and microbial culture  
Four bacterial strains were used in this study: Gram negative bacteria included 
Escherichia coli, Pseudomonas aeruginosa and Gram positive bacteria included 
Staphylococcus aureus, Bacillus subtilis. These test microorganisms were obtained 
from the Microbiology Laboratory, Microbiology Division, Institute of Biological 
Sciences, Faculty of Science, University of Malaya, Malaysia. Bacterial strains were 
cultivated at 37±2 °C and maintained on nutrient agar (Difco, USA) slant at 4±2 °C.  
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3.4.3 Agar disc diffusion assay 
Preparation of test discs 
The crude methanol and fractionated extracts (hexane and ethyl acetate) were 
dissolved in 10 % aqueous DMSO (not toxic to germs at this percentage (Berahou et al., 
2007) and the water extracts were dissolved in distilled water to two different 
concentrations of 50 and 500 mg/ml. The extract solutions were then sterilized by 
filtration through a 0.45 µm membrane filter. The sterile discs (6 mm in diameter) were 
impregnated with 10 µl of the extracts (50 and 500 µg/disc). Negative controls were 
prepared using discs impregnated with 10 % aqueous DMSO (solvent control) and 
virgin discs (blank control). Standard discs of the antibiotic gentamycin (10 g) and 
ampicilin (10 g) were used as the positive antibacterial controls for all bacterial strains. 
 
Preparation of inocula 
 The inocula of bacterial strains were prepared from 18 hour-old culture and 
suspensions were adjusted to 0.5 McFarland standard turbidity [~10
6
 colony forming 
units (CFU) per millilitre] using McFarland Nephelometer standard according to the 
National Committee for Clinical Laboratory Standards (Ezoubeiri et al., 2005).  
 
Procedure of agar disc diffusion assay 
 Antimicrobial activity was determined against four bacterial pathogens 
according to agar disc diffusion assay of Berahou et al. (2007) and National 
Committee for Clinical Laboratory Standards (2005), with some modifications. Petri 
plates were prepared by pouring 20 ml of Mueller Hinton agar. The inoculum was 
spread on the top of the solidified media, using sterile swab to ensure thorough 
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coverage of the plates and a uniform thick lawn of growth following incubation. The 
plates were then allowed to dry for 10 min to facilitate absorption of the broth into the 
agar. The discs were placed on the surface of the inoculated agar and the plates were 
left 30 min at room temperature to allow the diffusion of the extract before their 
incubation for 24 h at 37±2 °C.  
The antibacterial activity was evaluated by measuring the zone of complete 
growth inhibition surrounding the discs (Figure 3.1). The diameters of inhibition zones 
were measured in millimetres using Vernier Calipers. The diameter of inhibition zones 
reported here including the diameter of the disc (6 mm). All tests were repeated thrice 
to minimize test error.  An inhibition zone of 14 mm or greater (including diameter of 
the disc) was considered as high antibacterial activity (Ramzi and Ulrike, 2005).       
 
 
 
 
 
Figure 3.1: Example of the agar disc diffusion assay. The diameters of inhibition 
zones (including the diameter of the disc) were measured in millimetres. 
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3.4.4 Broth dilution assay 
 The minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of the extracts were determined by broth dilution assay according 
to the method of Furiga et al. (2009) with some modifications.   
 
Determination of minimum inhibitory concentration (MIC) 
Briefly, bacterial strains were cultured overnight on Mueller Hinton broth and 
adjusted to a final density of 0.5 McFarland standard turbidity (~10
6
 colony forming 
units (CFU) per millilitre) using McFarland Nephelometer standard according to the 
National Committee for Clinical Laboratory Standards. Then, the cultures were 
inoculated into tubes containing extract dilutions to obtain the following final 
concentration: 10, 20, 30, 40 and 50 mg/ml for each tested extracts and incubated at 37 
°C for 24 h. Blank control was prepared by virgin media. Each MIC experiment was 
repeated three times. Inhibition of bacterial growth in the test tubes containing tested 
extracts was judged by comparison with growth in blank control plates. The MIC was 
defined as the lowest concentration which no visible growth was observed. Extracts 
with MIC values < 10 mg/ml were considered active.  
 
Determination of minimum bactericidal concentration (MBC) 
 For MBC determination, an aliquot (10 µl) from each tubes of tested extracts 
and controls in MIC determination was cultured onto Mueller Hinton agar plates after 
incubation to determine if the inhibition was reversible or permanent. The plates were 
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then incubated at 37 °C for 24 h. Each MIC experiment was repeated three times. 
Blank control was prepared by virgin media. The MBC was defined as the lowest 
concentration of tested extracts that did not permit any visible growth after the 
incubation period.  
 
3.4.5 Statistical analysis 
All samples were prepared in triplicate for comparison of values. All data were 
recorded as means ± standard deviation. Statistical analysis was carried out with 
Microsoft excel.  
 
3.5. In vitro cytotoxicity assay 
3.5.1 Cell lines and culture medium 
Human nasopharyngeal epidermoid carcinoma cell line (KB), human cervical 
carcinoma cell line (CasKi), human colon carcinoma cell line (HCT 116), hormone-
dependent breast carcinoma cell line (MCF7), human lung carcinoma cell line (A549) 
and non-cancer human fibroblast cell line (MRC-5) were purchased from the American 
Tissue Culture Collection (ATCC, USA). The viability of the cells was checked before 
and after treatment by the trypan blue exclusion dye method. Frozen cell stocks were 
stored in liquid nitrogen (-196 °C) prior to use.  
KB cells were maintained in Medium 199 (Sigma); CasKi, A549 and MCF7 
cells in RPMI 1640 medium (Sigma); HCT 116 in McCOY’S 5A Medium (Sigma) and 
MRC-5 cells in EMEM (Eagle Minimum Essential Medium) (Sigma), supplemented 
80 
 
with 10% foetal bovine serum (FBS, PAA Lab, Austria), 100 µg/ml penicillin or 
streptomycin (PAA Lab, Austria) and 50 µg/ml of fungizone (PAA Lab, Austria) 
(Appendix A, no.1). The cells were cultured in a 5 % CO2 incubator (Shel Lab water-
jacketed) kept at 37 °C in a humidified atmosphere. The culture was subcultured every 
two to three days as needed and routinely checked under an inverted microscope (IMT-
2 Olympus, Japan) for any contamination (Appendix A, no.4).  
 
3.5.2 In vitro neutral red cytotoxicity assay 
The neutral red cytotoxicity assay is based on the initial protocol described by 
Borenfreund and Puerner (1984) with some modifications and it determines the 
accumulation of the neutral red dye in the lysosomes of viable and uninjured cells.  
Briefly, cells were detached from the tissue culture flask with 0.25 % trypsin-
EDTA solution and PBS solution and washed in culture medium. The cell pellet was 
obtained by centrifugation at 1000 rpm for 5 min. The density of the viable cells was 
counted by 0.4 % of tryphan blue (Appendix A, no.2) exclusion in a haemocytometer. 
The cells (1x10
4
/well) were then plated in a 96-well microtiter plate (Nunc) in a volume 
of 190 µl. The plate was incubated in a CO2 incubator at 37 °C for 24 h to allow the 
cells to adhere and achieve 60-70 % confluence at the time of the addition of the test 
agents (i.e. test extracts and test compounds). After 24 h of incubation, the cells were 
treated with different concentrations (1, 10, 50 and 100 µg/ml) of each test agents in 
three replicate tests. The plates were incubated for 72 h at 37 °C in a 5 % CO2 incubator. 
DMSO was used to dilute the test agents and the final concentration of DMSO in test 
wells and control wells used was not in excess of 1 % (v/v). No effect due to the 
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DMSO was observed. Doxorubicin was used as the positive control. The well 
containing untreated cells is the negative control.  
At the end of the incubation period, the media were replaced with medium 
containing 50 µg/ml neutral red. The plates were incubated for another 3 h to allow for 
uptake of the vital dye into the lysosomes of viable and uninjured cells. After the 
incubation period, the media were removed and cells were washed with the neutral red 
washing solution. The dye was eluted from the cells by adding 200 µl of neutral red 
resorb solution and further incubated for 30 min at room temperature with rapid 
agitation on a microtiter plate shaker (LT BioMax 500). Dye absorbance was measured 
at 540 nm using ELISA reader (Titertek Multiskan MCC/340). Three replicate plates 
were used to determine the cytotoxicity activity of each test agent.  The cytotoxic effect 
of each test agent was evaluated based on percentage inhibition values.  
The percentage of inhibition (%) of was calculated according to the following 
formula: 
 
The average of three replicates was then obtained. Cytotoxicity of each test 
agent is expressed as IC50 value. The IC50 value is the concentration of test agents that 
cause 50 % inhibition or cell death, averaged from the three experiments, and was 
obtained by plotting the percentage inhibition versus concentration of test agents. 
According to US NCI (United States National Cancer Institute) plant screening 
program, a plant extract is generally considered to have active cytotoxic effect if the 
IC50 value, following incubation between 48 to 72 h, is 20 μg/ml or less, while it is 4 
μg/ml or less for pure compounds (Lee and Houghton, 2005; Geran et al., 1972). 
 
Percentage of inhibition (%) = OD control – OD sample x 100% 
OD control  
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3.5.3 Statistical analysis 
All samples were prepared in triplicate for comparison of values. All data were 
recorded as means ± standard deviation. Statistical analysis was carried out with 
Microsoft excel.  
 
3.6 Detection of DNA fragmentation (apoptosis) 
Cell culture and maintenance of cell were described in Appendix A (no.4). 
DNA fragmentation was detected using DeadEnd
TM
 Colorimetric Apoptosis Detection 
System as described by the manufacturer (Promega). Briefly, cells (5x10
5 
cells/ml) 
were subcultured into 24 well plates and incubated for 12-24 h to allow the cells to 
adhere. When the cells reached confluency between 60-70 %, the medium was replaced 
with fresh medium.  Subsequently, the cells were stimulated with the tested extract or 
compound at concentration required for 50 % inhibition growth of cancer cells (refer to 
section 4.4.3 and 4.9) for 24 h. Only extracts or compounds which were active in 
cytotoxic activity were further evaluated for detection of DNA fragmentation. Control 
cells were treated with the same final concentration of DMSO present in the treated 
wells. Positive control cells were treated with DNase I.  
After stimulation, the cells were fixed with 4 % (w/v) paraformaldehyde in PBS 
(pH 7.4) for 25 min at room temperature and rinsed twice with PBS. Then, the cells 
were immersed in 0.2 % (v/v) Triton X-100 solution for 5 min and rinsed with PBS. 
The cells were then incubated in 100 μl equilibration buffer (supplied with the kit) for 
5–10 min. Subsequently, 100 μl of reaction buffer containing TdT enzyme and 
biotinylated nucleotide mix was added to the cells, covered with coverslips and 
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incubated for 1 h at 37 °C. The reaction was terminated with by immersing the slide in 
2× SSC for 15 min followed by washing with PBS and 0.3 % (v/v) hydrogen peroxide 
for 5 min. The slides were then incubated with 100 μl sterptavidin HRP solution for 
30 min, rinsed with PBS and finally incubated with DAB components until a light 
brown background developed. The stained cells were immediately observed under the 
light microscope. Using this procedure, apoptotic nuclei were stained dark brown. 
Example of the induction of apoptosis by the DNase I (positive control) and DMSO 
(negative control) are showed in Figure 3.2.     
 
 
 
   (A)     (B) 
 
Figure 3.2: Induction of apoptosis by the DNase I and DMSO on the KB cells. KB 
cells were treated with DNase I (positive control, A) and DMSO (negative control, 
B) for 24 hrs and subjected to DeadEnd
TM 
Colorimetric Apoptosis Detection 
System (Promega). Dark stained nuclei (arrows) of the KB cells were observed 
after cell treatment with DNase I whereas no stained nucleus in cells treated with 
DMSO was detected. A-B: 400x magnification. 
 
3.7 Determination of the expression level of apoptotic-related genes 
The mRNA expression levels of widely established apoptotic-related genes, i.e. 
p53, caspase-3 and c-myc were carried out by real-time reverse transcriptase-
polymerase chain reaction (RT-qPCR) using LUX (Light Upon eXtension) primers. 
The assay was started with preparation of quantitative standard (QSTD) (section 3.7.1), 
followed by validation and optimization of qPCR assay using LUX primers (section 
3.7.2) and application of optimized qPCR assay to experiment set (section 3.7.3).  
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3.7.1 Preparation of quantitative standard (QSTD) for real-time quantification 
 The quantitative standards (QSTD) of widely established apoptotic-related 
genes (p53, caspase-3, c-myc) and ß-actin were prepared by using one-step RT-PCR. 
These QSTD were used as DNA templates for optimization of RT-qPCR and also to 
prepare standard curve for the RT-qPCR assay after further diluted in 10-fold with 
diethyl pyrocarbonate (DEPC) treated water. The inclusion of standard curve on every 
run is an important control to measurement.  
 
Cell culture  
Cell culture and maintenance of cell were described in Appendix A (no.4). 
Briefly, untreated cells (1x10
6 
cells/well) were sub-cultured into 24 well plates and 
incubated for 4 h before RNA extraction.  
 
RNA extraction  
 For QSTD preparation, total cellular RNA was isolated from the untreated cells 
using RNeasy minikit (Qiagen) according to manufacturer’s protocol. Briefly, the cells 
were trypsinized and collected as a cell pellet in a 1.5 ml microcentrifuge tube prior to 
lysis. The cell pellet was loosened thoroughly by flicking the tube. 350 µl of Buffer 
RLT was added to the cell pellet and mixed by pulse-vortexing for 15 seconds. RNA 
was precipitated by adding 1 volume (350 µl) of 70 % ethanol (molecular grade) to cell 
lysate and mixed well gently by pipetting. 700 µl of the solution was then transferred to 
an RNeasy spin column placed in a 2 ml collection tube (supplied) and centrifuge at 
10000 rpm for 15 seconds (the flow-through was discarded after centrifuge). 
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Subsequently, 700 µl of Buffer RW1 was added to the RNeasy spin column and 
centrifuge at 10000 rpm for 15 seconds to wash the spin column membrane (the flow-
through was discarded after centrifuge). Then, 500 µl of Buffer RPE was added to the 
RNeasy spin column and centrifuge at 10000 rpm for 15 seconds (the flow-through was 
discarded after centrifuge). This step was repeated with the longer centrifuge time (2 
min). This long centrifugation dried the spin column membrane, ensuring that no 
ethanol was carried over during RNA elution as residual ethanol might interfered with 
downstream reactions. After centrifugation, the RNeasy spin column was carefully 
removed from the collection tube so that the column did not contact with the flow 
through to prevent the carryover of ethanol. The RNeasy spin column was placed in a 
new 2 ml collection tube and centrifuge at full speed (~14 000 rpm) for 1 min. This is 
to eliminate any possible carryover of Buffer RPE. Finally, the RNeasy spin column 
was placed in a new 1.5 ml collection tube (DNase/RNase free) and 50 µl of RNase 
free water was added directly to the spin column membrane. The spin column and the 
collection tube were then centrifuge at 10000 rpm for 1 min to elute the RNA. The 
eluted RNA was then stored in -70 °C till used.   
 
Determination of nucleic acid concentrations 
Nucleic acid quality encompasses both its purity (absence of protein and DNA 
contamination, absence of inhibitors) and its integrity. The concentration of extracted 
nucleic acid was determined by measuring the absorbance using a spectrophotometer 
(Eppendorf BioPhotometer plus). The quantity of the nucleic acid was determined at a 
wavelength of 260 nm.  
The quality of RNA is very important for the reproducibility and biological 
relevance of the subsequent quantitative real-time PCR (qPCR). The ratio between the 
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absorbance values at 260 and 280 nm (A260/A280) provided an estimate of the purity of 
RNA with respect to contaminants that absorb in the spectrum, such as protein. The 
pure RNA has an A260/A280 ratio of 1.9-2.1.  
 
One step RT-PCR 
 The extracted RNA was reversed transcribed into cDNA and used as the 
template for PCR amplification with OneStep RT-PCR kit (Qiagen). Briefly, the RT-
PCR was carried out in a final volume of 20 µl containing 1x PCR Buffer (with MgCl2), 
400 µM of each dNTP, 0.25 µM of each primer, OneStep RT-PCR enzyme mix, 1 µg 
of RNA template and appropriate volume of RNase-free water. The preparation of 
master mix for RT-PCR is shown in Table 3.5.  
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Table 3.5: Reaction components for one-step RT-PCR 
 
Component  Volume/reaction (µl) Final 
concentration 
Master mix 
5x QIAGEN OneStep RT-PCR Buffer*  
 
4 
 
1x 
dNTP Mix  
(containing 10 mM of each dNTP) 
0.8 400 µM of each 
dNTP 
 
Primer mix (10 µM )** 0.5 0.25 µM of each 
primer 
 
QIAGEN OneStep RT-PCR Enzyme 
Mix 
 
1 - 
RNase-free water 
 
11.7 - 
Template RNA 5 Approximately 
1 µg/reaction 
Total volume  20 - 
*Contains 12.5 mM MgCl2  
**Primer mix was prepared by mixing each forward and reverse primer with 
appropriate volume of DEPC treated distilled water and dissolving the lyophilized 
pellet in tube by vortexing followed by a brief spin.  
 
The thermal cycling profile of RT-PCR assay consisted of 30 min reverse 
transcription (RT) step performed at 50 °C, 15 min of initial PCR activation step (Taq 
polymerase activation) at 95 °C, followed by 40 cycles of PCR at 95 °C denaturation 
for 30 seconds, 50 °C of annealing for 40 seconds and 72 °C extension for 1 min, and 
terminated with an additional extension step for 5 min at 72 °C. The RT-PCR was 
performed in LabCycler 96-well Gradient Thermalcycler (SensoQuest). The thermal 
cycling profile is outlined in Table 3.6.  
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Table 3.6: Thermal cycling profile of one-step RT-PCR 
 
Step  
Reverse transcription  50 
o
C    30 min 
Initial PCR activation step       95 
o
C    15 min 
3step cycling:  
Denaturation 95
 o
C    30 s 
Annealing  50
 o
C    40 s 
Extension  72
 o
C    1 min         
Number of cycle 40 
Final extension 72
 o
C    5 min 
Indefinite 4
 o
C  
 
The oligonucleotide sequences of the PCR primers used herein were designed 
based on the human mRNA encoding the respective genes (Table 3.7). The PCR 
products were analyzed by gel electrophoresis. 5 µl aliquot of the 20 µl PCR product 
was loaded to a 1.25 % (w/v) agarose gel (Sea Kem LE agarose) in 1X TBE buffer with 
a 100-bp ladder as molecular weight marker. The results were scored as positive or 
negative by the presence or absence of a band. 
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Table 3.7: The sequence of primers used in RT-PCR for preparation of QSTD 
 
Primer Strand Sequence GC % Tm  Reference  
p53  Forward TGT GGA GTA TTT GGA TGA CA 40 50.3 Tan et al., 2005 
p53  Reverse GAA CAT GAG TTT TTT ATG GC                  35 47.5  
Caspase-3  Forward TCA CAG CAA AAG GAG CAG TTT                 42.9 54.9 Tan et al., 2005 
Caspase-3  Reverse CGT CAA AGG AAA AGG ACT CAA 42.9 52.7  
c-myc  Forward GAA CAA GAA GAT GAG GAA GA                  40 48.7 Tan et al., 2005 
c-myc  Reverse AGT TTG TGT TTC AAC TGT TC                  35 49.0  
ß-Actin  Forward TCA CCC TGA AGT ACC CCA TC                  55 54.7 Tan et al., 2005 
ß-Actin  Reverse CCA TCT CTT GCT GCA AGT CC                  55 55.4  
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Specificity test of primer 
 Before further proceed to PCR product purification, specificity of the primers 
need to be confirmed. The PCR products were checked for undesired or unspecific 
sequences. Primer specificity was evaluated by performing PCR with single set of 
primers against the QSTD for each gene (i.e. p53, caspase-3, c-myc and ß-actin). The 
PCR was carried out as the 3 step cycling profile described in Table 3.6. The PCR 
products were analyzed by gel electrophoresis. 5 µl aliquot of the 20 µl PCR product 
was loaded to a 1.25 % (w/v) agarose gel (Sea Kem LE agarose) in 1X TBE buffer with 
a 100-bp ladder as molecular weight marker. The results were scored as positive or 
negative by the presence or absence of a band.  
 
PCR product purification  
 The PCR product was purified using simple ethanol precipitation method. 
Firstly, 1 ml of cold absolute ethanol (molecular grade) was added to the PCR product 
and mixed well gently by pipetting. Subsequently, the tube contained the solution was 
centrifuge at full speed (approximately 14 000 rpm) for 15 min and a pellet was 
precipitated at the bottom of the tube after centrifuge. The flow-through was discarded 
gently after centrifuge. The pellet was then washed twice with 70 % ethanol (molecular 
grade). Lastly, the pellet was air-dried and dissolved in 50 µl RNase-free water. 
 Actually, there are many alternative protocols (e.g., Qiagen columns, Microcon 
filters). However, this is the cheapest and most reliable protocol.  
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Quantification of DNA 
The concentration of purified PCR product was determined by measuring the 
absorbance using a spectrophotometer (Eppendorf BioPhotometer plus). The ratio 
between the absorbance values at 260 and 280 nm (A260/A280) provided an estimation of 
the purity of DNA with respect to contaminants that absorb in the spectrum, such as 
protein. The pure DNA has an A260/A280 ratio of 1.8. The QSTD were stored in -70 °C 
till used.   
From the reading of spectrophotometer (µg/ml or ng/µl), the copy numbers of 
the QSTD for each genes (i.e. p53, caspase-3, c-myc and ß-actin) were calculated using 
the following equation: 
 
 
 
The 6.023 x 10
23 
is the number of copies per mole while 640 is a constant for dsDNA.  
These copy numbers were important for preparation of standard curve in qPCR 
assay. Series of 10-fold dilutions of QSTD were later being prepared using DEPC 
treated water and the template was ranging from 10
3
 to 10
10
. These dilutions were 
amplified with qPCR according to the procedure stated in ‘Amplification of qPCR’ 
under section 3.7.2. Linear regression equations for obtained Ct values were calculated.  
 
3.7.2 Validation and optimization of qPCR assay using LUX primers  
 The PCR method used for preparation of QSTD was adapted to real-time format 
by using LUX primers (Invitrogen), Platinum Taq DNA polymerase (Invitrogen) and 
dNTP mix (Promega). The qPCR assays were performed in Rotor-Gene 6000 
Number of copies/µl = DNA concentration (g/µl) x 6.023 x 10
23
 
PCR product length (bp) x 640 
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(Corbette). For the optimization of the qPCR assay, QSTD prepared in section 3.7.1 
was used as DNA template.  
 
LUX primers 
 The sequences of the fluorogenic forward primer and the corresponding 
unlabeled reverse primer were designed and ordered using proprietary software called 
D-LUX Designer (Invitrogen, http://www.invitrogen.com/lux). The characteristics of 
the LUX primers, such as length and Tm, are included in the primer designed by the 
software to output primer pairs that are located throughout the target (input) sequence. 
The sequences of the primers were checked using the NCBI Blast software.   
Each fluorogenic LUX primer is labelled with one of two reporter dyes, either 
FAM (6-carboxy-fluorescein) or JOE (6-carboxy-4’,5’-dichloro-2’,7’-dimethoxy-
flurescein). In the present study, FAM-labelled primer set was used to detect genes of 
interest (p53, caspase-3 and c-myc) while a JOE-labelled primer set was used to detect 
a housekeeping gene (ß-actin) as an internal control. The sequence of LUX primers 
used in the present qRT-PCR study is shown in Table 3.8.  
 
 
 
 
 
 
93 
 
Table 3.8: The sequence of LUX primers used in qPCR 
 
Primer Strand Sequence Dye label GC % Tm Amplicon length 
p53  Reverse cgagcGTGTTGTTGGGCAGTGCTcG  FAM 60 67.55 84 
p53  Forward AAGAGAATCTCCGCAAGAAAGG 45.45 61.18 
Caspase-3  Forward cggcTAAAATACCAGTGGAGGCcG   FAM 50 62.12 84 
Caspase-3  Reverse CATCCTTTGAATTTCGCCAAGA  40.91 63.44 
c-myc  Forward cgccGAGGAGAATGTCAAGAGGcG  FAM 55 62.29 96 
c-myc  Reverse ATCTGGTCACGCAGGGCAAA  55 66.23  
ß-Actin  Reverse cgtaccCATCACGATGCCAGTGGTAcG  JOE 57.14 67.07 68 
ß-Actin  Forward ACGTTGCTATCCAGGCTGTGC 57.14 64.78 
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Amplification by qPCR 
Briefly, the qPCR assay was carried out in a final volume of 10 µl. A master 
reagent mix that contained all the components required for qPCR except the template 
DNA was prepared according to the number of reactions desired (included samples, 
non-reverse-transcriptase control (NRTC) and non-template control (NTC). The master 
mix was then divided into portions of 8 µl in a 0.1 ml strip tube (Corbette). Lastly, 2 µl 
of nucleic acid (DNA) template was added into each tube. The preparation of master 
mix for qPCR is shown in Table 3.9 while the thermal cycling profile is outlined in 
Table 3.10. 
 
Table 3.9: Reaction components for qPCR 
Component  Volume / reaction (µl) Final concentration 
Master mix 
10x PCR Buffer*  
 
1 
 
1x 
dNTP Mix  
(containing 10 mM of each dNTP) 
0.5 500 µM of each 
dNTP 
 
LUX primer mix** 1.5 0.3 µM 
 
Platinum Taq DNA polymerase 0.15 - 
 
MgCl2 (20 mM) 1.5 3.0 mM 
 
RNase-free water 3.35 - 
 
Template DNA 2 - 
Total volume  10 - 
* Without MgCl2 
**LUX primer mix was prepared by mixing forward and reverse primer with 
appropriate volume of DEPC treated distilled water and dissolving the lyophilized 
pellet in tube by vortexing followed by a brief spin.  
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Table 3.10: Thermal cycling and melting profile of qPCR 
3step cycling:  
Denaturation 95
 o
C    15 s 
Annealing  55
 o
C    15 s 
Extension  72
 o
C    20 s         
Number of cycle 35 
Melting condition:   
Ramp from 72 
o
C to 95
 o
C  
Rising by 1 
o
C each step   
Wait for 90 s of pre-melt conditioning on first step   
Wait for 5 s for each step afterwards  
 
Melting curve analysis 
Melting curve analysis was performed after the thermo cycling of qPCR 
amplification to identify the presence of primer dimmers and analyze the specificity of 
the reaction. In the present study, melting curve analysis was programmed to hold 90 
seconds of pre-melt conditioning on first step, ramp from 72 
o
C to 95 
o
C and rising by 1 
o
C each step. All amplicon for a particular primer pair should have the same Tm 
(melting temperature), unless there are contamination, mispriming or primer dimmers 
artefacts. The melting profile of qPCR is outlined in Table 3.10. 
 
Controls 
 Two types of negative controls were used in the present study, which were: i) 
non-reverse-transcriptase control (NRTC), which is a minus reverse-transcriptase 
control (or "No Amplification Control") that containing the master mix reagents and the 
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RNA template without reverse transcriptase procedure. ii) non-template control (NTC), 
which NTC includes all of the RT-PCR reagents except the DNA/RNA template. Both 
NRTC and NTC were used during the entire assay development and assay evaluation.  
 
Validation and optimization of the LUX RT-qPCR assay 
(i) Specificity test of primer 
The specificity of each LUX primers (p53, caspase-3, c-myc and ß-actin) was 
assessed against the purified DNA of QSTD of each gene (p53, caspase-3, c-myc and 
ß-actin), to confirm that each set of primers amplified only the specific genome. The 
DNA-primer mix preparation is shown in Table 3.11, the preparation of master mix for 
primer specificity test is shown in Table 3.12 while the thermal cycling profile is 
outlined in Table 3.10. 
 
Table 3.11: DNA-primer mix preparation for optimization assay 
       QSTD 
Primer  
c-myc p53 caspase-3 ß-actin 
c-myc A B C D 
p53 E F G H 
caspase-3 I J K L 
ß-actin M N O P 
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Table 3.12: Reaction components for qPCR 
Component  Volume / reaction (µl) Final concentration 
Master mix 
10x PCR Buffer*  
 
1 
 
1x 
dNTP Mix  
(containing 10 mM of each dNTP) 
0.5 500 µM of each 
dNTP 
 
Platinum Taq DNA polymerase 0.15 - 
MgCl2 (20 mM) 1.5 3.0 mM 
RNase-free water 3.35 - 
Template DNA-LUX primer mix** 
(A-P in Table 3.11) 
 
3.5 - 
Total volume  10 - 
*Without MgCl2 
**LUX primer mix was prepared by mixing forward and reverse primer with 
appropriate volume of DEPC treated distilled water and dissolving the lyophilized 
pellet in tube by vortexing followed by a brief spin.  
 
(ii) Optimization of the concentrations of LUX primers and MgCl2  
The optimization were performed by using a matrix of concentrations of each 
LUX primer mix and concentrations of the MgCl2 (Table 3.13) to determine the 
optimal concentrations of LUX primer and MgCl2 yielding the lowest Ct values, hence, 
the highest amplification efficiencies. The matrix of primer-MgCl2 mix is shown in the 
Table 3.13, the preparation of master mix for primer specificity test is shown in Table 
3.14 while the thermal cycling profile is outlined in Table 3.10. 
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Table 3.13: Concentrations of Primer-MgCl2 mix for optimization assay 
             [MgCl2]  (mM) 
[Primer] (uM) 
6.0 4.5 3.0 1.5 
0.3 A B C D 
0.5 E F G H 
0.6 I J K L 
 
Table 3.14: Reaction components for qPCR 
Component  Volume / reaction (µl) Final concentration 
Master mix 
10x PCR Buffer*  
 
1 
 
1x 
dNTP Mix  
(containing 10 mM of each dNTP) 
0.5 500 µM of each 
dNTP 
 
Platinum Taq DNA polymerase 0.15 - 
RNase-free water 3.35 - 
MgCl2-LUX primer mix** 
(A-L in Table 3.13) 
 
3 - 
Template DNA 2  
Total volume  10 - 
*Without MgCl2 
**LUX primer mix was prepared by mixing forward and reverse primer with 
appropriate volume of DEPC treated distilled water and dissolving the lyophilized 
pellet in tube by vortexing followed by a brief spin.  
 
 
 
 
99 
 
(iii) Optimization of the annealing temperature (TA) 
The optimization of TA was carried out as described in ‘Amplification by qPCR’ 
under section 3.7.2, except the TA in the thermal cycling profile. Three different TA 
were tested, which were 50 °C, 55 °C and 60 °C.   
 
Determination of the lowest detection limit and sensitivity of the LUX RT-qPCR 
assay 
 The detection limit and sensitivity of the LUX qPCR assay was assessed by 
determining the Ct values of serial 10-fold dilutions of purified QSTD, covering the 
range between 10
3
 and 10
10 
copies. Standard curves prepared with these dilutions were 
used in every experiment of each gene.   
  
3.7.3 Application of optimized qPCR assay to experiment set  
The qPCR assay which has been optimized (section 3.7.2) was applied to the 
experiment set in the present study. The mRNA expression levels of the apoptotic-
related genes, i.e. p53, caspase-3 and c-myc in extract-treated cells were carried out 
using the two-step RT-qPCR. The mRNA level of ß-actin was used as internal control 
for template levels. Only extracts or compounds which were active in cytotoxic activity 
and detected with DNA fragmentation were tested in the gene expression study. 
This present two-step RT-qPCR assay used RNA which was isolated from the 
extract-treated cells using RNeasy minikit (Qiagen) at 6 time points as starting material 
in a reverse transcription reaction to generate first-strand cDNA with Sensiscript 
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Reverse Transcriptase kit (Qiagen). The cDNA was then quantified in separate qPCR 
amplification.  
   
Cell culture  
Cell culture and maintenance of cell were described in Appendix A (no.4). 
Briefly, cells (1x10
6 
cells/well) were sub-cultured into 24 well plates and incubated for 
4 h before stimulation. Concentration of tested extracts needed to achieve 50 % growth 
inhibition was used to stimulate the cells over the period of 6 h at 6 time points, which 
were 0 h (control), 15 min, 30 min, 1 h, 3 h and 6 h. Only extracts or compounds which 
were active in cytotoxic activity and detected with DNA fragmentation were tested in 
the gene expression study.  
 
RNA extraction  
 Total cellular RNA from the treated cells was extracted using RNeasy minikit 
(Qiagen) according to manufacturer’s protocol at 6 time points, which were 0 h 
(control), 15 min, 30 min, 1 h, 3 h and 6 h. The extracted RNAs were then quantified 
using a spectrophotometer (Eppendorf BioPhotometer plus) as mentioned in 
‘Quantification of DNA’ under section 3.7.1. 
 
cDNA synthesis  
 To achieve comparable reaction efficiency for the reverse transcription reaction 
and therefore to allow the direct comparison of mRNA concentrations from different 
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time points of the samples, the RNA templates were standardized to contain the same 
amount of total RNA before reverse transcription. 50 ng of RNA template was reversed 
transcript into cDNA using Sensiscript Reverse Transcriptase kit (Qiagen) according to 
manufacturer’s protocol. Briefly, PCR was carried out in a final volume of 20 µl 
containing 1x Buffer RT, 0.5 mM of each dNTP, 1 µM of Oligo-dT primer, Sensiscript 
reverse transcriptase and appropriate volume of RNase-free water. The preparation of 
master mix for RT-PCR is shown in Table 3.15.  
 
Table 3.15: Reaction components for cDNA synthesis 
Component  Volume / reaction (µl) Final concentration 
Master mix 
10x Buffer RT 
 
2 
 
1x 
dNTP Mix  
(containing 5 mM of each dNTP) 
2 0.5 mM of each  
dNTP 
 
Oligo-dT primer (10 µM )* 2 1 µM  
Sensiscript reverse transcriptase 1 - 
RNase-free water 11 - 
Template RNA 2 50 ng/reaction 
Total volume  20 - 
*the Oligo-dT primer (Qiagen) was not provided in kit.  
 
The cDNA synthesis step was performed in LabCycler 96-well Gradient 
Thermalcycler (SensoQuest). The synthesis profile consisted of 60 min incubation at 
37 °C and inactivation of Sensiscript reverse transcriptase at 93 °C for 5 min, followed 
by rapid cooling on ice.  
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qPCR amplification  
 The PCR amplification was performed in a total volume of 10 µl as described in 
section 3.7.2. Briefly, the master reagent mix that contained all the components 
required for qPCR except the template DNA was prepared according to the number of 
reactions desired (included samples, standards, non-reverse-transcriptase control 
[NRTC] and non-template control [NTC]). The master mix was then divided into 
portions of 8 µl in a 0.1 ml strip tube (Corbette). Lastly, 2 µl of nucleic acid (DNA) 
template was added into each tube. The preparation of master mix for qPCR is shown 
in Table 3.9. The series of 10-fold dilutions of QSTD were used to prepare the standard 
curve.  
Thus, every qPCR assay of each extract (or compound tested) for each gene 
needed 42 reactions for every run, which included 6 unknowns (cDNAs of samples at 6 
time points), 8 QSTD template control (to prepare standard curve), 6 NRTC (non-RT 
controls for the samples at 6 time points) and 1 NTC. All reactions were performed in 
duplicates.      
 Lastly, the data was analyzed with Rotor-Gene 6000 (Corbette) software. The 
results of samples were projected on the standard curve generated with series dilution 
of QSTD.  
 
3.7.4 Statistical analysis 
In the present study, relative quantitation using two standard curves method (or 
relative fold change method) was used to quantitate alterations in mRNA levels using 
RT-qPCR. The ß-actin used as internal control was compared to a gene of interest (p53, 
caspase-3 or c-myc) for every sample at 6 time points. A sample (at every time point) 
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therefore has to be analyzed twice, firstly with the gene of interest and secondly with 
the internal control. Two standard curves have to be run to obtain two values (internal 
control and gene of interest) for the one sample.   
For each standard curve, the relative standard consisted samples and calibrator 
(which is the QSTD in this study), which was used to create a dilution series with 
arbitrary units. Each standard curve was generated by performing 8 independent serial 
dilutions of the QSTD template, together with samples (at different time points) and 
negative control reactions (NTC and NRTC). Each concentration of QSTD, samples 
and negative controls for standard curve preparation was assaying in duplicate to allow 
a determination of reproducibility. To maximize accuracy, the dilutions of the QSTD 
should be made over the range of copy numbers that include the amount of target 
mRNA expected in the experimental RNA samples (example: Figure 3.3).   
The copy numbers of the QSTD were entered in the setting; the dilution curve, 
NTC, NRTC and unknowns (experimental samples were entered into the setting as 
unknown) that needed to be quantitated using the standard curve generated with QSTD 
were also defined in the setting. The copy numbers of experimental samples were 
calculated after real-time amplification from the linear regression of that standard curve. 
The real-time software (Rotor-Gene 6000 series software) was then calculated PCR 
efficiency value for every standard curve, analyzed the data and reported the copy 
number of DNA in each of the unknown samples (example: Figure 3.3).   
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Figure 3.3: Result analyzed by the software 
 
Lastly, the data of copy numbers obtained from the two standard curves were 
then exported to Excel using the export function in the software. The copy number of 
the experimental gene (p53, caspase-3 and c-myc) at each point of time was normalized 
relative to that from ß-actin and the ratio in untreated sample was assigned as 1.  
The results were expressed as the means ± standard deviation. Statistical 
significance of the difference among treatments was determined using the Student’s t-
test. The p-value < 0.05 was considered statistically significant.  
 
3.8 Acute oral toxicity 
3.8.1 Test animals 
Experiment was performed on healthy ICR (Imprinting Control Region) mice (5 
weeks of age, body weight 23-28 g), obtained from Laboratory Animal Centre, Faculty 
of Medicine, University of Malaya.  The female mice were confirmed nulliparous and 
Dilution curve of QSTD 
Copy number target gene 
expe 
(copy number) 
 
Y= -3.583x + 46.008 
R= 0.99942 
Reaction efficiency= 0.90165 
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non-pregnant. The mice were assigned to five dosage groups and one control groups 
with ten mice (five male and five female) for each test group. The weight variation of 
mice used on study did not exceed ± 20 % SD of the mean body weight of each sex. 
The experimental procedures involving animals were approved by the University of 
Malaya Animal Experimental Ethnics Committee [Ethical number: 
ISB/05/08/2009/SKS (R)].  
 
3.8.2 Procedure of acute oral toxicity  
The acute oral toxicity of the crude methanol extracts of both Pereskia species 
were evaluated in mice using the procedure described by OECD (Organization for 
Economic Co-operation and Development, 1998) with some modifications. The mice 
were housed in suspended, stainless steel, wire-mesh cages in experimental animal 
room. The temperature was maintained at 23 ± 3 °C and relative humidity was 50-60 % 
before and after treatment with extract. The animal room was artificially illuminated 
(fluorescent light) on an approximate 12-hr light/dark cycle. The mice were 
acclimatized to the laboratory conditions for at least five days prior to commencement 
of the experiments. The mice were randomly selected for use in the study and marked 
to provide individual identification. Conventional mouse diets with unlimited supply of 
drinking water were available ad libitum except during the fasting period. The mice 
were starved approximately 12 hrs prior to dosing, but they had free access to drinking 
water. Before and after treatment with extract, the mice were caged in groups by sex 
and dose levels. The extracts were suspended in vehicle (10 % Tween-80 in distilled 
water). Stock concentration of 200 mg/ml was prepared and the mice were 
administrated with 0.2 ml of extract for every 10 g of the mice body weight. The mice 
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were administered with doses of 500, 1000, 1500, 2000 and 2500 mg/kg of extracts. 
Food was returned to the animals approximately 3-4 hrs after dosing. The mice were 
observed carefully for any signs of toxicity for the first 4 hours after the treatment 
period, and daily thereafter for a period of 14 days. Observations for mortality, signs of 
illness, injury, pain, distress, allergic reactions, changes of outer appearance, 
behavioural alterations (i.e. ataxia, hyperactivity, hypoactivity) and general stimulation 
or sedation were conducted twice daily. The observations were recorded systematically; 
individual records were maintained for each mouse.  
 
3.9 Extraction, isolation and identification of chemical constituents from the 
bioactive extracts  
3.9.1 Instrumentation  
NMR (Nuclear Magnetic Resonance) spectra were recorded on a JOEL 400 
MHz FT NMR spectrometer at 400 MHz for 
1
H NMR (
1
H Nuclear Magnetic 
Resonance) and at 100.40 MHz for 
13
C NMR (
13
C Nuclear Magnetic Resonance). 
Internal standards used in 
1
H NMR spectra was TMS (: 0.00) for CDCl3; in 
13
C NMR 
was CDCl3 (: 77.0).  
GCMS (Gas Chromatography and Mass Spectra) analysis was performed using 
Agilent Technologies 6980N gas chromatograph equipped with a 5979 Mass Selective 
Detector (70 eV direct inlet); a HP-5ms (5 % phenyl methyl siloxane) capillary column 
(30.0 m x 250 µm x 0.25 µm) initially set at 60 C for 10 min, then programmed to 230 
C at 3 C min-1 and held for 1 min at 230 C using helium as the carrier gas at a flow 
rate of 1 ml min
-1
.  
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The total ion chromatogram obtained was auto integrated by ChemStation and 
the components were identified by comparison with an accompanying mass spectral 
database (NIST 05 MS Library, 2002). Only mass spectral fragmentation pattern that 
gave greater than 90 % match were accepted.  
The GC (Gas Chromatography) analysis was performed on a Shidmadzu GC 
14A equipped with a FID detector using fused-silica capillary HP-5ms column (30.0 m 
length x 250 µm; 0.25 m film thickness) with helium as carrier gas at a flow rate of 1 
ml
 
min
-1
. Column temperature was programmed initially at 60 C for 10 min, then 
programmed to 230 C at 3 C min-1 and held for 1 min at 230 C. 
 
3.9.2 Column chromatography  
 Column chromatography was performed using Merck Kieselgel 60 PF253 Art No 
7734.1000 and 9385.1000 with particle size 0.063-0.200 mm and 0.040-0.0063 mm, 
respectively. The gel was made into slurry with solvent before it was packed onto the 
column and then allowed to equilibrate for at last an h before use. After the sample was 
introduced to the column, solvent with increasing polarity gradient was used to elute 
the chemical compounds from the column. Fractions collected were monitored by TLC 
and appropriate fractions were combined and where necessary subjected to further 
separation. 
 
3.9.3 Thin Layer Chromatography (TLC)  
Thin layer chromatography (TLC) was routinely used to detect and separate the 
various compounds. The extracts from chromatography was examined by TLC using 
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precoated 20 x 20 cm glass plates, 0.25 mm thickness, silica gel F254 (Merck, 
Darmstadt, G.F.R). The TLC plates were spotted with a piece of fine glass capillary 
tube and then developed in saturated chromatography tanks with various solvent 
systems at room temperature. The spots were visualized by examination of the TLC 
plates under UV light (254 and/or 343 nm), followed by applying iodine vapour or 
spray reagent. 
 
3.9.4 Preparative-Thin Layer Chromatography (Prep-TLC)  
Preparative-Thin Layer Chromatography (prep-TLC) was used in the 
purification of compounds. The samples were introduced onto the plates as a 
continuous streak 2 cm above the base of the plates using capillary tubes. The plates 
were developed in a chromatographic tank saturated with the developing solvent at 
room temperature. The plates were then air-dried, and the desired band was scrapped 
out and extracted with a suitable solvent. 
 
3.9.5 Identification of compounds in hexane extracts of P. bleo and P. grandifolia 
using GCMS 
 
The hexane extracts of both Pereskia spp. showed strong antioxidant activities 
in the antioxidant screenings (Section 4.2).  Thus, the hexane extracts of both Pereskia 
spp. were subjected to GCMS analysis to identify the chemical constituents in the 
extracts.  
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3.9.6 Extraction and isolation of chemical constituents from the bioactive ethyl 
acetate extract of P. bleo  
Based on the results of bioactivity screenings, such as antioxidant activity 
(Section 4.2), antimicrobial activity (Section 4.3) and preliminary cytotoxicity 
screening (Section 4.4), the ethyl acetate extract of P. bleo was identified as the 
bioactive extract. The cell death elicited by the ethyl acetate extract also clearly 
demonstrated DNA fragmentation, indicating apoptotic cell death as the major 
mechanism involved (Section 4.5.2). In addition, LUX RT-qPCR analysis also showed 
that the apoptosis elicited by the ethyl acetate extract on KB cells was mediated largely 
via p53 although the role of caspase-3 and c-myc cannot be ruled out [Section 4.6.5 (i)]. 
Thus, further chemical investigation was directed to the ethyl acetate extract of P. bleo.  
The extraction and fractionation procedures leading to the isolation of 
compounds is shown in Figure 3.4 and 3.5. Firstly, dried, ground leaves of P. bleo 
(1050.56 g) were extracted (3x) with methanol (1.5 L each time). The methanol-
containing extract obtained was initially treated with charcoal, then filtered over Celite
®
 
and the filtrate was evaporated under reduced pressure to give a crude methanolic 
extract (99.44 g). Treatment with charcoal was necessary to remove the high content of 
chlorophyll present in the extract. The presence of chlorophyll interfered with efforts at 
chromatographic separation.   
The crude methanol extract was then further partitioned with ethyl acetate and 
water using a separating funnel. The ethyl acetate-soluble layer was concentrated in 
vacuo giving an 18.34 g ethyl acetate fraction, which was subjected to flash silica gel 
column chromatography over Merck Kieselgel 60 (0.063-0.200 mm mesh size); elution 
starting with chloroform (10 L), and then with chloroform-methanol [9:1 (9 L)] and 
finally methanol (7.6 L). The chloroform (X), chloroform-methanol (Y) and methanol 
eluents (Z) were concentrated to give 4.89 g, 12.70 g and 3.04 g respectively, and then 
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subjected to cytotoxicity screening. Further purification was directed to the fraction X 
as it was found to be active in the cytotoxicity screening.  
The active chloroform fraction (X; 3.47 g) which was a dark brown residue 
obtained, was then purified over a column (3 cm diameter x 49 cm height) packed with 
180 g of Merck Kieselgel 60 (0.063 - 0.200 mm mesh size) and the components were 
separated by successive elution, initially with hexane followed by hexane enriched with 
increasing percentages of dichloromethane, monitoring with TLC, gave several sub-
fractions (A- L).  
Compound 1 (21 mg) was isolated from the sub-fraction B [dichloromethane-
hexane (1:9) fraction, 192.7 mg], after further purification using prep-TLC 
(preparative-TLC) with ethyl acetate: hexane (1:9) as developing solvent system. 
Repeated prep-TLC on the sub-fraction F [dichloromethane-hexane (1.6:8.4) fraction, 
64.2 mg], using chloroform as the developing solvent yielded compound 2 (10.6 mg).  
Subsequently, further elution of X fraction with dichloromethane-hexane (6:4) 
yielded sub-fraction G (475.5 mg), which was then subjected to silica gel column 
chromatography over Merck Kieselgel 60 (0.063-0.200 mm size mesh size), eluting 
initially with hexane, followed by hexane enriched with increasing percentages of 
dichloromethane. Compound 3 (41.2 mg) was isolated from the fraction obtained upon 
elution with dichloromethane-hexane (1.6: 8.4) on silica gel column. 
Compound 4 (39.6 mg) and mixture A (20.5 mg) were obtained from sub-
fraction I upon elution of X fraction with dichloromethane-hexane (8: 2). Lastly, 
elution with dichloromethane yielded sub-fraction J (206.7 mg) containing compound 
5. Compound 5 (5.4 mg) was obtained after prep-TLC using chloroform as the 
developing solvent.  
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All the above compounds were identified using GC-MS analysis and NMR 
techniques (whenever necessary).  
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CC: column chromatography; MeOH: methanol; EtOAc: ethyl acetate; H2O: water; 
CHCl3: chloroform  
 
Figure 3.4: The extraction and fractionation procedures leading to the isolation of 
chemical constituents from the bioactive ethyl acetate extract of P. bleo 
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CC: column chromatography; MeOH: methanol; EtOAc: ethyl acetate; H2O: water; 
CHCl3: chloroform; CH2Cl2: dichloromethane 
 
Figure 3.5: The extraction and isolation of compounds 1-5 and mixture A from the 
bioactive ethyl acetate extract of P. bleo 
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3.9.7 Extraction and isolation of chemical constituents from the bioactive ethyl 
acetate extract of P. grandifolia 
 
Based on the results of bioactivity screenings, such as antioxidant activity 
(Section 4.2), antimicrobial activity (Section 4.3) and preliminary cytotoxicity 
screening (Section 4.4), both the hexane and ethyl acetate extracts of P. grandifolia 
were identified as bioactive extracts. The selected cancer cell deaths treated with 
bioactive extracts clearly demonstrated DNA fragmentation, indicating apoptotic cell 
death as the major mechanism involved (Section 4.5.2). In addition, LUX RT-qPCR 
analysis showed that the hexane and ethyl acetate extracts killed the selected cancer 
cells via p53, caspase-3 and c-myc activation [Section 4.6.5 (ii)]. The active ingredients 
in hexane and ethyl acetate extracts may lead to valuable compounds. Some of the 
antioxidant compounds appeared in the ethyl acetate extract might also appear in the 
hexane extract of P. grandifolia or vice versa. Further chemical investigation was thus 
directed to the ethyl acetate extract of P. grandifolia. Fractionation into hexane and 
then ethyl acetate extraction was avoided as the yield of ethyl acetate extract obtained 
was very low (refer to Table 4.3).  
The extraction and fractionation procedures leading to the isolation of 
compounds is shown in Figure 3.6 and 3.7. Firstly, dried and ground leaves P. 
grandifolia (1020.98 g) were extracted (3x) with methanol (1.5 L each time) at room 
temperature. The methanol-containing extract obtained was initially treated with 
charcoal, then filtered over Celite
®
 and the filtrate was evaporated under reduced 
pressure to give a crude methanolic extract (28.84 g). Treatment with charcoal was 
necessary to remove the high content of chlorophyll present in the extract. The presence 
of chlorophyll interfered with efforts at chromatographic separation.   
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The crude methanol extract was then further partitioned with ethyl acetate and 
water using a separating funnel. The ethyl acetate-soluble layer was concentrated in 
vacuo giving a 5.09 g ethyl acetate fraction. The ethyl acetate fraction (4 g) was 
subjected to silica gel column chromatography (200 g) over Merck Kieselgel 60 (0.063-
0.200 mm mesh size); initial elution with hexane followed by hexane enriched with 
increasing percentages of dichloromethane, monitoring with TLC, to give several main 
fractions: A (0.12 g), B (1.42 g), C (0.09 g), D (0.21 g), E (0.24 g) and F (1.04 g). 
Fr. B (1.42 g) obtained was subjected to silica gel column chromatography (70 
g); elution with hexane followed by hexane enriched with increasing percentages of 
dichloromethane gave several sub-fractions (Fr.B1-B5). Fr.B3 (102 mg) which was 
further subjected to silica gel column chromatography (1 g). Successive elution with 
hexane followed by hexane enriched with increasing percentages of chloroform gave 4 
(10 mg) and 2 (5 mg). Components in Fr.B5 (350 mg) were obtained in the same 
manner as for Fr.B3 yielding 8 (4 mg). Repeated prep-TLC of Fr. F (1.04 g) using 
chloroform as developing solvent, yielded compound 1 (5 mg) and a mixture B (28 
mg). 
All the above compounds were identified using GC-MS analysis and NMR 
techniques (whenever necessary).  
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MeOH: methanol; EtOAc: ethyl acetate; H2O: water 
Figure 3.6: The extraction and fractionation procedures leading to the isolation of 
chemical constituents from the bioactive ethyl acetate extract of P. grandifolia 
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CC: column chromatography; MeOH: methanol; EtOAc: ethyl acetate; H2O: water; 
CHCl3: chloroform; CH2Cl2: dichloromethane 
 
Figure 3.7: The extraction and isolation of compounds 1, 2, 4, 8 and mixture B 
from the bioactive ethyl acetate extract of P. grandifolia 
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3.10 Screening for alkaloids 
The alkaloid screening methods were conducted according to the method of 
Santos et al. (1978) with some modification.  
 
3.10.1 Preparation of Wagner’s reagent 
2.00 g of potassium iodide and 1.30 g of iodine were dissolved in enough 
distilled water to make 100 ml. 
 
3.10.2 Preliminary alkaloid test 
Hydrochloric acid (5 ml) was added to 20 g of methanol extract and stirred 
while heating for about 5 min. After the sample was cooled to room temperature, 
powdered sodium chloride (0.5 g) was added to the sample. The sample was then 
stirred and filtered. Sufficient fresh 2 M hydrochloric acid was added to wash the 
filtrate and bring the filtrate to a final volume of 5 ml. A few drops of Wagner’s reagent 
were added to 1 ml of aliquot. The results were observed and recorded as follows: + 
slight turbidity; ++ definite turbidity and +++ heavy turbidity. 
No precipitate or turbidity observed can be assumed as absence of alkaloids in 
the plant material. A (+), (++) or (+++) recorded was a preliminary evidence that 
alkaloids are present but this test must be confirmed.      
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3.10.3 Confirmatory test for alkaloids 
Twenty eight percent (28 %) of ammonia was added drop wise to the remaining 
4 ml of aliquot to render the solution alkaline to litmus. The alkaline solution was 
extracted three times with 10 ml chloroform each time. The combined chloroform 
extracts was evaporated using rotary evaporator. (The alkaline aqueous layer was 
reserved for the test for quaternary and / or amine oxide bases). Hydrochloric acid (2 M, 
5 ml) was added to the residue with stirring over a steam bath for about two min and 
cooled to the room temperature. Then, it was filtered and a few drops of Wagner’s 
reagent were added to the filtrate. The result was observed and the turbidity was 
recorded as (+), (++) or (+++) as in the preliminary test. A (+), (++) or (+++) recorded 
was indicative of the presence of a primary, secondary or tertiary alkaloids.     
 
3.10.4 Test for quaternary and/ or amine oxide bases 
Hydrochloric acid (2 M) was added drop wise to the alkaline aqueous layer 
above with stirring until the solution was acidic to litmus. Then, it was filtered and a 
few drops of Wagner’s reagent were added to the filtrate. Wagner’s test was repeated 
on the solution as in the preliminary test. A (++) or (+++) result observed in the test 
may be taken as an indication of the presence of quaternary and / or amine oxide bases. 
A (+) reaction may be the result of incomplete chloroform extraction and is considered 
negative for quaternary bases. 
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CHAPTER 4 
RESULTS AND DISCUSSIONS 
 
4.1 Extraction yield of P. bleo and P. grandifolia 
Solvent extraction is the most popular method used in sample preparation. The 
yield of methanol extracts of P. bleo and P. grandifolia is shown in Table 4.1.  
 
Table 4.1: Yield of methanol extracts of P.  bleo and P. grandifolia 
Plants Samples /Extracts Weight (g) 
P. bleo 
Fresh samples 4526.79 
Dried and ground plant material 752.92 (16.63 %) 
Methanol extract 79.81 (10.60 %) 
P. grandifolia 
Fresh samples 410.18 
Dried and ground plant material 37.05 (9.03 %) 
Methanol extract 9.91 (26.75 %) 
 
Before extraction, the plant material needs to be dried to avoid the presence of 
water in the extracts. The moisture content in the leaves of P. grandifolia was higher 
than P. bleo as the yield of dried and ground leaves of P. grandifolia (9.03 %) was 
much lower than P. bleo (16.63 %). The percentage of crude methanol extract yield 
was based on the weight of dried and ground plant materials. The yield of crude 
methanol extract of P. grandifolia (26.75 %) was higher than P. bleo (10.60 %). Table 
4.2 and Table 4.3 show the yield of extracts fractionated from P. bleo and P. 
grandifolia crude methanol extracts. Methanol was used as the extraction solvent due to 
its polarity and its known ability to extract compounds such as phenolics, flavonoids 
and other polar materials (Velioglu et al., 1998).  
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Table 4.2: Yield of extracts fractionated from P.  bleo crude methanol extract 
Extracts 
Yield of extracts (g) 
[extracted from 33.58 g of 
methanol extract] 
 
Percentage (%) 
Hexane 2.19 6.52 
Ethyl acetate 0.99 2.95 
Water 18.14 54.02 
 
 
Table 4.3: Yield of extracts fractionated from P.  grandifolia crude methanol 
extract 
 
Extracts 
Yield of extracts (g) 
[extracted from 7.84 g of  
methanol extract] 
 
Percentage (%) 
Hexane 1.29 16.45 
Ethyl acetate 0.56 7.14 
Water 3.86 49.23 
 
As indicated by Yan et al. (1999), a single solvent may not be enough to 
identify certain extracts responsible for the activity. The crude methanol extracts were 
further fractionated into hexane, ethyl acetate and water extracts. The percentage yield 
of fractionated extracts was based on the weight of crude methanol extract. For both 
Pereskia spp., the water fraction was the most abundant fraction (54.02 % for P. bleo 
and 49.23 % for P. grandifolia) among the fractionated extracts in each species while 
the ethyl acetate fraction gave the lowest yield which 2.95 % for P. bleo and 7.14 % for 
P. grandifolia. 
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4.2 Antioxidant activity of P. bleo and P. grandifolia extracts 
Free radicals are considered as important factors in the etiology of cancer, and 
components with antioxidant activity have received particular attention as potential 
inhibitors of several cancers (Dedoussis et al., 2005). Various methods have been 
developed to measure total antioxidant activity, but none of them is an ideal reference 
method (Erel, 2004) and these assays are not scientifically justified (Becker et al., 
2004). The use of different methods is thus necessary in antioxidant activity assessment. 
Previous studies show that no single testing method is sufficient to estimate the 
antioxidant activity of a test sample (Frankel and Meyer, 2000; Huang et al., 2005). 
The combination of four methods (i.e. Folin-Ciocalteau method, scavenging activity on 
1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, reducing power assay and ß-carotene 
method) used in this study, was suitable to evaluate the antioxidant activity of P. bleo 
and P. grandifolia. In general, a radical is generated in the assay, and the antioxidant 
response of the sample against the radical is measured (Erel, 2004). To our knowledge, 
there is no antioxidant study reported for both P. bleo and P. grandifolia. Antioxidant 
activity of P. bleo and P. grandifolia was evaluated as it had not been determined 
previously.  
 
4.2.1 Determination of reducing capacity of P. bleo and P. grandifolia extracts 
using Folin-Ciocalteau method 
 
The Folin-Ciocalteau reagent–based assay gained popularity and is commonly 
known as the total phenols (or phenolic) assay which has become a routine assay in 
studying phenolic antioxidants. However, a recent report by Huang et al. (2005) stated 
that the Folin-Ciocalteau Reagent actually measures a sample’s reducing capacity, but 
this is not reflected in the name ‘total phenol assay’. The exact chemical nature of the 
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Folin-Ciocalteau reagent is not known, but it is believed to contain heteropoly-
phosphotunstates-molybdates. Sequences of reversible one- or two- electron reduction 
reactions lead to blue species, possibly (PMoW11O40)
4-
. Basically, it is believed that the 
molybdenum is easier to be reduced in the complex (Huang et al., 2005). The electron-
transfer reaction occurs between reductants and Mo(VI) is as shown as below:  
 
The Folin-Ciocalteau reagent is not specific to phenolic compounds as it can 
also be reduced by many non-phenolic compounds [e.g. vitamin C and Cu(I)]. Phenolic 
compounds react with Folin-Ciocalteau reagent only under basic conditions (adjusted 
by a sodium carbonate solution to pH ~10). Dissociation of a phenolic proton leads to a 
phenolate anion, which is capable of reducing Folin-Ciocalteau reagent. This supports 
the notion that the reaction occurs through electron-transfer mechanism. The blue 
compounds formed between phenolate and Folin-Ciocalteau reagent are independent of 
the structure of phenolic compounds, therefore ruling out the possibility of coordination 
complexes formed between the metal center and the phenolic compounds (Huang et al., 
2005).  
The reducing capacity of P. bleo and P. grandifolia extracts, determined from 
regression quotation of calibration curve (y=0.0012x+0.0004, R
2
 = 0.9931, Figure 4.1) 
were expressed as mg of GAEs per gram of methanol or fractionated extracts. The 
absorbance value of the test extract after subtraction of control was translated into 
reducing capacity [mg/l of gallic acid equivalents (GAEs)] using the gallic acid 
calibration plot with the following formula: 
 
Reducing capacity (mg/l of GAEs) = (y- 0.0004) 
     0.0012 
 
Mo(VI)   + e          Mo(V) 
(yellow)                 (blue) 
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y = 0.0012x + 0.0004
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The reducing capacity of P. bleo and P. grandifolia extracts are shown in Table 
4.4.  BHA was used as positive reference standard in the study.  
Figure 4.1: The gallic acid calibration graph 
 
Table 4.4: Reducing capacity of P. bleo and P.  grandifolia extracts 
Plants / 
Standard 
Extracts Reducing capacity 
(mg of GAEs/g of methanol or fractionated extracts) 
 
P. bleo 
 
Methanol 27.88 ± 0.28 
a
 
Hexane 23.15 ± 0.35 
a
 
Ethyl acetate 40.12 ± 0.66 
b
 
Water 27.70 ± 0.18 
a
 
P. grandifolia 
 
Methanol 38.54 ± 0.48 
b
 
Hexane 19.08 ± 0.43 
a
 
Ethyl acetate 45.99 ± 0.30 
b
 
Water 35.79 ± 0.33 
b
 
BHA  
(positive reference standard) 
 
252.97 ± 2.81  
GAEs, gallic acid equivalents  
Values expressed are mean ± standard deviation of three measurements. Means with 
different letters in the same column for each species are significantly different (p < 0.05, 
ANOVA).   
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Generally, the P. grandifolia showed significantly higher reducing capacity than 
P. bleo. The highest amount was found in the ethyl acetate extract of P. grandifolia 
with 45.99 mg of GAEs/g of extract. For both Pereskia spp., the reducing capacity in 
the ethyl acetate extracts were the highest (40.12 mg of GAEs/g of extract for P. bleo 
and 45.99 mg of GAEs/g of extract for P. grandifolia), followed by the methanol 
extracts, water extracts and hexane extracts, although the yield of ethyl acetate extracts 
were the lowest among the fractionated extracts for both Pereskia spp. (Table 4.2 and 
Table 4.3). The significantly higher reducing capacity in the ethyl acetate extracts than 
in the crude methanol extracts was probably due to the purification and concentration 
of chemical constituents throughout the fractionation procedure. The high reducing 
capacity of ethyl acetate for both plant samples might contribute toward their 
antioxidant and related activity. The methanol, hexane and water extracts of P. bleo had 
similar amount of reducing capacity (p < 0.05) while the reducing capacity of methanol 
and water extracts of P. grandifolia were similar (p < 0.05).  Figure 4.2 shows the 
comparison of reducing capacity (mg of GAEs/g of extract) of both Pereskia spp.   
Figure 4.2: Reducing capacity of P. bleo and P. grandifolia extracts 
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4.2.2 Scavenging activity of P. bleo and P. grandifolia extracts on 1,1-diphenyl-2-
picrylhydrazyl (DPPH) radicals  
Free radical scavenging is one of the known mechanisms by which antioxidants 
inhibit lipid oxidation. The method of scavenging DPPH free radicals can be used to 
evaluate the antioxidant activity of specific compounds or extract in a short time 
(Cheung et al., 2003). This method is sensitive and only requires small amount of 
samples (Blois, 1958) and allows testing of both lipophilic and hydrophobic substances 
(Kulisic et al., 2004). The proton radical-scavenging action is known to be one of the 
various mechanisms for antioxidation.  
The DPPH assay was always believed to involve hydrogen atom transfer 
reaction, however, a recent paper by Foti et al. (2004) suggested otherwise. On the 
basis of the kinetic analysis of the reaction between phenols and DPPH, Foti and co-
workers (2004) suggested that the reaction in fact behaves like an electron transfer 
reaction. The authors found that the rate-determining step for this reaction consist of a 
fast electron-transfer process from the phenoxide anions to DPPH. The hydrogen atom 
abstraction from the neutral ArOH by DPPH becomes a marginal reaction path, 
because it occurs very slowly in strong hydrogen-bond-accepting solvents, such as 
methanol and ethanol (Huang et al., 2005).  
DPPH radical scavenging activity is determined by a colorimetric assay. DPPH 
is a nitrogen-centred free radical, stable at room temperature, and produces a purple 
solution in methanol. The reducing capability of the DPPH radical is determined by the 
decrease in its absorbance induced by antioxidants. The decrease in absorbance of 
DPPH radical caused by antioxidants is due to the reaction between antioxidant 
molecules and radical, which results in the scavenging of the radical by electron 
transfer (Figure 4.3). This is visualized as a discolouration from purple to yellow. 
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(Gülçin et al., 2004; Duh et al., 1999; Chang et al., 2002; Gülçin et al., 2003). The 
principal of DPPH radical scavenging assay is shown in Figure 4.3.  
 
 
 
 
Figure 4.3: The principal of DPPH radical scavenging assay (Foti et al., 2004) 
 
Extracts of P. bleo and P. grandifolia contained active substances that were 
capable of scavenging DPPH radicals (Figure 4.4 and 4.5). In the DPPH scavenging 
assay, extracts of P. bleo and P. grandifolia were investigated through the free radical 
scavenging activity via their reaction with the stable DPPH radicals. The radical 
scavenging effects of both Pereskia spp. extracts and positive reference standards on 
DPPH are shown in Figure 4.4, Figure 4.5 and Figure 4.6. Scavenging effects of 
extracts on DPPH radicals increased with increased concentrations of extracts. Table 
4.5 shows the scavenging activity (IC50 values) of extracts on the inhibition of 
scavenging activity of DPPH radicals. 
ArOH
H
+
ArO-
X
ArO
. .
+ X
- H
+
ArO. + H-X (Yellow)
(Purple)
X. = DPPH.
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Figure 4.4: Scavenging effect of P. bleo extracts on DPPH radical. Each value is 
expressed as mean ± standard deviation of three measurements. 
 
Figure 4.5: Scavenging effect of P. grandifolia extracts on DPPH radical. Each 
value is expressed as mean ± standard deviation of three measurements. 
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Figure 4.6: Scavenging effect of positive reference standards (BHA and ascorbic 
acid) on DPPH radical. Each value is expressed as mean ± standard deviation of 
three measurements. 
 
Table 4.5: The scavenging activity (IC50 values) of P. bleo and P. grandifolia 
extracts on the inhibition of scavenging activity of DPPH radicals 
 
Plants / Standards Extracts IC50 values (mg/ml) IC50 values (µg/ml) 
P. bleo 
Methanol < 1 750 
Hexane < 1 210 
Ethyl Acetate < 1 225 
Water 1.70 - 
P. grandifolia 
Methanol < 1 860 
Hexane < 1 285 
Ethyl Acetate < 1 140 
Water > 5 - 
Positive reference 
standard 
Ascorbic acid - 19 
BHA - 11 
 
The P. grandifolia water extract with IC50 value of > 5 mg/ml, was not effective 
in scavenging DPPH radical while the P. bleo water extract expressed considerable 
scavenging effect (IC50 1.70 mg/ml). Extracts that possessed IC50 values less than 1.0 
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mg/ml were retested for their scavenging activity on more intensive concentration 
(Table 3.3) to determine the IC50 values (Figure 4.7 and Figure 4.8). The ethyl acetate 
extract of P. grandifolia showed the best DPPH scavenger with the lowest IC50 140 
µg/ml, followed by the hexane and ethyl acetate extracts of P. bleo with IC50 values of 
210 and 225 µg/ml respectively. For both Pereskia spp., the stronger scavenging 
activity in the hexane and ethyl acetate fractions than in the crude methanol extracts 
was probably due to the concentration of antioxidant compounds in the respective 
extracts.  
 
Figure 4.7:  Scavenging effect of lower concentrations of P. bleo extracts on DPPH 
radical to determine the IC50 values. Each value is expressed as mean ± standard 
deviation of three measurements. 
131 
 
0
10
20
30
40
50
60
70
80
90
0 100 200 300 400 500 600 700 800 900 1000
Sc
av
en
gi
ng
 e
ff
ec
t (
%
)
Concentration (µg/ml)
Methanol Hexane Ethyl Acetate
Figure 4.8: Scavenging effect of lower concentrations of P. grandifolia extracts on 
DPPH radical to determine the IC50 values. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
Generally, in comparison to both positive reference standards, which were 
ascorbic acid (IC50 19 µg/ml) and BHA (IC50 11 µg/ml), all the extracts displayed weak 
scavenging activity (Table 4.5). These results revealed that extracts of both Pereskia 
spp., except water extract of P.  grandifolia, were free radical inhibitors or scavengers, 
acting possibly as primary antioxidants. The extracts might react with free radicals, 
particularly peroxy radicals, which are the major propagators of the autoxidation chain 
of fat, thereby terminating the chain reaction (Mau et al., 2002). According to Huang et 
al. (2005), many antioxidants that react quickly with peroxyl radicals may react slowly 
or may even be inert to DPPH.  
The Folin-Ciocalteu method, generally measures the total reducing capacity of a 
sample; thus results obtained generally correlate with redox and antioxidants capacities 
measured by other electron transfer-based antioxidant capacity assay [e.g. DPPH, 
Ferric ion reducing antioxidant parameter (FRAP) and Trolox equivalent antioxidant 
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capacity (TEAC)]. This is not surprising due to the similarity of chemistry between the 
assays.  
 
4.2.3 Reducing power assay of P. bleo and P. grandifolia extracts 
Different studies have indicated that the antioxidant effect is related to the 
development of reductones (Duan et al., 2006; Dorman et al., 2003 and Shon et al., 
2003) as reductones were reported to be terminators of free radical chain reactions. 
Thus the antioxidant activity of both Pereskia spp. extracts and fractions may be related 
to their reductive activity. In this assay, the yellow colour of the test solutions change to 
various shades of green and blue depending upon the reducing power of each extract. 
The presence of reductants (i.e. antioxidants) in the extract would result in the 
reduction of the Fe
3+
/ ferric cyanide complex to the ferrous form (Fe
2+
) as shown below:  
 
The Fe
2+
 ions can therefore be monitored by measuring the formation of Pearl’s 
Prussian blue at 700 nm. Increased absorbance at 700 nm indicates an increase in 
reducing power of test samples (Lih et al., 2001). 
Ascorbic acid and BHA which were used as positive reference standards in the 
present study showed significantly high reducing power (p < 0.05),  which indicated 
high UV absorption (2.343- 2.616) at wavelength 700 nm. The reducing powers of 
ascorbic acid and BHA at 5 mg/ml were 2.343 and 2.432, respectively and increased to 
2.579 and 2.616, respectively at 20 mg/ml. The reducing power of P. bleo extracts, P. 
grandifolia extracts and positive reference standards are shown in Table 4.6 and Figure 
4.9-4.11.  
    Fe
3+
     +              e                                       Fe
2+
 
(yellow)       (from antioxidant)                      (blue) 
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The reducing power of all Pereskia spp. extracts varied significantly with 
different concentrations (p < 0.05; Table 4.6). The reducing power of all the extracts 
gradually increased with increasing concentration of the extracts. This indicated that all 
of the extracts possessed the ability (either strong or weak) to reduce Fe
3+
/ ferric 
cyanide complex to the ferrous form when evaluated by reducing power assay. 
However, the reducing power of the positive reference standards (ascorbic acid and 
BHA) were relatively more pronounced than the tested extracts. 
Hexane extract showed significantly (p < 0.05) the highest reducing activity 
among the extracts of P. bleo with 1.633 at 5 mg/ml, 1.846 at 10 mg/ml and 2.072 at 15 
mg/ml and 2.222 at 20 mg/ml (Table 4.6). The water and methanol extracts possessed 
some considerable reducing activity compared to the positive reference standards while 
the ethyl acetate extract showed the lowest (p < 0.05) reducing power among the 
extracts of P. bleo (Figure 4.10). 
Among the P. grandifolia extracts, methanol and hexane extracts appeared to 
possess significantly (p < 0.05) the highest reducing activity, in comparison to ascorbic 
acid and BHA as reference compounds (Figure 4.11). Reducing power of methanol 
extract of P. grandifolia were 1.056, 1.946, 2.204 and 2.460 when tested at 
concentrations of 5, 10, 15 and 20 mg/ml respectively while reducing power of hexane 
extract of P. grandifolia was 1.557 at 5 mg/ml and 2.015 at 20 mg/ml (Table 4.6). The 
reducing power of water extract of P. grandifolia was significantly (p < 0.05) the 
lowest at 0.168, 0.227, 0.350 and 0.466 when tested at concentrations of 5, 10, 15 and 
20 mg/ml respectively among all the extracts for both Pereskia spp. The reducing 
power of the methanol extract 2.460 at 20 mg/ml were comparable to that of ascorbic 
acid and BHA at 15 mg/ml.   
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For both Pereskia spp., the stronger reducing power in the hexane extracts than 
other fractionated extracts was probably due to the concentration of antioxidant 
compounds in the extract. The results presented here revealed that the hexane extracts 
of P. bleo and P. grandifolia are electron donors and might contained higher amounts 
of reductones, which could react with free radicals, converting them to more stable 
products, and terminating radical chain reaction. The hexane extracts of both Pereskia 
spp. were found to contain mainly methyl esters. It is highly probable that the lone pairs 
of electron on the carbonyl oxygen can be easily donated to the ferric ions in the 
reducing power assay. Methyl palmitate, methyl linoleate, methyl α-linolenate and 
phytol were identified from the hexane extract of P. bleo by GCMS analysis whilst 
methyl palmitate, methyl linoleate, methyl α-linolenate and methyl stearate were 
identified from the hexane extract of P. grandifolia (section 4.8.1 and 4.8.2).  
 
 
   
 
 
 
135 
 
Table 4.6: Reducing powers of extracts of P. bleo and P. grandifolia at various concentrations 
Plants / Standards Extracts 
Concentrations of extracts (mg/ml) 
5 10 15 20 
P. bleo 
Methanol 0.645 ± 0.03 
awi
 1.100 ± 0.05 
bxi
 1.465 ± 0.03 
cxi
 1.605 ± 0.04 
dxi
 
Hexane 1.633 ± 0.02 
axj
 1.846 ± 0.03 
byj
 2.072 ± 0.06 
czj
 2.222 ± 0.04 
dzj
 
Ethyl acetate 0.665 ± 0.00 
awj
 0.890 ± 0.07 
bwi
 1.009 ± 0.00 
cwi
 1.155 ± 0.05 
dwi
 
Water 0.670 ± 0.06 
awj
 1.175 ± 0.02 
bxj
 1.676 ± 0.05 
cyj
 1.834 ± 0.03 
dyj
 
P. grandifolia 
Methanol 1.056 ± 0.05 
ayj
 1.946 ± 0.08 
bzj
 2.204 ± 0.10 
czj
 2.460 ± 0.00 
dzj
 
Hexane 1.557 ± 0.02 
azi
 1.827 ± 0.03
 byi
 2.009 ± 0.03 
cyi
 2.015 ± 0.01 
cyi
 
Ethyl acetate 0.664 ± 0.00 
axi
 0.952 ± 0.04 
bxj
 1.343 ± 0.14 
cxj
 1.560 ± 0.06 
dxj
 
Water 0.168 ± 0.00 
awi
 0.227 ± 0.01 
bwi
 0.350 ± 0.01 
cwi
 0.466 ± 0.01 
dwi
 
Positive reference 
standard 
Ascorbic acid 2.343 ± 0.05 
a
 2.451 ± 0.02 
b
 2.496 ± 0.02 
b
 2.579 ± 0.04 
c
 
BHA 2.432 ± 0.01 
a 
 2.458 ± 0.03 
a
 2.549 ± 0.02 
b
 2.616 ± 0.02 
c
 
Absorbance values expressed are mean ± standard deviation of triplicate measurements.  
For the same extract or standard with different concentrations, means in the same row with different letters (a-d) were significantly different (p < 0.05, 
ANOVA). For different species with the same concentration and same extraction solvent, means with different letters (i,j) were significantly different 
(p < 0.05, ANOVA). For the same species with the same concentration but different extraction solvent, means with different letters (w-z) were 
significantly different (p < 0.05, ANOVA). 
 
 
136 
 
2.2
2.3
2.4
2.5
2.6
2.7
0 5 10 15 20
A
b
so
rb
a
n
ce
7
0
0
 n
m
Concentration (mg/ml)
Ascorbic acid BHA
0.0
0.5
1.0
1.5
2.0
2.5
3.0
0 5 10 15 20
A
bs
or
ba
nc
e 
70
0 
nm
Concentration (mg/ml)
Ascorbic acid BHA Methanol
Hexane Ethyl acetate Water
 
Figure  4.9: Reducing powers of ascorbic acid and BHA (reference compounds). 
Each value is expressed as mean ± standard deviation. 
 
 
Figure  4.10: Reducing powers of extracts of P. bleo at various concentrations. 
Each value is expressed as mean ± standard deviation. 
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Figure  4.11: Reducing powers of extracts of P. grandifolia at various 
concentrations. Each value is expressed as mean ± standard deviation. 
 
4.2.4 ß-Carotene bleaching activity of P. bleo and P. grandifolia extracts 
ß-Carotene in this model system undergoes rapid discoloration in the absence of 
an antioxidant. The mechanism of bleaching of ß-carotene is a free-radical-mediated 
phenomenon resulting from the hydroperoxides formed from linoleic acid by air 
oxidation. The antioxidant activity of carotenoids is based on the radical adducts of 
carotenoids with free radical formed from linoleic acid. The linoleic acid free radical, 
formed upon the abstraction of a hydrogen atom from one of its diallylic methylene 
groups, attacks the highly unsaturated ß-carotene molecules. As a result, ß-carotene 
molecules lose their double bonds by oxidation in this model system. In the absence of 
an antioxidant, the ß-carotene molecule loses its chromophore and characteristic orange 
colour, which can be monitored spectrophotometrically. The presence of different 
antioxidants can hinder the extent of ß-carotene bleaching by neutralizing the linoleate-
free radical and other free radicals form in the system (Jayaprakasha et al., 2001; Wong 
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et al., 2009; Kumaran and Joel Karunakaran, 2006). Thus, this forms the basis by 
which Pereskia extracts can be screened for their antioxidant potential.  
 Table 4.7 shows the antioxidant activities of the Pereskia extracts and BHA 
with the coupled oxidation of ß-carotene and linoleic acid. The antioxidant activities of 
the extracts for both Pereskia spp. varied significantly with different concentrations (p 
< 0.05; Table 4.7, Figure 4.12 and Figure 4.13). The ß-carotene bleaching activity of all 
the extracts gradually increased with increasing concentration of the extracts. 
For both P. bleo and P. grandifolia, the water extracts showed significantly (p < 
0.05) the lowest antioxidant activity while the ethyl acetate extracts presented 
significantly (p < 0.05) the highest activity (at all concentrations tested). This indicated 
that compounds with the strongest antioxidant activity in the ß-carotene-linoleate assay 
system were also of medium polarity.  
 The ethyl acetate extracts of P. bleo and P. grandifolia exhibited 83.68 % and 
83.13 % antioxidant activity respectively at 20 mg/ml which was nearly comparable to 
that of BHA standard at 20 mg/ml (92.46 %; Table 4.7). It is probable that the 
antioxidative components in the Pereskia extracts can reduce the extent of ß-carotene 
destruction by neutralizing the linoleate free radical and other free radicals formed in 
the system.  
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Table 4.7: Antioxidant activity (%) of P. bleo and P. grandifolia extracts measured by ß-carotene bleaching method 
 
Plants / Standard Extracts 
Concentrations of extracts (mg/ml) 
4 8 16 20 
P. bleo 
Methanol 34.62 ± 0.98 
axj
 37.90 ± 0.62 
awi
 64.03 ± 2.96 
bxyj
 72.96 ± 2.78 
cxi
 
Hexane 40.57 ± 1.15 
axyi
 46.11 ± 1.17 
bxi
 62.38 ± 4.19 
cxi
 73.31 ± 1.60 
dxj
 
Ethyl acetate 42.21 ± 4.05 
ayi
 52.87 ± 4.71 
byi
 69.92 ± 3.22 
cyi
 83.68 ± 0.57 
dyi
 
Water 27.97 ± 5.24 
awj
 36.84 ± 2.45 
bwi
 48.38 ± 2.27 
cwi
 46.17 ± 1.56 
cwi
 
P. grandifolia 
Methanol 17.83 ± 0.94 
awi
 43.13 ± 3.58 
bwi
 56.21 ± 2.63 
cwi
 74.48 ± 1.94 
dyi
 
Hexane 40.97 ± 0.64 
axi
 53.64 ± 0.75 
bwj
 60.54 ± 2.08 
cwi
 65.51 ± 1.76 
dxi
 
Ethyl acetate 55.04 ± 3.12 
ayj
 58.53 ± 1.52 
axi
 68.68 ± 3.47 
bxi
 83.13 ± 3.99 
czi
 
Water 15.66 ± 2.88 
awi
 39.22 ± 2.52 
byi
 55.68 ± 1.96 
cwj
 55.60 ± 0.82 
cwj
 
BHA (Positive reference standard) 70.80 ±1.09 
a
 79.00 ± 0.52 
b
 88.56 ± 0.82 
c
 92.46 ± 2.52 
d
 
Values expressed are mean ± standard deviation of triplicate measurements.  
For the same extract or standard with different concentrations, means in the same row with different letters (a-d) were significantly different (p < 0.05, 
ANOVA). For different species with the same concentration and same extraction solvent, means with different letters (i,j) were significantly different 
(p < 0.05, ANOVA). For the same species with the same concentration but different extraction solvent, means with different letters (w-z) were 
significantly different (p < 0.05, ANOVA). 
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Figure  4.12: Antioxidant activity (%) of P. bleo extracts measured by ß-carotene 
bleaching method. Each value is expressed as mean ± standard deviation. 
 
Figure  4.13: Antioxidant activity (%) of P. grandifolia extracts measured by ß-
carotene bleaching method. Each value is expressed as mean ± standard deviation. 
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4.2.5 Comparison of antioxidant activity of P. bleo and P. grandifolia extracts 
The differences in each antioxidant activity detection system lie in the unique 
characteristic of each test. This explains why employment of different method to 
measure antioxidant activity with various mechanisms may lead to different 
observations. Thus, it is not possible to make an absolute comparison of different 
methods. There are several methodological limitations for antioxidant determinations. 
The possible synergistic action among the different components present in the extracts 
cannot currently be ruled out. The most widely used methods for determining 
antioxidant activity are those that involve the generation of radical species, whereby the 
presence of antioxidants determines the disappearance of radicals (Cao et al., 1993). It 
is important to use different assays, instead of a single assay to assess and compare the 
antioxidant capacity of a sample of extract. 
A combination of four methods applied in this study gave valuable information 
to evaluate the antioxidant activity of P. bleo and P. grandifolia and could be 
recommended for other similar investigations. For P. bleo, the ethyl acetate extract 
showed the highest reducing capacity measured by Folin-Ciocalteau method and the 
highest antioxidant activity in ß-carotene bleaching assay significantly (p < 0.05). In 
contrast, it is the hexane extract of P. bleo showed significantly (p < 0.05) the highest 
antioxidant activity when determined by the scavenging effect on DPPH radical and the 
reducing power assay.  
For P. grandifolia, the reducing capacity, DPPH scavenging and the ß-carotene 
bleaching activities of the ethyl acetate extract was significantly the highest among the 
extracts (p < 0.05). The hexane extract of P. grandifolia possessed significantly (p < 
0.05) highest reducing power capacity among the extracts.  
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Based on the results of the antioxidant assays, it is thus suggested that the 
antioxidant activities of hexane extracts in both Pereskia spp. were not solely 
contributed by phenolic compounds but other antioxidants in the extracts.  Some of the 
antioxidant compounds appeared in the ethyl acetate extracts might also appear in the 
hexane extracts or vice versa.  
The synergism among the antioxidants in the mixture made the antioxidant 
activity, not only dependent on the concentration of antioxidant, but also on the 
structure and interaction among the antioxidants (Sun and Ho, 2005). This might 
explain why the extracts of P. bleo (methanol, hexane and water extracts) and P. 
grandifolia (methanol and water extracts) with nearly similar reducing capacity 
measured by Folin-Ciocalteau method varied remarkably in their antioxidant activity. 
 
4.3 Antimicrobial activity of P. bleo and P. grandifolia extracts 
There are many methods to determine antimicrobial activities but there is no 
single all-embracing bioassay to evaluate the antimicrobial activity of a sample. 
Therefore, the evaluation process generally involves the use of a number of 
antimicrobial bioassay methods and careful comparison of all the data in order get an 
appropriate conclusion (Rahman et al., 2001). There are three major methods for 
antimicrobial testing: (i) agar diffusion method, (ii) broth dilution method and (iii) 
bioautographic method. For the current study, agar diffusion method and broth dilution 
method was chosen to determine the antimicrobial activity of the plant extracts.  
In the agar diffusion method, paper disc impregnated with certain amount of 
tested sample are placed on the surface of the medium. The plates were incubated and 
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the zones of inhibition around each disc are measured. On the other hand, the broth 
dilution method was used to determine the minimum inhibitory concentration (MIC) 
and minimum bactericidal concentration (MBC) (Destoumieux et al., 1999). The MIC 
was defined as the lowest concentration of the test sample at which the microorganism 
does not demonstrate visible growth, determined by inoculating the bacteria into a 
culture medium containing various concentrations of a proposed antibiotic. The MBC 
was determined as the lowest concentration at which no growth occurred on the agar 
plate (Randrianarivelo et al., 2009). 
This study is a preliminary evaluation of antimicrobial activity of P. bleo and P. 
grandifolia extracts. The antimicrobial activity of P. bleo and P. grandifolia extracts 
were tested against two Gram positive bacteria (namely Staphylococcus aureus and 
Bacillus subtilis) and two Gram-negative bacteria (namely Escherichia coli and 
Pseudomonas aeruginosa). Generally, the positive controls (gentamycin and ampicilin) 
utilized to evaluate the efficacy of the extracts are standard antibiotics as indicated for 
each microorganism. 
To our knowledge, little information is available on the antimicrobial properties 
of P. bleo and no information on P. grandifolia. Ruegg et al. (2006) reported that the 
methanol and dichloromethane extracts of the aerial part of P. bleo did not show active 
antimicrobial activity against Escherichia coli, Staphylococcus aureus, Klebsiella 
pneumoniae, Mycobacterium smegmatis, Candida albicans, Pseudomonas aeruginosa 
and Helicobacter pylori.    
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4.3.1 Agar disc diffusion assay of P. bleo and P. grandifolia extracts 
 Agar disc diffusion method of antimicrobial susceptibility test was developed 
in 1940s. In 1940, Heatley introduced the use of adsorbent paper for carrying 
antimicrobial solutions. The procedure, which is accepted by the National Committee 
for Clinical Laboratory Standards (NCCLS), is a modification of that described by 
Bauer, Kirby, Sherris and Turk (commonly known as the Kirby-Bauer test).    
 The results of the antimicrobial activity measured by zones of inhibition of the 
extracts and positive reference standards (gentamycin and ampicilin) are shown in 
Table 4.8. The antimicrobial effect of the positive reference standards (gentamycin and 
ampicilin) were relatively more pronounced compared to the tested extracts. However, 
there is no agreement on the level of acceptance for plant extracts when compared with 
standards. No zones of clearance were produced by the DMSO only control disc 
(negative control).    
None of the extracts showed activity against Escherichia coli. The water 
extracts of both Pereskia spp. showed no inhibition against all the bacteria tested in this 
study. Generally, among the investigated extracts of each species, the ethyl acetate 
extracts exhibited the highest antibacterial effect. 
For P. bleo, none of the extracts showed activity against Escherichia coli and 
Staphylococcus aureus. The methanol, hexane and ethyl acetate extracts of P. bleo at 
concentration of 500 mg/ml exhibited modest inhibition at 9.8, 9.5 and 8.5 mm 
respectively against Pseudomonas aeruginosa. When the concentrations of these three 
extracts are lowered to 50 mg/ml, a slight decline in the inhibition zone were shown by 
the methanol and ethyl acetate extracts whilst the hexane extract showed no inhibition 
at all (Table 4.8). The hexane and ethyl acetate extracts of P. bleo also showed modest 
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inhibition against Bacillus subtilis at 8.2 and 7.8 mm, respectively at 500 mg/ml 
concentration.   
However, only the ethyl acetate extract of P. grandifolia showed some mild 
antimicrobial activity against Pseudomonas aeruginosa, Staphylococcus aureus and 
Bacillus subtilis at concentration of 500 mg/ml, with inhibition of 8.0, 9.2 and 8.5 mm 
respectively. 
In summary, both Pereskia spp. did not demonstrate any promising 
antimicrobial activity against all tested bacterial in agar diffusion assay. The ethyl 
acetate extracts showed some mild activity among the extracts of each species.   
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Table 4.8: Results of the antimicrobial tests of the investigated plants in agar diffusion assay 
Plant Extracts 
Concentration  
(mg/ml) 
Inhibition zone (mm)
a
 against 
Gram negative Gram positive 
E. coli P. aeruginosa S. aureus B. subtilis 
P. bleo 
Methanol 
50 - 8.3 ± 0.1 - - 
500 - 9.8 ± 0.1 - - 
Hexane 
50 - - - - 
500 - 9.5 ± 0.0 - 8.2 ± 0.1 
Ethyl acetate 
50 - 7.3 ± 0.1 - - 
500 - 8.5 ± 0.1 - 7.8 ± 0.0 
Water 
50 - - - - 
500 - - - - 
P. grandifolia 
Methanol 
50 - - - - 
500 - - - - 
Hexane 
50 - - - - 
500 - - - - 
Ethyl acetate 
50 - - - - 
500 - 8.0 ± 0.1 9.2 ± 0.1 8.5 ± 0.2 
Water 
50 - - - - 
500 - - - - 
Positive reference 
standards 
Gentamycin (10 g/disc) 20.7 18.0 ± 0.1 22.0 ± 0.5 19.0 ± 0.0 
Ampicilin (10 g/disc) 16.0 32.5 ± 0.2 37.0 ± 0.0 38.5 ± 0.1 
Values expressed are mean ± standard deviation of triplicate measurements.  
-: no activity. Negative controls did not show any activity; 
a 
Inhibition zones including the diameter of the paper disc (6 mm).
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4.3.2 Broth dilution assay  
(i) MIC and MBC of P. bleo extracts 
Extracts with MIC and MBC values < 10 mg/ml were considered relatively 
active. The MIC and MBC values of P. bleo extracts were all above 20 mg/ml, ranging 
from 30 to > 50 mg/ml (Table 4.9).  In most cases, the MBC values of P. bleo extracts 
were equivalent to the MIC values (bactericidal effect), except for both hexane and 
ethyl acetate extracts against Escherichia coli and Bacillus subtilis, for which the MBC 
values were higher than MIC values (bacteriostatic effect). The higher MBC value 
than MIC value of the extract suggested that the extract inhibited growth of the test 
microorganisms while being bactericidal at higher concentration. The results here 
generally demonstrated higher antibacterial activity against gram positive bacteria 
strains.  
 All the extracts showed weak antimicrobial activity against Pseudomonas 
aeruginosa, with the same MIC and MBC values of > 50 mg/ml. The water extract 
demonstrated the weak antimicrobial activity against all the tested bacteria with the 
MIC and MBC values of > 50 mg/ml in all cases. It seems that the antimicrobial 
compounds could belong to the lipophilic group rather than to the hydrophilic. 
Methanol extract exhibited the same MIC and MBC values > 50 mg/ml against all the 
tested bacteria, except against Bacillus subtilis with MIC and MBC values of 40 
mg/ml, which is the lowest MIC value among the tested bacteria. The hexane extract 
showed the lowest MIC values against Escherichia coli (MIC value 30 mg/ml), 
followed by Bacillus subtilis (MIC value 40 mg/ml). The MBC values for both 
inhibitions were the same (> 50 mg/ml), which were higher than the MIC values. For 
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ethyl acetate extract, the lowest MIC value was detected against Bacillus subtilis (30 
mg/ml), followed by MIC value against Staphylococcus aureus (40 mg/ml). 
In summary, all the extracts demonstrated weak antimicrobial activity against 
the tested microorganisms, except the hexane and ethyl acetate extracts which showed 
some mild activity against Escherichia coli and Bacillus subtilis respectively with 
MIC values of 30 mg/ml.  
 
 (ii) MIC and MBC of P. grandifolia extracts 
Table 4.9 shows the MIC and MBC of P. grandifolia extracts after 24 h 
incubation with tested bacteria. All the extracts demonstrated weak antimicrobial 
activity against the tested microorganisms with MIC and MBC values of > 50 mg/ml, 
except ethyl acetate extract which showed very mild activity against Bacillus subtilis 
respectively with MIC values of 50 mg/ml.  
 
 
 
149 
 
Table 4.9: MIC and MBC of P. bleo and P. grandifolia extracts after 24 h incubation with bacteria 
Plants Extracts 
E. coli P. aeruginosa S. aureus B. subtilis 
MIC 
(mg/ml) 
MBC 
(mg/ml) 
MIC 
(mg/ml) 
MBC 
(mg/ml) 
MIC 
(mg/ml) 
MBC 
(mg/ml) 
MIC 
(mg/ml) 
MBC 
(mg/ml) 
P. bleo 
Methanol > 50 > 50 > 50 > 50 > 50 > 50 40 40 
Hexane 30 > 50 > 50 > 50 50 50 40 > 50 
Ethyl acetate 50 > 50 > 50 > 50 40 40 30 40 
Water > 50 > 50 > 50 > 50 > 50 > 50 > 50 > 50 
P. grandifolia 
Methanol > 50 > 50 > 50 > 50 > 50 > 50 > 50 > 50 
Hexane > 50 > 50 > 50 > 50 > 50 > 50 > 50 > 50 
Ethyl acetate > 50 > 50 > 50 > 50 > 50 > 50 50 > 50 
Water > 50 > 50 > 50 > 50 > 50 > 50 > 50 > 50 
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4.3.3 Comparison of antimicrobial activity of P. bleo and P. grandifolia 
Many synthetic antimicrobial agents have been introduced in clinical practices. 
However, in recent years, a number of antibiotics have lost their effectiveness due to 
the drug resistance and organ toxicity especially when these antibiotics are used for an 
extended period. 
The antimicrobial activity of the tested extracts against gram negative bacteria 
was either low or inactive. Generally, gram negative bacteria i.e. Escherichia coli 
show higher resistance against the antimicrobial agents.  Escherichia coli which was 
studied in this project, is one of the insensitive gram negative bacteria strains. In fact, 
gram negative bacteria, especially Escherichia coli are frequently reported to have 
multi drug resistance against many antibiotics available in the market (Alonso et al., 
2000; Sader et al., 2002).   As a result, it is not surprising that all the extracts tested in 
agar disc diffusion assay were not responding against Escherichia coli.  
The results of the zone in the disc diffusion assay showed some correlation with 
the MIC and MBC obtained using a standardized broth dilution technique. From the 
antimicrobial assays in this project, the extracts of both Pereskia spp. were not 
demonstrated promising results against the tested microorganisms, which were 
Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus 
subtilis. The results here were thus in agreement with Ruegg et al. (2006), which 
reported that the methanol and dichloromethane extracts of the aerial part of P. bleo 
were not showed active antimicrobial activity against Escherichia coli, Pseudomonas 
aeruginosa  and Staphylococcus aureus. However, the extracts of Pereskia spp. were 
only tested against four microorganisms in this project. Thus, it cannot be concluded 
that the Pereskia spp. are not active against all the microorganisms.  
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The ethyl acetate extracts of both Pereskia spp. showed some mild activity 
against the tested bacteria. There might be some active antimicrobial components in the 
extracts but low in quantity and were not present in sufficient concentrations to be 
effective. The active components of the extract may be characterized and tested for 
their safety and efficacy to uncover their therapeutic potential in modern and traditional 
medicine against infectious diseases. Alternatively, study of the synergistic interaction 
of active antimicrobial compounds isolates from the ethyl acetate extracts with 
commercial antibiotics might be useful to exploit these potential extracts in the 
combination therapy of infectious diseases caused by multi drug-resistant 
microorganisms.   
 
4.4 In vitro neutral red cytotoxicity assay 
 Cytotoxicity assay is a rapid, standardized, sensitive and inexpensive method to 
measure drug-induced alterations in metabolic pathways or structural integrity which 
may or may not be related directly to cell death (Wilson, 1986).  Cytotoxicity assays 
are widely used in in vitro toxicology studies.  
The neutral red assay was chosen in this study to determine cytotoxic effect of 
Pereskia spp. extracts and isolated compounds against selected human cell lines, with 
doxorubicin as the positive control. The selected human cell lines were human 
nasopharyngeal epidermoid carcinoma cell line (KB), human cervical carcinoma cell 
line (CasKi), human colon carcinoma cell line (HCT 116), hormone-dependent breast 
carcinoma cell line (MCF7), human lung carcinoma cell line (A549) and non-cancer 
human fibroblast cell line (MRC-5). 
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Briefly, the neutral red cytotoxicity assay is a rapid, reliable, inexpensive, 
simple, sensitive and reproducible quantitative in vitro assay for the screening of 
potentially toxic agents. It is a colorimetric assay measuring the uptake of the neutral 
red, a supravital dye, by functional lysosomes after the cells were exposed to test 
compounds over a range of concentrations. Living cells take up the neutral red, which 
is concentrated within the lysosomes of the cells.  
Neutral red (3-amino-m-dimethylamino-2-methyl-phenazine hydrochloride) has 
been used previously for identification of vital cells in cultures (DeRenzis and 
Schechtman, 1973). It is a weak cationic dye that readily penetrates cell membranes by 
non-ionic diffusion, accumulating intracellularly in lysosomes, where it binds with 
anionic sites in the lysosomal matrix. Alterations of the cell surface or the sensitive 
lysosomal membrane can lead to lysosomal fragility and other changes that gradually 
become irreversible. Such changes brought about by the action of xenobiotics result in 
a decreased uptake and binding of neutral red dye. Based on the rationale that damaged 
and dead cells will lose their ability to retain neutral red dye, it is possible to distinguish 
between viable, damaged or dead cells using the neutral red cytotoxicity assay. Thus, 
this assay can be applied to determine the cytotoxicity effects of a series of extracts 
(Fotakis and Timbrell, 2006; Borenfreund and Puerner, 1985, 1986).  
Different cytotoxicity assays might give different results depending on the test 
agent and the cytotoxicity used. Assays like MTT and LDH, which are dependent on 
enzymatic reactions, might be influenced by enzyme inhibitors like chloroquine 
(Weyermann et al., 2005). Fotakis and Timbrell (2006) reported that the neutral red 
assay and the MTT assay are the most sensitive cytotoxicity assay that show 
statistically significant difference between the treated cells and the controls, especially 
in detecting early toxicity. They also suggested that the neutral red assay is a useful tool 
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to detect lysosomal damage when used in conjunction with other tests in order to 
distinguish between cytotoxicity and organelle damage. Furthermore, Weyermann et al. 
(2005) pointed out that inexpensive assay like the neutral red uptake assay is sufficient 
when a more expensive test kits fails.  
In the present study, the stock materials of the test extracts and compounds were 
dissolved in 100 % DMSO. Five and ten microlitre of a solution of each test extract or 
compound obtained by diluting the stock solution with appropriate quantity of DMSO 
10 % was added to each well. The small amount of DMSO present in the wells 
(maximum 0.5 %) was proven not to affect the experiments. Houghton and Raman 
(1998) also reported that at concentrations below 3 % v/v, DMSO is usually not toxic to 
the cells.  
For the determination of the effective concentration of inhibition of cell 
proliferation, cell lines were incubated with the extract in multiple concentrations. The 
amount of neutral red dye accumulated can be extracted from the lysosomes and 
quantitated spectrophotometrically by comparing with neutral red dye recovered from 
untreated control cell culture. The results are expressed as IC50 values which can be 
obtained from concentration-response curves. The IC50 values are established using 
different concentrations of each test agent tested on the cells. The IC50 value is the 
effective concentration (µg/ml or µM) of test extract or compound that cause 50 % 
inhibition or cell death (Borenfreund and Puerner, 1986, Chapuis et al., 1988, Liebsch 
and Spielmann, 1995).  
According to the US NCI (United States National Cancer Institute) plant 
screening program, a plant extract is generally considered to have active cytotoxic 
effect if the IC50 value, following incubation between 48 to 72 h, is 20 μg/ml or less, 
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while it is 4 μg/ml or less for pure compounds (Lee and Houghton, 2005; Boik, 2001; 
Geran et al., 1972, 1997; Swanson and Pezzuto, 1990). 
 
4.4.1 Cytotoxic activity of P. bleo and P. grandifolia extracts  
 (i) Human nasopharyngeal epidermoid carcinoma cell line (KB) 
The in vitro growth inhibitions of KB cells by P. bleo and P. grandifolia 
extracts are shown in Figure 4.14 and Figure 4.15, respectively. The percentage of 
inhibition of KB cells increased with increased extract concentrations. For both 
Pereskia spp., the ethyl acetate extracts showed the most effective cytotoxicity when 
tested at the highest concentration of 100 µg/ml, followed by methanol extracts and 
hexane extracts. The water extracts showed less than 50 % inhibition rate when tested 
at high concentrations of 100 µg/ml.  
Table 4.10 summarise the cytotoxicity (IC50 values in µg/ml) of both Pereskia 
spp. extracts towards KB cells. For P. bleo, the ethyl acetate extract possessed the 
strongest cytotoxic effect with an IC50 value of 4.5 µg/ml against KB cells, followed by 
methanol and hexane extracts with IC50 values of 6.5 g/ml and 28.0 g/ml, 
respectively.  
For P. grandifolia, the hexane extract possessed the strongest cytotoxicity with 
an IC50 value of 5.0 µg/ml towards KB carcinoma cells. This is followed by ethyl 
acetate and methanol extracts with IC50 values of 16.0 g/ml and 34.0 g/ml, 
respectively. However, the IC50 values of water fractions were above 100 µg/ml for 
both Pereskia spp.  
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Figure 4.14: The in vitro growth inhibitions of KB cells by P. bleo extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
Figure 4.15: The in vitro growth inhibitions of KB cells by P. grandifolia extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
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Table 4.10: The IC50 values of P. bleo and P. grandifolia extracts tested against KB 
cell line 
Plants Extracts IC50 values (µg/ml) 
P. bleo 
Methanol 6.5 
Hexane 28.0 
Ethyl Acetate 4.5 
Water > 100.0 
P. grandifolia 
Methanol 34.0 
Hexane 5.0 
Ethyl Acetate 16.0 
Water > 100.0 
 
 (ii) Human cervical carcinoma cell line (CasKi) 
The ethyl acetate extracts of both Pereskia spp. showed the most effective 
cytotoxicity against CasKi cells when tested at the highest concentration of 100 µg/ml 
(Figure 4.16 and Figure 4.17) in comparison to other extracts. Water extracts of both 
Pereskia spp. showed very low inhibition rate at a high concentration of 100 µg/ml 
with the IC50 value of above 100 µg/ml. 
 Cytotoxicity (IC50 values in µg/ml) of P. bleo and P. grandifolia extracts 
towards CasKi cells are summarized in Table 4.11. For P. bleo, the crude methanol 
extract possessed the strongest cytotoxicity with an IC50 value of 40.5 µg/ml against 
CasKi carcinoma cells. This is followed by the ethyl acetate and hexane extracts with 
IC50 values of 58.0 g/ml and 89.5 g/ml, respectively. For P. grandifolia, the ethyl 
acetate extract possessed the strongest cytotoxicity with an IC50 value of 21.0 µg/ml 
towards CasKi carcinoma cells. This is followed by hexane and methanol extracts with 
IC50 values of 40.0 g/ml and 50.0 g/ml, respectively. It can thus be concluded that 
only the ethyl acetate extract of P. grandifolia has relatively active cytitixic effect on 
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the CasKi cell line based on the guideline proposed on cytotoxicity by the US NCI 
plant screening program.   
Figure 4.16: The in vitro growth inhibitions of CasKi cells by P. bleo extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
Figure 4.17: The in vitro growth inhibitions of CasKi cells by P. grandifolia 
extracts determined by neutral red cytotoxicity assay. Each value is expressed as 
mean ± standard deviation of three measurements. 
 
158 
 
Table 4.11: The IC50 values of P. bleo and P. grandifolia extracts tested against 
CasKi cell line 
 
Plants Extracts IC50 values (µg/ml) 
P. bleo 
Methanol 40.5 
Hexane 89.5 
Ethyl Acetate 58.0 
Water > 100.0 
P. grandifolia 
Methanol 50.0 
Hexane 40.0 
Ethyl Acetate 21.0 
Water > 100.0 
 
(iii) Human colon carcinoma cell line (HCT 116)  
Cytotoxicity (IC50 values in µg/ml) of P. bleo and P. grandifolia extracts 
towards HCT 116 cells is summarized in Table 4.12. Percentage of inhibition of HCT 
116 cells increased with increase extract concentrations. For P. bleo, the ethyl acetate 
extract possessed the strongest cytotoxicity with an IC50 value of 22.0 µg/ml towards 
HCT 116 carcinoma cells. This is followed by crude methanol and hexane extracts with 
IC50 values of 41.0 g/ml and 67.5 g/ml, respectively. However the IC50 value of 
water extract was above 100 µg/ml (Figure 4.18).  
For P. grandifolia, the hexane extract possessed the strongest cytotoxicity with 
an IC50 value of 25.5 µg/ml towards HCT 116 carcinoma cells. This is followed by 
ethyl acetate and methanol extracts with IC50 values of 52.0 g/ml and 53.0 g/ml, 
respectively. However the IC50 value of water extract was above 100 µg/ml (Figure 
4.19). 
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Figure 4.18: The in vitro growth inhibitions of HCT 116 cells by P. bleo extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
 
 
Figure 4.19: The in vitro growth inhibitions of HCT 116 cells by P. grandifolia 
extracts determined by neutral red cytotoxicity assay. Each value is expressed as 
mean ± standard deviation of three measurements. 
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Table 4.12: The IC50 values of P. bleo and P. grandifolia extracts tested against 
HCT 116 cell line 
 
Plants Extracts IC50 values (µg/ml) 
P. bleo 
Methanol 41.0 
Hexane 67.5 
Ethyl Acetate 22.0 
Water > 100.0 
P. grandifolia 
Methanol 53.0 
Hexane 25.5 
Ethyl Acetate 52.0 
Water >100.0 
 
 (iv) Hormone-dependent breast carcinoma cell line (MCF7) 
Cytotoxicity (IC50 values in µg/ml) of P. bleo and P. grandifolia extracts 
towards MCF7 cells is summarized in Table 4.13. Percentage of inhibition of MCF7 
cells increased with the increase extract concentrations. For P. bleo, the hexane extract 
possessed the strongest cytotoxicity with an IC50 value of 25.0 µg/ml towards MCF7 
carcinoma cells (Figure 4.20). This is followed by ethyl acetate and methanol extracts 
with IC50 values of 28.0 g/ml and 39.0 g/ml, respectively. However the IC50 value of 
water fraction was above 100 µg/ml.  
For P. grandifolia, the ethyl acetate extract possessed the strongest cytotoxicity 
with an IC50 value of 20.0 µg/ml towards MCF7 carcinoma cells (Figure 4.21). This is 
followed by hexane and methanol extract with IC50 values of 49.0 g/ml and 88.0 
g/ml, respectively. However the IC50 value of water fraction was above 100 µg/ml.  
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Figure 4.20: The in vitro growth inhibitions of MCF7 cells by P. bleo extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
 
 
 
Figure 4.21: The in vitro growth inhibitions of MCF7 cells by P. grandifolia 
extracts determined by using neutral red cytotoxicity assay. Each value is 
expressed as mean ± standard deviation of three measurements. 
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Table 4.13: The IC50 values of P. bleo and P. grandifolia extracts tested against 
MCF7 cell line 
Plants Extracts IC50 values (µg/ml) 
P. bleo 
Methanol 39.0 
Hexane 25.0 
Ethyl Acetate 28.0 
Water > 100.0 
P. grandifolia 
Methanol 88.0 
Hexane 49.0 
Ethyl Acetate 20.0 
Water > 100.0 
 
 (v) Lung carcinoma cell line (A549) 
The in vitro growth inhibitions of A549 cells by P. bleo and P. grandifolia 
extracts are shown in Figure 4.22 and Figure 4.23, respectively. Percentage of 
inhibition of A549 cells increased with the increase extract concentrations. Cytotoxicity 
(IC50 values in µg/ml) of crude extract and fractions of P. bleo and P. grandifolia 
towards A549 cells are summarized in Table 4.14.  
For P. bleo, the ethyl acetate extract possessed the strongest cytotoxicity with an 
IC50 value of 41.0 µg/ml towards A549 carcinoma cells. This is followed by methanol 
extract with IC50 value of 56.0 g/ml. However the IC50 values of hexane and water 
extracts were above 100 µg/ml.  
For P. grandifolia, the hexane, ethyl acetate and methanol extracts possessed 
cytotoxicity with IC50 values of 44.0, 45.0 and 60.0 µg/ml respectively towards A549 
carcinoma cells. However the IC50 value of water extract was above 100 µg/ml.  
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Figure 4.22: The in vitro growth inhibitions of A549 cells by P. bleo extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
 
 
Figure 4.23: The in vitro growth inhibitions of A549 cells by P. grandifolia extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
 
 
164 
 
Table 4.14: The IC50 values of P. bleo and P. grandifolia extracts tested against 
A549 cell line 
 
Plants Extracts IC50 values (µg/ml) 
P. bleo 
Methanol 56.0 
Hexane > 100.0 
Ethyl Acetate 41.0 
Water > 100.0 
P. grandifolia 
Methanol 60.0 
Hexane 44.0 
Ethyl Acetate 45.0 
Water > 100.0 
 
 (vi) Human fibroblast cell line (MRC-5) 
The IC50 values (µg/ml) of P. bleo and P. grandifolia towards MRC-5 cells is 
summarized in Table 4.15. For P. bleo, all extracts possessed low cytotoxic towards 
MRC-5 cells. The IC50 values of all fractions are above 100 µg/ml, except methanol 
extract with IC50 value of 61.0 µg/ml (Figure 4.24).  
For P. grandifolia, all methanol extract and fractions of P. grandifolia had low 
cytotoxic activity towards MRC-5 cells. The IC50 values of all fractions are above 100 
µg/ml, except methanol extract with IC50 value of 68.5 µg/ml (Figure 4.25).  
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Figure 4.24: The in vitro growth inhibitions of MRC-5 cells by P. bleo extracts 
determined by neutral red cytotoxicity assay. Each value is expressed as mean ± 
standard deviation of three measurements. 
 
Figure 4.25: The in vitro growth inhibitions of MRC-5 cells by P. grandifolia 
extracts determined by neutral red cytotoxicity assay. Each value is expressed as 
mean ± standard deviation of three measurements. 
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Table 4.15: The IC50 values of P. bleo and P. grandifolia extracts tested against 
MRC-5 cell line 
 
Plants Extracts IC50 values (µg/ml) 
P. bleo 
Methanol 61.0 
Hexane > 100.0 
Ethyl Acetate > 100.0 
Water > 100.0 
P. grandifolia 
Methanol 68.5 
Hexane > 100.0 
Ethyl Acetate > 100.0 
Water > 100.0 
 
4.4.2 Cytotoxic activity of doxorubicin  
Doxorubicin is clinically used for the treatment of a great variety of cancer 
disease (Gillle et al., 2002; Carter, 1975 and Khana et al., 1998). It has been one of the 
most extensively used agents in the chemotherapy regimens of cancer patients for the 
past 30 years (Weiss, 1992). In spite of the routine use of this drug its major adverse 
effect, the dose-dependent cardiotoxicity, cannot be prevented yet (Gillle et al., 2002). 
In the present study, doxorubicin was used as the positive control for the cytotoxicity 
assay. Thus, doxorubicin was screened for its cytotoxic activity on the selected human 
cancer cell lines, such as KB, CasKi, HCT 116, MCF7, A549 and non-cancer MRC-5 
cell line.  
Based on the result, it can be concluded that doxorubicin is not only cytotoxic 
against all the human cancer cell lines tested, but also the non-cancer human MRC-5 
cell line (Table 4.16 and Figure 4.26). Doxorubicin possessed very strong cytotoxicity 
with IC50 values of 0.0125, 0.0060, 0.3600, 0.0755, 0.2200 and 0.5500 µg/ml against 
KB, CasKi, HCT 116, MCF7, A549 and MRC-5 cells respectively. This result supports 
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the statement that doxorubicin is a potent cytostatic drug which is applied for the 
treatment of cancer diseases but the routine use of this drug could bring major adverse 
effect (Gillle et al., 2002).   
 
Figure 4.26: The in vitro growth inhibitions of selected human cells by doxorubicin 
as positive reference standard determined by neutral red cytotoxicity assay. Each 
value is expressed as mean ± standard deviation of three measurements. 
 
Table 4.16: The IC50 values of doxorubicin against various cancer and non-cancer 
cell lines tested 
 
Cell line IC50 values in µg/ml (µM) 
KB 0.0125   (0.023) 
CasKi 0.0060   (0.011) 
HCT 116 0.3600   (0.663) 
MCF7 0.0755   (0.139) 
A549 0.2200   (0.401)
 
MRC-5 0.5500   (1.01) 
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4.4.3 Comparison of cytotoxic activity of P. bleo and P. grandifolia 
The results of preliminary cytotoxicity screening of the methanol and 
fractionated extracts of both Pereskia spp. against various cancer and non-cancer cell 
lines are summarized in Table 4.17.  
The ethyl acetate extracts of both Pereskia spp. in general gave higher 
inhibition and stimulation values against various cancerous cell lines compared to other 
extracts. The ethyl acetate extract of P. bleo was selectively toxic against the KB cells. 
Both ethyl acetate extracts displayed distinctively cytotoxicity effect on KB cell line, 
which reached IC50 values at relatively low concentration. The ethyl acetate extract of P. 
bleo was more active with IC50 value of 4.5 µg/ml against KB cells, in comparison to 
16.0 µg/ml shown by that of P. grandifolia. The ethyl acetate extract of P. grandifolia, 
on the other hand displayed good inhibition against MCF7 cells with IC50 of 20.0 µg/ml. 
The active ingredients in the ethyl acetate extract may lead to valuable compounds that 
may have the ability to kill KB cancer cells but exert no damage to normal cells (IC50  > 
100.0 µg/ml against normal cells, MRC-5). The stronger inhibitory effect of the ethyl 
acetate extracts in comparison to the crude methanol extracts was probably due to the 
partial purification process whereby the active ingredients are concentrated in the ethyl 
acetate extract. 
Meanwhile, the hexane extract of P. grandifolia also demonstrated remarkable 
high inhibition towards KB cells with IC50 value of 5 µg/ml, in comparison to the 
hexane extract of P. bleo.  The water extracts of both Pereskia spp. were found to have 
no effect on the cancer cell lines (IC50 > 100.0 µg/ml in all cases). All the extracts of 
both Pereskia spp. demonstrated weaker cytotoxicity profile against the CasKi and 
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A549 cells compared to other cells and no activity against normal cells (IC50 > 100.0 
µg/ml). 
From Table 4.17, it is observed that the crude methanol extract of P. bleo 
showed a higher inhibitory effect than the fractionated extracts against the CasKi cells. 
This might be explained as the compounds that are active against the CasKi cells had 
decomposed during the fractionation process. In addition, observed activity in the total 
extracts might be due to synergism between components which were separated as a 
result of the fractionation process. The synergism among the components in the mixture 
contributed to the cytotoxic activity, not only dependent on the concentration of certain 
components, but also on the structure and interaction among the components.  
In addition, the cytotoxic effect of the positive reference standards (doxorubicin) 
were relatively more pronounced than the tested extracts. Although the cytotoxic 
activities of these extracts are not as effective as doxorubicin, they however have low 
toxicity against normal MRC5 cell line in comparison to doxorubicin.   
In summary, the findings from the cytotoxic activity of both Pereskia spp. 
extracts support the common belief that ethnopharmacological selection of Pereskia 
spp. is a useful criterion in drug discovery. It is interesting to note that the extract of the 
plant showed much less cytotoxicity against the normal cell line, and, if this also occurs 
in vivo (section 4.7), the use of this plant by locals for the treatment of cancer would 
have some scientific support. The active extracts were being investigated further to 
detect the DNA fragmentation (section 4.5) and to determine the active ingredients 
(section 4.8 and 4.9) present in the extract since these might identify valuable lead 
compounds in the light of their ability to kill cancer cells  but exert little damage as 
possible on normal cells.  
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Table 4.17: Comparison between IC50 values of P. bleo and P.  grandifolia extracts 
against various cancer and non-cancer cell lines 
 
Plants / 
Standard 
Extracts 
IC50 (µg/ml) 
KB CasKi HCT 116 MCF7 A549 MRC-5 
P. bleo Methanol 6.5 40.5 41.0 39.0 56 61.0 
 Hexane 28.0 89.5 67.5 25.0 > 100 > 100.0 
 
Ethyl 
Acetate 
4.5 58.0 22.0 28.0 41 > 100.0 
 Water > 100.0 > 100.0 > 100.0 > 100.0 > 100 > 100.0 
P. 
grandifolia 
Methanol 34.0 50.0 53.0 88.0 60 68.5 
Hexane 5.0 40.0 25.5 49.0 44 > 100.0 
Ethyl 
Acetate 
16.0 21.0 52.0 20.0 45 > 100.0 
Water > 100.0 > 100.0 > 100.0 > 100.0 > 100 > 100.0 
Doxorubicin 
(Positive reference 
standard) 
0.0125 0.0060 0.3600 0.0755 0.2200 0.5500 
IC50  ≤  20.0 µg/ml: Active 
 
4.5 Detection of DNA fragmentation 
Chromosomal DNA fragmentation at internucleosomal sites is the earliest 
hallmark of the nuclear events and the most extensively studied biochemical event in 
apoptosis. Apoptosis has become increasingly important to many areas of biomedical 
research and internucleosomal DNA fragmentation is frequently used to show the 
existence of apoptosis (Zhu and Wang, 1997).   
In this study, DNA fragmentation was detected using DeadEnd
TM
 Colorimetric 
Apoptosis Detection System as described by the manufacturer (Promega). DeadEnd
TM
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Colorimetric Apoptosis Detection System is a modified TUNEL (terminal 
deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling) assay, which 
actually takes advantage of the multiple free DNA ends generated by activated 
endonucleases to insert labeled dUTP that can be later detected by light microscopy. An 
analysis of DNA fragmentation with the DeadEnd
TM
 Colorimetric Apoptosis Detection 
System can provide the first step toward the understanding of cell death mechanism.   
 
4.5.1 DeadEnd
TM
 Colorimetric Apoptosis Detection System (Promega) 
The DeadEnd
TM 
Colorimetric Apoptosis Detection System is a non-radioactive 
system designed to provide simple, accurate and rapid detection of apoptotic cells in 
situ at the single cell level. The system can be used to assay apoptotic cell death in 
cultured cells by measuring nuclear DNA fragmentation, an important biochemical 
indicator of apoptosis in many cell types.   
Apoptotic cells have been clearly labeled in vibratome sections of rat brain after 
axotomy-induced neuronal death in the lateral geniculate nucleus (LGN) (Agarwala and 
Kalil, 1998; O’Brien et al., 1998), in Jurkat cells after anti-Fas treatment (O’Brien et al., 
1998, Weis et al., 1992), and in HL-60 cells after anisomycin treatment (Polverino and 
Patterson, 1997). According to the technical bulletin of product (2005), the DeadEnd
TM 
Colorimetric Apoptosis Detection System labels fragmented DNA in situ and have 
been tested in all of these systems.    
The DeadEnd
TM 
Colorimetric Apoptosis Detection System is ideal for labelling 
apoptotic nuclei in cultured cells, while allowing for a concurrent morphological 
assessment. The system end-labels the fragmented DNA in situ in apoptotic cultured 
cells. It is based on a modified TUNEL assay. 
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In the DeadEnd
TM 
Colorimetric Apoptosis Detection System, biotinylated 
nucleotide is incorporated at the 3’-OH DNA ends using the Terminal 
Deoxynucleotidyl Transferase, Recombinat (rTdT) enzyme. Horseradish peroxidase-
labeled streptavidin (Streptavidin HRP) is then bound to these biotinylated nucleotides, 
which are detected using the peroxidase substrate, hydrogen peroxide, and the stable 
chromogen, diaminobenzidine (DAB). Using this procedure, apoptotic nuclei are 
stained dark brown.   
 
4.5.2 Induction of apoptosis by the cytotoxic active extracts of P. bleo and P. 
grandifolia on the selected human cancer cells  
According to the results of preliminary cytotoxicity screening (section 4.4.3 and 
Table 4.17), the extracts of P. bleo (methanol and ethyl acetate) and P. grandifolia 
(hexane and ethyl acetate) were active against KB cells. The ethyl acetate extract of P. 
grandifolia, on the other hand, displayed a remarkable inhibition against MCF7 cells 
with IC50 of 20.0 µg/ml. In order to determine whether apoptosis play an important role 
in mediating cell death of the selected cells elicited by the active extracts of P. bleo and 
P. grandifolia, a modified TUNEL assay using DeadEnd
TM 
Colorimetric Apoptosis 
Detection System (Promega) was carried out.  
The cells treated with the cytotoxic active extracts produced dark brown stained 
nuclei with similar observation found in the positive control cells treated with DNase I 
(example: Figure 3.2) indicating the presence of DNA fragmentation which is the 
hallmark of apoptosis (Bowen et al., 1998). DNase I is an endonuclease that degrades 
both double-stranded and single-stranded DNA. None of the cell nucleus in the 
negative control cells were stained (Figure 3.2). Thus, it is tempting to speculate that 
the cell deaths elicited by the extracts were mediated via apoptotic mechanism.   
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 It is well known that in apoptosis, the earliest recognized morphological 
changes are compaction and segregation of the nuclear chromatin, with the result of 
chromatin margination and condensation of the cytoplasm (Kerr et al., 1972). 
Progression of the condensation is accompanied by convolution of the nuclear and cell 
outlines followed by breaking up of the nucleus into discrete fragments and by budding 
of the cell as a whole to produce membrane-bounded apoptotic bodies. The apoptotic 
bodies are quickly ingested by nearby cells and degraded within their lysosomes (Kerr 
et al., 1972, 1994). The cellular events in apoptosis are accomplished quickly, with 
only a few min elapsing between onset of the process and the formation of cluster of 
apoptotic bodies. The KB cells treated with P. bleo (methanol and ethyl acetate extracts) 
and P. grandifolia (hexane and ethyl acetate extracts) and MCF7 cells treated with 
ethyl acetate extract of P. grandifolia, clearly demonstrated DNA fragmentation 
(Figure not shown), indicating apoptotic cell death as the major mechanism involved. 
 
4.6 Determination of the expression level of apoptotic-related genes  
Although a number of investigators have demonstrated a correlation between 
results obtained with the TUNEL method and ultrastructural features of apoptosis 
(Kimura et al., 1997; Li et al., 1995), others have reported that this method is not 
specific enough for apoptosis (Ansari et al., 1995; Stadelmann et al., 1998). Therefore, 
in addition to TUNEL which detected DNA fragmentation, gene expression level of 
apoptotic-related genes induced in the cells treated with active extracts of Pereskia spp. 
and isolated compounds, were evaluated to determine the mechanism of extract-
induced apoptosis.  
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More recently, real-time florescent nucleic acid amplification techniques were 
developed and were proven to be rapid and sensitive (Chen et al., 2004). RT-qPCR 
significantly simplifies and accelerates the process of producing reproducible 
quantification of mRNAs (Bustin, 2000). However, this technique has not been 
commonly employed in natural products and there are no reports so far on LUX RT-
qPCR methods for gene expression study in natural products.  
In the present study, a protocol for the evaluation of mRNA expression levels of 
apoptotic genes by real-time reverse transcriptase–polymerase chain reaction (RT-
qPCR) using LUX (Light Upon eXtension) primers has been established. The assay 
was started with preparation of quantitative standard (QSTD), followed by optimization 
of qPCR using LUX primers and application of optimized RT-qPCR assay to the 
experiment set (section 3.7). Only extracts or compounds which were active in the 
cytotoxic activity screening and detected with DNA fragmentation were tested in the 
gene expression study. 
The QSTD of p53, caspase-3, c-myc and ß-actin were prepared by using one-
step RT-PCR. These QSTD were used as DNA templates for optimization of RT-qPCR 
and also to prepare a standard curve for the RT-qPCR assay after 10-fold dilution. For 
relative quantification, the target PCR products were compared with these QSTD PCR 
products in which the concentrations were known. The aim of these QSTD was to 
provide a more accurate standard for quantification of nucleic acid. In addition, for 
effective quantification, the reaction must be stopped before amplification reaches the 
plateau phase (oversaturation) (Kellogg et al., 1990), so serial dilutions of the QSTD 
must be employed to ensure that the linear part of the curve is used. 
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4.6.1 The choice of using LUX chemistry for RT-qPCR assay in gene expression 
study  
LUX primer technology, which has already been described for DNA and 
mRNA quantification approaches (Aitichou and Ibrahim, 2005; Chen et al., 2004) was 
used in the present study. The increase of the fluorescence signal is directly 
proportional to the amount of amplified DNA. The LUX primers combine the best of 
probe-based and SYBR Green detection. The LUX primer offers the sensitivity, 
specificity and dynamic range of TaqMan® probes, while providing the ease-of-use, 
cost-effectiveness and melting curve analysis capability of SYBR Green (Table 4.18). 
Unlike the current well known TaqMan® probes, LUX primers technology does not 
require an expensive probe (Chen et al., 2004). The LUX assay only needs a specific 
primer set with a single labeled, self-quenched primer and a corresponding unlabeled 
one. It is more reliable than the real-time method using DNA binding dyes (e.g. SYBR 
green), which is frequently used in qPCR reactions to monitor DNA synthesis. 
However, the disadvantage is that SYBR Green will bind to any dsDNA in the reaction, 
including primer-dimers and other non-specific reaction products, which results in an 
overestimation of the target concentration and may produce potentially misleading 
results due to the lack of specificity of the dyes. A previous study also indicated that the 
LUX primers technology is reliable for quantitation of gene expression and the result is 
similar to the probe-based quantitative assay (Brian et al., 2003). LUX fluorogenic 
primers can be designed and ordered via online software 
(http://www.invitrogen.com/lux). 
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Table 4.18: Comparison of chemistry options for real-time amplification 
 TaqMan® 
Probes 
Molecular 
Beacons 
SYBR Green LUX Primers 
Sensitivity ••• ••• • ••• 
Dynamic range ••• ••• • ••• 
Specificity ••• ••• • ••• 
Multiplexing •• •• N/A ••• 
Melting curve analysis N/A N/A ••• ••• 
Ease of design • • ••• ••• 
Cost • • ••• ••• 
• Sensitivity; N/A: Not available 
 
The LUX assay also has the advantage of speed increment and is less laborious 
over the gel-based RT-PCR technique which is the popular gene expression tool 
applied in natural products. The LUX assay took 88 min to complete the amplification 
reaction (including the melting curve analysis) and the process was viewed in real time, 
while conventional RT-PCR methods usually take more about 3 hs or more for gene 
amplification (no melting curve analysis) and half an h or more to run the gel and 
examine the result. Furthermore, the LUX assay is a closed-tube technique which 
reduces the risk of contamination and reaction variability. Thus, the advantage of the 
LUX real-time assay is more apparent when compared to conventional method to 
measure gene expression.     
 
4.6.2 Validation and optimization of the LUX RT-qPCR assay 
The RT-qPCR is a complex assay and all physical and chemical components of 
the reaction are interdependent. Assay optimization is the key to better sensitivity, 
specificity, reproducibility and a wider linear dynamic range. Although optimization of 
PCR reactions used to be an essential part of assay development, recent trends towards 
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high throughput and rapid data reporting have resulted in the elimination of this step in 
many laboratories. Indeed, some manufacturers claim it is not necessary to optimize the 
assay when using their particular reagents or chemicals. However, it is clear that the 
optimization step can significantly improve assay detection sensitivity (Nolan et al., 
2006).  
In the present study, the PCR method used for preparation of QSTD was 
adapted to real time format by using LUX primers (Invitrogen), Platinum Taq DNA 
polymerase (Invitrogen) and dNTP mix (Promega), performed in Rotor-Gene 6000 
(Corbette). For the optimization of the qPCR assay, an aliquot of the QSTD dilution 
was used as template for the qPCR amplification.  
The optimization of a qPCR assay basically depends upon five factors: 
specificity test of primer, primer concentration, MgCl2 concentration, annealing 
temperature and sensitivity of the test. The optimized qPCR assay should fulfil the 
following criteria in the given order of priority: (i) absence of, or minimal, primer 
dimmers; (ii) lowest Ct, i.e. the primer and MgCl2 combination resulting in the most 
sensitive and efficient reaction; (iii) highest end point fluorescence (ΔRn), which is 
likely to signify the highest number of amplicon products being formed, and (iv) 
absence of positive signal in NTC (Nolan et al., 2006).  
 
 (i) Specificity test of LUX primers 
 Primers are the most crucial component in PCR reactions because they 
determine the sensitivity, specificity and efficiency of the assay. However, a primer 
might sometimes forms undesired secondary structural pairing such as primer dimmer 
artifacts. Primer dimer artifacts refer to the primers which anneal to themselves and 
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create small templates for PCR amplification. The presence of primer dimmers in 
samples containing template decreases the efficiency of a PCR reaction.  
The sequences of the LUX primers (Table 3.8) used were designed by 
proprietary software called D-LUX Designer (Invitrogen, 
http://www.invitrogen.com/lux). The characteristics of the LUX primers, such as 
amplicon size, primer length and primer Tm, are included in the primer design by the 
software to output primer pairs that are located throughout the target (input) sequence.  
The software also performed a BLAST search of the designed sequence against known 
database to eliminate cross-reactivity.   
Each fluorogenic LUX primer was labelled with one of two reporter dyes, either 
FAM (6-carboxy-fluorescein) or JOE (6-carboxy-4’,5’-dichloro-2’,7’-dimethoxy-
flurescein). In the present study, FAM-labelled primer set was used to detect apoptotic 
related genes (p53, caspase-3 and c-myc) while JOE-labelled primer set was used to 
detect internal reference gene (ß-actin).  
During the amplification, the real-time qPCR machine (Rotor-Gene 6000, 
Corbette) detected fluorescence in each cycle, excited and detected the FAM-labelled 
LUX primers at their excitation/emission wavelength of 470/510 nm in green channel 
while JOE-labelled LUX primers were excited and detected at 530/555 nm in yellow 
channel.  
 The specificity of each LUX primers (p53, caspase-3, c-myc and ß-actin) was 
assessed against the QSTD of each gene (p53, caspase-3, c-myc and ß-actin), to 
confirm that each set of primers amplified only the specific genome. The results are 
shown in Figure 4.27 and 4.28. Specific PCR products were further analyzed by 
melting curve analysis and the results are shown in Figure 4.29 and 4.30.  
179 
 
 
 
 
 
 
 
 
 
Figure 4.27: The specificity of FAM-labelled LUX primers in green channel. 
The specificity of four set of primers (c-myc, p53, caspase-3 and ß-actin) was 
established using the QSTD of the four apoptotic genes (c-myc, p53, caspase-3 and 
ß-actin). A: LUX primer of p53 against QSTD of p53; B: LUX primer of c-myc 
against QSTD of c-myc; C: LUX primer of p53 against QSTD of p53; NTC: non-
template control; Yellow lines: non-specific genome of (c-myc, p53, caspase-3) of 
each LUX primers set. 
 
As shown in Figure 4.27, the FAM-labelled primers (p53, caspase-3, c-myc) 
were correctly amplified the specific genome of each primer. Positive amplifications of 
each pair of LUX primer and QSTD generated sigmoid amplification curves. There was 
no amplification (flat line) detected for the non-specific genome of each LUX primers 
set (yellow flat lines in Figure 4.27) and NTC. The amplification curve of JOE-labelled 
primer (ß-actin LUX primer) was not shown in Figure 4.27 as JOE-labelled primer was 
not detected at wavelength of 470/510 nm in green channel. The JOE-labelled primer 
can only be detected at 530/555 nm in yellow channel (Figure 4.28).  As shown in 
Figure 4.28, the ß-actin LUX primer, which was a JOE-labelled LUX primer was 
correctly amplified the genome of ß-actin.  
 
 
A 
B 
C 
NTC 
NTC 
JOE-labelled primer 
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Figure 4.28: The specificity of JOE-labelled LUX primers in yellow channel. D: 
LUX primer of ß-actin against QSTD of ß-actin; NTC: non-template control; 
Yellow lines: non-specific genome (c-myc, p53, caspase-3) against ß-actin LUX 
primer. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.29: Melting curve of FAM-labelled LUX primers in green channel. A:  
LUX primer of p53 against QSTD of p53; B: LUX primer of c-myc against QSTD 
of c-myc; C: LUX primer of p53 against QSTD of p53; grey lines: NTC; Yellow 
lines: non-specific genome of (c-myc, p53, caspase-3) of each LUX primers set. 
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Figure 4.30: Melting curve of JOE-labelled LUX primers in yellow channel. D:  
LUX primer of ß-actin against QSTD of ß-actin; Grey line: non-template control; 
Yellow lines: non-specific genome (c-myc, p53, caspase-3) against ß-actin LUX 
primer. 
 
 
Melting curve analysis during qPCR is important to identify the presence of 
primer dimmers, analyze the specificity of the reaction and confirm specific 
amplification with LUX primers. Specific PCR product melts in a specific manner 
produce a melting temperature (Tm) peak in melting curve analysis. There was no 
primer dimmers detected in the melting analysis of Figure 4.29 and 4.30, indicating that 
the designed LUX primers were specific and sensitive. In Figure 4.29 and 4.30, Tm for 
c-myc, p53, caspase-3 and ß-actin were 85 °C, 86.5 °C, 80 °C and 83 °C, respectively. 
The difference between experimental Tm and Tm predicted by the software (Table 3.8) 
was due to the higher concentration of Mg
2+
 added in the experiment which increased 
the Tm of PCR products.  
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 (ii) Optimization of the concentrations of LUX primers and MgCl2 
 The thermodynamic stability (ΔG) of a primer differs for different primers and 
varies with primer concentration (Nolan et al., 2006). Therefore, it is important to use 
primers at concentrations that result in optimal hybridization and priming. Indeed, the 
manufacturers claim that it is not necessary to optimize primer concentrations when 
using their particular products. However, it is clear that the rationale underlying the 
original recommendations remain valid and that optimization of primer concentration 
can significantly improve assay detection sensitivity (Nolan et al., 2006).  
In addition, Mg
2+
 concentrations required strict control because Mg
2+
 affects 
enzyme activity and increases the Tm of dsDNA (Eckert and Kunkel, 1991). The 
results indicated that the lowest detection limit for LUX primers and MgCl2 were 0.3 
µM and 3.0 mM respectively as both of the concentrations fulfilled the following 
criteria in the given order of priority: (i) absence of primer dimmers, (ii) lowest Ct, i.e. 
the primer and MgCl2 combination resulting in the most sensitive and efficient reaction, 
(iii) absence of signal in NTC (Nolan et al., 2006).  
 
 (iii) Optimization of the annealing temperature (TA) 
The setting of the PCR thermocycling profile would affect the overall 
performance of the PCR assay. The TA is one of the key factors in determining the 
annealing rate of a specific primer. The Tm of a primer can be predicted by 
bioinformatics software though the actual TA must be determined empirically based on 
the predicted Tm by performing gradient TA PCR.  
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In the present study, three different TA were tested for optimization, which were 
50 °C, 55 °C and 60 °C.  There was no significant different among these three TA (data 
not shown). Thus, the TA was set to 55 °C as suggested by the kit.  
 
 (iv) Determination of the lowest detection limit and sensitivity of the LUX RT-
qPCR assay 
 According to previous report (Chen et al., 2004), the LUX assay was 10-fold 
more sensitive than the conventional RT-PCR method, while the amount of RNA 
used in the LUX method is only one-fifth of the gel based. In the present study, the 
lowest detection limit (or primer’s sensitivity) of the LUX RT-qPCR were determined 
by performing amplification of 10-fold serial dilution of purified QSTD of each 
tested gene using LUX primers.  A 10-fold difference in concentration corresponds to 
3.3 cycles. For standard curve analysis, it is important to confirm that the slope of 
curve lies between -3.2 and -3.6, the R
2
 value is above 0.98 and the reaction 
efficiency is above 0.90. The standard curve was prepared in every run of qPCR.  
 The lowest detection limits of the four QSTD genes were same, which was 10
3
 
copies while the reaction efficiencies of the four QSTD genes were > 0.90 and R
2 
(coefficients of linear regression) of the dynamic range were > 0.99900 (example: 
Figure 4.31). The reaction efficiencies of p53, caspase-3, c-myc and ß-actin obtained 
were 0.99943. 0.99976, 0.99955 and 0.99984, respectively, while the R
2 
of p53, 
caspase-3, c-myc and ß-actin obtained were 0.90673, 0.91393, 0.90304 and 0.90996, 
respectively. This indicates that the assay were linear over each of their quantitation 
range. Therefore, the lowest limit of quantitation of LUX assay was set at x10
3
 
copies/µl.  
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 Amplification curve 
Figure 4.31: The standard curve and amplification curve obtained by the LUX 
qPCR assays on the dilution series of ß-actin QSTD template. The lowest detection 
limit of ß-actin QSTD was 10
3
 copies/µl. 
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4.6.3 Considerations for RT-qPCR procedures  
 (i) Reagents  
The amplification depends on the activity and the quality of the enzyme Taq 
polymerase, availability of essential components such as dNTPs and the nature of the 
target DNA. Thus, the use of good PCR reagents or master mixes would have a strong 
effect on PCR efficiency. Oligo-dT was used during cDNA synthesis in the present 
study. It is more specific than random priming, and is the best method to use when the 
aim is to obtain a faithful cDNA representation of the mRNA pool. It is also the most 
appropriate choice when aiming to amplify several target mRNAs from a limited RNA 
sample (Bustin et al., 2005).  
 
 (ii) Negative controls  
Every run of qPCR assay of each extract (or compound tested) for each gene, 
was included cDNA of samples, QSTD dilutions, non-reverse-transcriptase control 
(NRTC) and non-template control (NTC). The QSTD dilutions, NRTC and NTC were 
used during the entire assay development and assay evaluation. 
Amplification of QSTD standard curve was included, analyzed and data 
reported to reveal the amplification efficiency and sensitivity of every PCR assay, to 
check for consistency of reaction and to confirm that the quantification of samples (at 6 
time points) has been carried out within the dynamic range of that assay.      
It is virtually impossible to completely eliminate genomic DNA from RNA 
preparations. Therefore, it is important to include negative controls in RT-qPCR 
experiments. Two types of negative controls were used in the present study, which 
were NRTC and NTC. NRTC was a minus reverse-transcriptase control (or "no 
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amplification control") that containing the master mix reagents and the RNA template 
without reverse transcriptase procedure. If a product was seen in the NRTC, it probably 
indicated that contaminating DNA was present in the sample. 
On the other hand, NTC included all of the RT-PCR reagents except the 
DNA/RNA template. Typically the RNA/DNA template was simply substituted with 
nuclease-free water. NTC was essential to check for non-specific signal arising from 
primer dimmers or template contamination. No product should be synthesized in the 
NTC; if a product was amplified, it indicated that one or more of the RT-PCR reagents 
was contaminated with the amplicon.  
 
 (iii) Internal reference gene 
The reliability of any RT-qPCR experiment can be improved by including an 
invariant internal reference gene (or so-called endogenous reference or housekeeping 
genes) in the assay to correct for sample to sample variations in RT-qPCR efficiency 
and errors in sample quantification. The expression level of a good control should not 
vary across the samples being analyzed.   
The ideal internal standard should be expressed at a constant level among 
different tissues of an organism, at all stages of development, and should be unaffected 
by the experimental treatment. In addition, an internal reference gene should also be 
expressed at roughly the same level as the RNA under study (Bustin, 2000). There are 
three RNAs which are most commonly used to normalize patterns of gene expression, 
which are glyceraldehydes-3-phosphate-dehydrogenase (GADPH), ß-actin and 
ribosomal RNAs (rRNA).  
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 GADPH is particularly an unpopular choice in cancer research due to its 
increased expression in aggressive cancers (Goidin, 2001).  The issue of the choice of 
an internal control has also been reviewed by Suzuki et al. (2000). The authors 
recommended caution in the use of GADPH as a internal control as it has been shown 
that its expression may be regulated in proliferating cells and recommended ß-actin as a 
better active reference. GADPH is severely criticized as internal control by others too 
(Bustin, 2000; Dheda, 2004; Aerts et al., 2004).  
 In the present study, the mRNA level of ß-actin was used as an internal control 
for template levels. ß-actin mRNA is expressed at moderately abundant levels in most 
cell types and encodes a ubiquitous cytoskeleton protein. It was one of the first RNAs 
to be used as an internal standard, and it is still advocated as a quantitative reference for 
RT-PCR assays (Kreuzer et al., 1999). This is despite widespread evidence that its 
levels of transcription can vary widely in response to experimental manipulation in 
human breast epithelial cells, and blastomeres, as well as in various porcine tissues and 
canine myocardium (Bustin, 2000).  
 
4.6.4 Data analysis  
 All the reactions were performed in duplicates as suggested by Nolan et al. 
(2006). Nolan et al. (2006) indicated that reactions carried out in duplicate are 
generally sufficient as triplicate is needed to perform only if Cts are > 35. All replicates 
should be within 0.5 Ct of each other. The reactions should be repeated if the data of 
the replicates differ by > 0.5 Ct. The minimum difference of 5 Ct between the NRTC 
and sample data point must be ensured. The reactions should be repeated if the data 
between the NRTC and sample differ < 5 Ct.  
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All the reactions were run for 35 cycles. This is because above 35 cycles the 
variability will be greater and quantification may be unreliable (Nolan et al., 2006). It is 
also important to ensure that the dynamic range spans the Ct values anticipated for 
experimental analysis (example: Figure 3.3). It is not valid to extrapolate quantification 
values of test samples beyond the values of the samples in the dilution series tested.  
 
Relative quantitation using two standard curves method 
The term relative quantitation is used when two or more genes are compared to 
each other with the result being a ratio. An endogenous control or a housekeeping gene 
is normally compared to a gene of interest. There are several ways of doing relative 
quantitation, such as relative quantitation using two standard curves and comparative 
ΔΔCt method. The main difference between absolute and relative quantitation is that 
absolute quantitation results in an output amount of copy numbers while relative 
quantitation uses relative numbers (e.g. fold differences) where the results are given as 
a ratio. The result is the comparison between the ratios.  
In the present study, relative standard curve method was used to quantitate 
alterations in mRNA levels using RT-qPCR. The standard curve method is the most 
common approach to determine relative quantification. Analysis of the data from the 
standard curve can provide a substantial amount of information of the assay. Relative 
quantification determines the changes in steady-state transcription of a gene and is 
often adequate.   
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4.6.5 Expression level of apoptosis-related genes in the cytotoxic active extract-
treated cells 
 
In order to determine the expression level of apoptosis-related genes induced in 
the cytotoxic active extract-treated cells, the mRNA levels of p53, caspase-3 and c-myc 
were evaluated by two-step RT-qPCR. The mRNA level of ß-actin was used as internal 
control for template levels. Only extracts which were active in cytotoxic activity and 
detected with DNA fragmentation were tested in the gene expression study. 
Concentration of the extract needed to achieve 50 % growth inhibition (IC50) was used 
to stimulate the cells over the period of 6 h. The qPCR assay which has been optimized 
(section 4.6.2) was applied to the experiment set in the present study.  
 
(i) Expression level of apoptosis-related genes in the P. bleo cytotoxic active 
extract-treated cells 
Methanol extract  
 Figure 4.32 show the time dependency effects of mRNA levels of p53, caspase-
3 and c-myc in KB cells induced with methanol extract of P. bleo. The expression of 
p53, caspase-3 and c-myc were highest at 30 min, 15 min and 6 h, respectively. The 
mRNA expression level of caspase-3 was markedly increased when the KB cells were 
treated with the methanol extract of P. bleo at 15 min (4.9-fold increase as compared to 
control cells) and significantly (p < 0.05) decreased 1.5- to 1-folds after treatment for 
30 min to 3 h. Interestingly, the caspase-3 expression level was increased again at 6 h 
(1.9-fold increase as compared to control cells). Generally, a significant increase (p < 
0.05) level of c-myc expression was observed in KB cells cultured in the presence of 
methanol extract of P. bleo compared to control, except a drastic drop at 1 h. 
Meanwhile, the expression level of p53 mRNA was slightly increased at 30 min (1.5-
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fold increase as compared to control cells), and significantly decreasing (p < 0.05) 
thereafter, to the level below the baseline.   
 Thus, the results strongly indicate that the methanol extract of P. bleo killed the 
KB cells through apoptosis mechanism mainly via the activation of caspase-3 and c-
myc while the role of p53 cannot be ruled out. The activation of caspase-3 has been 
reported to be important in mediating some of the apoptotic pathways (Janicke et al., 
1998). The c-myc protein is also important in the induction of apoptosis (Evans et al., 
1992). These findings were in agreement with the study of Tan et al. (2005) and Er et 
al. (2007) on methanol extract of P. bleo. In the study done by Tan et al. (2005), the 
authors showed that the levels of caspase-3 and c-myc proteins were elevated in the T-
47D cells (human breast cancer cell line) treated with the methanolic extract of the 
leaves of P. bleo. However, the study was carried out using conventional semi-
quantitative RT-PCR which is not accurate enough while the current study was carried 
out using RT-qPCR assay. Nevertheless, Er et al. (2007) reported that there was an 
increase in the level of apoptosis in 4T1 (mouse mammary cancer cell line) and 
NIH/3T3 (normal mouse fibroblast cell line) cells treated with increasing 
concentrations of the P. bleo extract.  Thus, the current study confirmed the result of 
Tan et al. (2005) and Er et al. (2007).  
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Figure 4.32: The mRNA expression of p53, caspase-3 and c-myc detected in KB 
cells treated with methanol extract of P. bleo for different durations. Results are 
expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
 
Ethyl acetate extract  
Figure 4.33 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in KB cells induced with ethyl acetate extract of P. bleo. The expression 
of p53, caspase-3 and c-myc were highest at 1 h, 3 h and 6 h, respectively. A significant 
increase (p < 0.05) of p53 expression was observed in the KB cells treated with ethyl 
acetate extract of P. bleo at 15 min (4.7-fold increase as compared to control cells). 
However, the expression level of p53 was significantly reduced (p < 0.05) to 3.6-fold 
after 30 min incubation and significantly increased (p < 0.05) again to 4.8-fold at 1 h, 
and decreasing thereafter.  
Whilst, the expression level of caspase-3 was slightly increased at 15 min (1.7-
fold increase as compared to control cells), then decreased at 30 min and maintained 
approximately the same level thereafter (2.8-, 2.9- and 2.7-folds as compared to control 
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cells at 1 h, 3 h and 6 h, respectively). There was an gradually increase in the c-myc 
expression observed in the KB cells with the increasing of incubation time, with the 
highest level of c-myc expression observed at 6 h (2-fold increase as compared to 
control cells).  
Thus, the results here indicate that the apoptosis elicited by the ethyl acetate 
extract on KB cells was mediated largely via p53 although the role of caspase-3 and c-
myc cannot be ruled out. Previous studies have showed that tumour suppressor protein 
p53 was an important molecule for apoptosis and cell cycle arrest (May and May, 
1999). Studies to date have also demonstrated that many natural phytochemicals could 
induce apoptosis and cell cycle arrest in p53 pathway (Ayyoubi and Muhtasib, 2007; 
Roemer et al., 2001; Pillai et al., 2004). The significantly high expression of p53 in KB 
cells induced with ethyl acetate extract of P. bleo could be due to the presence of 
bioactive compound(s) in the leaves that can induce apoptosis in the cells.  
Figure 4.33: The mRNA expression of p53, caspase-3 and c-myc detected in KB 
cells treated with ethyl acetate extract of P. bleo for different durations. Results 
are expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
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(ii) Expression level of apoptosis-related genes in the P. grandifolia cytotoxic active 
extract-treated cells 
Hexane extract  
Figure 4.34 show the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in KB cells induced with hexane extract of P. grandifolia. The 
expression of p53, caspase-3 and c-myc were highest at 6 h, respectively. It is 
noteworthy to mention that the trend of p53, caspase-3 and c-myc mRNA expression 
levels in KB cells induced with hexane extract of P. grandifolia was similar. The 
mRNA expression levels of p53, caspase-3 and c-myc were lower than the control at 
incubation time of 15 min to 3 h and increased drastically when the cells were treated 
with the extract at 6 h (2.6-, 2.5- and 3.9-folds increase as compared to the control cells, 
respectively). However, the statistical analysis did not show any significant difference 
in the expression level of p53 compared to the control. Thus, the results suggest that the 
apoptotic effects of the hexane extract of P. grandifolia in the KB cells were associated 
with the increase in p53, caspase-3 and c-myc activation.  
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Figure 4.34: The mRNA expression of p53, caspase-3 and c-myc detected in KB 
cells treated with hexane extract of P. grandifolia for different durations. Results 
are expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
 
Ethyl acetate extract  
a) KB cell line 
Figure 4.35 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in KB cells induced with ethyl acetate extract of P. grandifolia. The 
expression of p53, caspase-3 and c-myc were highest at 6 h, 15 min and 6 h, 
respectively. The trend of p53 and c-myc mRNA expression levels was similar. The 
mRNA expression levels of p53 and c-myc were lower than the control at incubation 
time of 15 min to 3 h and increased drastically when the cells were treated with the 
extract at 6 h (13.1- and 4.7-folds increase as compared to the control cells, 
respectively). Meanwhile, the expression level of caspase-3 was significantly increased 
(p < 0.05) after 15 min incubation with the extract but decreasing thereafter to the level 
below control and increased again at 6 h (4.7-fold increase as compared to the control).   
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In summary, the significant increase (p < 0.05) of p53 expression (13.1-fold 
increase as compared to the control at 6 h) in contrast to the mild increase of caspase-3 
and c-myc expression after exposure to the extract indicated that the ethyl acetate 
extract of P. grandifolia killed the KB cells through apoptosis mechanism mainly via 
the activation of p53 whereas the role of p53 and caspase-3 cannot be ruled out.   
 
Figure 4.35: The mRNA expression of p53, caspase-3 and c-myc detected in KB 
cells treated with ethyl acetate extract of P. grandifolia for different durations. 
Results are expressed as means ± standard deviation. *: Significant difference 
from the control (p < 0.05). 
 
b) MCF7 cell line 
The time dependency effects of p53, caspase-3 and c-myc mRNA levels in 
MCF7 cells induced with ethyl acetate extract of P. grandifolia is shown in Figure 4.39. 
The expression of p53, caspase-3 and c-myc were highest at 15 min, respectively. 
Figure 4.36 shows that the steady state mRNA levels of p53 and caspase-3 were 
increased when the MCF7 cells were treated with the extract at 15 min (1.5- and 3.2-
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folds increase as compared to control cells, respectively). However, the expression 
levels of p53 and caspase-3 were decreasing thereafter, to the level below control.  
Whilst, the expression level of c-myc was significantly increased (p < 0.05) 
when the cells were treated with the extract at 15 min (4.3-fold increase as compared to 
control cells), but dropped to 1.7-fold after 30 min incubation and increased again to 2-
fold at 1 h. In summary, the results here indicate that the ethyl acetate extract of P. 
grandifolia killed the MCF7 cells through apoptosis mechanism via the activation of c-
myc.  
Figure 4.36: The mRNA expression of p53, caspase-3 and c-myc detected in MCF 
7 cells treated with ethyl acetate extract of P. grandifolia for different durations. 
Results are expressed as means ± standard deviation. *: Significant difference 
from the control (p < 0.05). 
 
 (iii) Summary of expression level of apoptosis-related genes in the Pereskia spp. 
cytotoxic active extract-treated cells 
 
In summary, LUX RT-qPCR assay offers significant advantages with respect to 
the rapidity, sensitivity and reproducibility of quantification assay for gene expression. 
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The protocol for the evaluation of mRNA expression levels of apoptosis-related genes 
using LUX RT-qPCR assay developed in this study can be recommended for gene 
expression study involving natural products. 
   The LUX RT-qPCR analysis [section 4.6.5 (i) and 4.6.5 (ii)] showed the mRNA 
expression levels of c-myc were markedly increased in the cancer cells treated with the 
cytotoxic active extracts while the p53 and caspase-3 expression were only slightly 
increased as compared to c-myc in all cases, except for the P. grandifolia ethyl acetate 
extract in KB cells. The apoptotic effects of the P. grandifolia ethyl acetate extract in 
KB cells were associated with increases in all three c-myc, p53 and caspase-3 
activation.   
The results obtained here suggest that the cytotoxic active extracts of P. bleo 
and P. grandifolia contain bioactive compounds capable of inducing apoptosis in 
selected cancer cell lines.  
 
4.7 Acute oral toxicity assessment of P. bleo and P. grandifolia crude extracts 
Investigation of the acute toxicity is the first step in the toxicological analysis of 
herbal drugs (Deciga-Campos et al., 2007).  Acute oral toxicity was undertaken in the 
present study to determine the safety parameters of the leaves of P. bleo and P. 
grandifolia. Mortality, clinical signs, gross findings and body weights of mice were 
observed and measured for 14 days after the oral administration of crude methanol 
extracts of both Pereskia spp. The crude methanol extracts were used in this acute oral 
toxicity study as consumers normally consume the whole plant leaves. 
Table 4.19 showed the results of the acute toxicity of the crude extracts of P. 
bleo and P. grandifolia. There were no deaths for all doses of crude methanol extracts 
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of P. bleo and P. grandifolia tested. Throughout the 14 days observation period, all the 
mice did not show changes in behavior (i.e. ataxia, hyperactivity, hypoactivity) or 
produce any variations in the general appearance, and gained weight with no adverse 
clinical signs of toxicity at any doses.  
Since there were no deaths for all doses tested for crude methanol extracts of 
Pereskia bleo and Pereskia grandifolia (the LD50 values of crude P. bleo and P. 
grandifolia extracts were > 2500 mg/kg); this indicated that both Pereskia spp. did not 
cause acute toxicity. According to the chemical labeling and classification of acute 
systemic toxicity based on oral LD50 values which was recommended by globally 
harmonized system of classification (GHS) (OECD, 1998), crude extracts of both 
Pereskia spp. are assigned to class 5 (LD50 > 2000 mg/kg), which are termed as lowest 
toxicity class (no label; unclassified). 
In summary, the result was in agreement to that of in vitro experiments, 
whereby crude methanol extracts of P. bleo and P. grandifolia did not show 
cytotoxicity against normal MRC-5 cells (Table 4.17). Based on the outcome of acute 
toxicity, the crude extracts of both Pereskia spp. can be regarded safe in experimental 
mice. However, the crude extracts of P. bleo may not be safe to consuming over a long 
period of time as there was a report that P. bleo has mutagenice effects (Er et al., 2007). 
Thus, further studies on the mutagenic and toxicity effect over a longer period of time 
involving detection of effects on vital organ functions should be carried out to ensure 
that the plants are safe for human consumption.  
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Table 4.19: Results of the potential toxic effect of the crude extracts of P. bleo and 
P. grandifolia in mice 
 
Plants Dose (mg/kg) 
0
a
 500 1000 1500 2000 2500 
M F M F M F M F M F M F 
P. bleo 0/5
b
 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
P. grandifolia 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 
M: male ICR mice; F: female ICR mice  
a
control group (treatment without extract) 
b
Number of animals dead/number of mice 
used.  
 
4.8 Chemical constituents from the bioactive extracts of P. bleo and P. grandifolia 
 The separation and purification of chemical constituents were carried out using 
one or a combination of several chromatographic techniques, such as column 
chromatography, TLC (Thin Layer Chromatography) and prep-TLC (preparative-TLC). 
The choice of techniques depends mostly on the solubility and polarities of the 
compounds to be separated.  
 Column chromatography was used first to separate large scale extract. The 
choice of the size and length of the column depends on the amount of the extract used. 
Approximately equal volume was collected for each fraction. These fractions were then 
concentrated using rotary evaporator and monitored for purity using TLC. The selection 
of a proper solvent is vitally important to separate the compounds from its crude. 
Fractions with similar composition were combined. If a single spot was seen on the 
TLC, purification was carried out, which sometimes needs to be done two or three 
times (or more) in order to obtain pure compounds before it could be sent for further 
analysis. In some cases where the compounds were not pure, a proper solvent system 
was determined.   
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 Technique such as prep-TLC was used sometimes for further separation by 
using TLC silica gel 60 F254 glass plates (20 cm x 20 cm; Merck). Separated 
compounds were recovered by scrapping off the appropriate zones on the developed 
plate, eluting with powder with suitable solvent. The solution was then concentrated 
using rotary evaporator and the purity of residue was checked using TLC. If a single 
substance is present, purification can be carried out to obtain pure compounds before it 
could be sent for further analysis. 
 
4.8.1 Identification of compounds in hexane extract of P. bleo using GCMS 
 
Four compounds were identified from the hexane extract of P. bleo by GCMS 
analysis (Appendix B), which were methyl palmitate (13.77 %), methyl linoleate 
(4.55 %), methyl α-linolenate (19.83 %) and phytol (57.99 %). The structures of the 
above compounds are illustrated in Figure 4.37.  
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Figure 4.37: Compounds identified from the hexane extract of P. bleo using 
GCMS analysis 
 
The mass-spectral data of the identified compounds in hexane extract of P. bleo 
are as follows.  
EI-MS m/z (%) (methyl palmitate):   
270 (3, [M]
+
), 239 (2, [M-OCH3]
+
, C16H31O1
+
), 227 (8), 213 (1), 199 (2), 185 (4), 171 
(4), 157 (2), 143 (16), 129 (8), 115 (2), 107 (1), 97 (8), 87 (70, CH2CH2CO2CH3
+
), 74 
(100, C3H6O2
+
), 65 (1), 55 (32).  
 The mass spectrum gave the molecular ion peak at m/z 270, which suggested a 
molecular formula to be C17H34O2 (Appendix B1). The comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl palmitate (or methyl hexadecanoate).  
O
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202 
 
EI-MS m/z (%) (methyl linoleate):   
294 (3, [M]
+
), 263 (2, [M-OCH3]
 +
, C18H31O1
+
), 220 (1), 178 (2), 164 (6), 150 (10), 135 
(11), 123 (12), 109 (25), 95 (58), 81 (82), 67 (100), 55 (86). 
 The mass spectrum gave the molecular ion peak at m/z 294, which suggested a 
molecular formula to be C19H34O2 (Appendix B2). The comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl linoleate [or methyl (Z,Z)-9,12-octadecadienoate].  
 
EI-MS m/z (%) (methyl α-linolenate):   
292 (2, [M]
+
), 264 (2), 249 (1), 236 (2), 222 (1), 207 (1), 199 (1), 191 (1), 181 (1), 173 
(2), 163 (2), 149 (10), 135 (12), 121 (16), 108 (32), 95 (56), 87 (17), 79 (100), 67 (70), 
55 (74). 
 The mass spectrum gave the molecular ion peak at m/z 292, which suggested a 
molecular formula to be C19H32O2 (Appendix B3). The comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl α-linolenate [or methyl (Z, Z, Z)-9,12,15-octadecatrienoate].  
 
EI-MS m/z (%) (phytol):   
278 (2, [M
+
-H2O]), 137 (5, [C10H18]
+
), 123 (40, [M-CH2]
+
), 109 (15, [M-CH2]
+
), 95 (36, 
[M-CH2]
+
), 81 (38, [M-CH2]
+
), 71 (100, (CH3)2CHCH2CH2
+
), 57 (62, (CH3)2CHCH2
+
). 
 The mass spectrum of phytol (Appendix B4) did not show a molecular ion peak. 
However, a peak at m/z 278 was observed corresponding to loss of H2O. This peak is 
most noticeable in the spectra of primary alcohols (Silverstein et al., 1998). The peak at 
m/z 137 is consistent with the fragment ion [C10H18]
+
. 
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 The fragmentation of phytol can be rationalized as follows: 
 
 
 
 
 
 
 
 
 
m/z = 278, [C20H38]
+
 
                
                          
     m/z = 137, [C10H18]
+ 
The mass spectrum of phytol gives a strong base peak at m/z 71 corresponding to the 
fragment ion (CH3)2CHCH2CH2
+
. 
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4.8.2 Identification of compounds in hexane extract of P. grandifolia using GCMS 
 
Four compounds were identified from the hexane extract of P. grandifolia by 
GCMS analysis (Appendix C), which were methyl palmitate (28.27 %), methyl 
linoleate (12.60 %), methyl α-linolenate (54.83 %) and methyl stearate (1.17 %). The 
structures of the above compounds are illustrated in Figure 4.38.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.38: Compounds identified from the hexane extract of P. grandifolia using 
GCMS analysis 
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The mass-spectral data of the identified compounds in hexane extract of P. 
grandifolia are as follows.  
EI-MS m/z (%) (methyl palmitate):   
270 (3, [M]
+
), 239 (2, [M-OCH3]
+
, C16H31O1
+
), 227 (8), 213 (1), 199 (2), 185 (4), 171 
(4), 157 (2), 143 (16), 129 (8), 115 (2), 107 (1), 97 (8), 87 (70, CH2CH2CO2CH3
+
), 74 
(100, C3H6O2
+
), 65 (1), 55 (32).  
 The mass spectrum gave the molecular ion peak at m/z 270, which suggested a 
molecular formula to be C17H34O2 (Appendix C1). A comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl palmitate (or methyl hexadecanoate).  
 
EI-MS m/z (%) (methyl linoleate):   
294 (3, [M]
+
), 263 (2, [M-OCH3]
 +
, C18H31O1
+
), 220 (1), 178 (2), 164 (6), 150 (10), 135 
(11), 123 (12), 109 (25), 95 (58), 81 (82), 67 (100), 55 (86). 
 The mass spectrum gave the molecular ion peak at m/z 294, which suggested a 
molecular formula to be C19H34O2 (Appendix C2). The comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl linoleate [or methyl (Z,Z)-9,12-octadecadienoate].  
 
EI-MS m/z (%) (methyl α-linolenate):   
292 (2, [M]
+
), 264 (2), 249 (1), 236 (2), 222 (1), 207 (1), 199 (1), 191 (1), 181 (1), 173 
(2), 163 (2), 149 (10), 135 (12), 121 (16), 108 (32), 95 (56), 87 (17), 79 (100), 67 (70), 
55 (74). 
 The mass spectrum gave the molecular ion peak at m/z 292, which suggested a 
molecular formula to be C19H32O2 (Appendix C3). The comparison with NIST mass-
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spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl α-linolenate [or methyl (Z, Z, Z)-9,12,15-octadecatrienoate].  
 
EI-MS m/z (%) (Methyl stearate):   
298 (6, [M]
+
), 267 (2), 255 (8), 241 (1), 227 (1), 213 (2), 199 (6), 185 (4), 143 (21), 129 
(6), 111 (3), 97 (8), 87 (69, CH2CH2CO2CH3
+
), 74 (100, C3H6O2
+
), 55 (30). 
The mass spectrum gave the molecular ion peak at m/z 298, which suggested the 
molecular formula to be C19H38O2 (Appendix C4). The comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl stearate (methyl octadeacanoate).  
 
Structural Determination of methyl ester 
The molecular ion peak of a methyl ester is usually distinct and prominent. All 
the methyl esters identified in the present study displayed the molecular ion peak. Mass 
spectrums of all the methyl esters show peak M
+
-OCH3 which represented the fragment 
ion C O
+
R  . The ion C O
+
R gives an easily recognizable peak for esters 
and occurs at M
+
- OCH3 in methyl esters (Silverstein et al., 1998).  
For methyl palmitate and methyl stearate, the molecular ion peak is mostly 
weak in the range m/z 130 to ~200, but becomes somewhat more intense beyond this 
range. For saturated fatty ester, the most characteristic peak results from McLafferty 
rearrangement and cleavage one bond removed from the C=O group. Thus, methyl 
palmitate and methyl stearate unbranched at the α carbon gives a strong base peak at 
m/z 74 which formally represented by the ion C3H6O2
+
 results from McLafferty 
rearrangement (Silverstein et al., 1998). Mass spectrum of methyl palmitate and methyl 
stearate showed peak (m/z 87) which formally represented by the ion 
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[CH2CH2CO2CH3]
+
 is always more intense than its homologs. McLafferty 
rearrangement of methyl palmitate is showed in Figure 4.39. 
 
 
 
 
 
 
 
 
+ 
 
 
 
 
Figure 4.39: McLafferty rearrangement of methyl palmitate 
 
4.8.3 Chemical constituents from the bioactive ethyl acetate extract of P. bleo  
On repeated chromatographic purification of the active ethyl acetate fraction, 
five compounds and a mixture were isolated and identified as 2,4-di-tert-butylphenol 
(1), α-tocopherol (2), phytol (3), ß-sitosterol (4), dihydroactinidiolide (5) and a mixture 
A which consisted of campesterol (6), stigmasterol (7) and β-sitosterol (4). All the 
compounds have not been reported for this plant. The structures of compounds 1-7 are 
illustrated in Figure 4.40.  
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Figure 4.40: Chemical constituents from the bioactive ethyl acetate extract of P. 
bleo 
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 (i) Structural determination of 2,4-ditert-butylphenol (1)  
 
 
 
  
 The mass spectroscopic and the NMR spectral data obtained for compound 1 
are shown as follows:  
 
EI-MS m/z (%):   
206 (15, [M]
+
), 191 (100, [M- CH3]
+
), 175 (4), 163 (6), 57 (32).  
 
1
H-NMR (CDCl3, 399.65 MHz) δ:  
1.24 (9H, s, three methyls), 1.36 (9H, s, three methyls), 6.53 (d, J=8.39 Hz, H-6), 7.02 
(dd, J=8.39, 2.40 Hz, H-5), 7.24 (d, J=2.40 Hz, H-3). 
 
13
C-NMR (CDCl3, 100.40 MHz) δ:  
151.7 (C-1), 135.2 (C-2), 123.5 (C-3), 143.0 (C-4), 124.0 (C-5), 115.9 (C-6), 30.0 (C-7), 
34.7 (C-8), 31.6 (C-9, 10, 11), 31.8 (C-12, 13, 14).  
 
 Compound 1 obtained as yellow-coloured crystalline powder was identified as 
2,4-di-tert-butylphenol from GC-MS analysis (NIST 05 mass-spectral library, 2002) 
and comparison with published data (Kamitori et al., 1984). The mass spectrum gave a 
molecular ion peak at m/z 206, which was consistent with the molecular formula of 
OH
1
1
3
2
4
5
6
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C14H22O (Appendix D). The spectrum also showed that a methyl group is lost much 
more readily than an α hydrogen at m/z 191 consistent with the fragment ion [M-CH3]
+
.  
 The H-, 
13
C- NMR and DEPT (Distortionless Enhancement by Polarisation 
Transfer) data (Appendix D1, D2 and D3) also support the existence of 2,4-di-tert-
butylphenol. The H-NMR showed the presence of two methyl singlet peaks at δ1.24 
and δ1.36 integrating for 9 protons each. The doublet at δ6.53 (J=8.39 Hz) was 
assigned to the aromatic H-6 proton. The H-5 proton was consistent with the peaks 
centred at δ7.02 which appeared as dd (J=8.39, 2.40 Hz). The peak at δ 7.24 (d, J=2.40 
Hz) assigned to H-3 was coupled to H-5 with coupling constant of 2.40 Hz. The 
13
C-
NMR spectrum showed the presence of 14 carbons with two methyl C peaks 
integrating for six carbons, one C-O, three aromatic methyl, two quaternary and two 
quaternary aromatic carbon peaks. The NMR spectra thus support the identification of 
compound 1 as 2,4-di-tert-butylphenol.  
2,4-Di-tert-butylphenol (1) is an antioxidant widely used in the plastic industries, 
and its presence in plants cannot readily be explained biogenetically. It is highly 
probable that the plant accumulated this compound from the soil it grew in, that might 
have contained the compound. In our experience, this compound has also been detected 
in other plants like Termitomyces heimi, Pleurotus sajor-caju and Hericium erinaceus 
collected from different locations to where the P. bleo leaves were obtained 
(unpublished data from our group of researchers working on Termitomyces heimi, 
Pleurotus sajor-caju and Hericium erinaceus). The presence of 2,4-di-tert-butylphenol 
(1) in our study is not an isolated case, as it has also been reported to exist in natural 
sources by other researchers (Yoon et al., 2006; Nogueira et al., 2001; Rana and 
Blazquez, 2007). To support our finding that 2,4-di-tert-butylphenol (1) is not an 
artifact, an extraction on P. bleo was repeated using redistilled methanol and ethyl 
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acetate. GC-MS analysis on the ethyl acetate extract still showed the presence of 2,4-di-
tert-butylphenol (1) representing one of the component in the total ethyl acetate extract. 
This shows that 2,4-di-tert-butylphenol (1) is present in the extract itself and not a 
solvent artifact.  
 2,4-Di-tert-butylphenol (1) is structurally related to the well known 
antioxidant BHA (butylated hydroxyanisole). Phenolic antioxidants were reported to 
have cytoctoxic activity against cancer cells (Russo et al., 2009; Kozubek and Tyman, 
1999) and exert anticarcinogenic activity, presumably through the induction of phase II 
detoxifying enzymes such as glutathione S-transferases and quinone reductase, which 
provides prevention of tumour initiation (Yoshioka et al., 1995; Yu et al., 1997). 
Phenolic antioxidants can also decrease oxidative stress-induced carcinogenesis by 
direct scavenging of ROS (Reactive Oxygen Species) (Tanaka et al., 1997) and by 
inhibiting cell proliferation secondary to the inhibition of protein phosphorylation 
(Schreck et al, 1992). In addition, phenolic compounds were reported to pose 
antimicrobial activity (Mitova et al., 2003). 
 Cytotoxic studies by Kadoma et al. (2009), Fujisawa et al. (2004) and Saito et 
al. (2001) also showed that 2,4-di-tert-butylphenol (1) was cytotoxic active against 
HSC-2 cells (human oral carcinoma cell line), HSG cells (human submandibular gland 
carcinoma cell line) and HGF cells (human gingival fibroblasts cell line). Furthermore, 
Yoon et al. (2006) reported that 2,4-di-tert-butylphenol (1) exhibited antioxidant 
activities on copper-mediated oxidation (IC50 value of 8.2 µM), AAPH-mediated 
oxidation (IC50 value of 9.9 µM) and SIN-1 mediated oxidation (52 %) in the TBARS 
assay. Kadoma et al. (2009) and Yoon et al. (2006) also reported that 2,4-di-tert-
butylphenol (1) showed strong radical scavenging activity in DPPH assay with IC20 
value of 1.01 mM.   
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 In addition, a study on the uterotrophic effect of 2,4-di-tert-butylphenol (1) 
tested in ovariectomized CD1 mice had been conducted by Yoshimitsu et al. (2006). 
These authors made the point that there is no uterotrophic effect observed as no obvious 
changes in uteri and vagina were noticed in 2,4-di-tert-butylphenol (1) treated mice.  
  It can thus be assumed that 2,4-di-tert-butylphenol (1) may be one of the 
constituents that contribute to the reducing capacity (section 4.2.1), antioxidant activity 
(section 4.2.2-4.2.4), antimicrobial activity (section 4.3) and cytotoxic activity (section 
4.4) of the ethyl acetate extract of P. bleo.  
 
(ii) Structural determination of α-tocopherol (2)  
 
 
 
 The mass spectrum fragmentation obtained for compound 2 ia shown as follows:  
 
EI-MS m/z (%): 
430 (34, [M
+
]), 205 (8, C13H17O2
+
), 165 (100, C10H13O2
+
).  
 
 Compound 2 was obtained as yellow viscous oil and identified as α-tocopherol 
through the GC-MS analysis (NIST 05 mass-spectral library, 2002) and comparison 
with published data (Pereira et al., 2002). The mass spectrum gave a molecular ion 
peak at m/z 430, consistent with the molecular formula of C29H50O2 (Appendix E). 
OHO
R
RR
32 
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 Vitamin E, a potent antioxidant, is one of the best quenchers for singlet oxygen, 
and can act as a chain-breaking antioxidant. It occurs in nature in ≥ 8 structurally 
related forms, i.e. four forms of tocopherols (α, ß, ɤ, δ) and four types of tocotrienols (α, 
ß, ɤ, δ). Among the various forms of vitamin E that have been identified, α-tocopherol 
(2) is the form that has been extensively studied and is present in most supplements 
(Jiang et al., 2001). 
 α-Tocopherol (2) is a dietary anti-oxidant capable of eliminating free radical 
damage, inducing apoptosis and decreasing oncogene expression (Bermudez et al., 
2007). It is regarded as an intracellular antioxidant and is found to protect cells from 
carcinogenic chemicals due to its activity in inhibiting the peroxidation of 
polyunsaturated fatty acids and its damaging free-radical-mediated consequences (Choi 
and Lee, 2009; Jiang et al., 2001). Previous studies indicated that α-tocopherol 
decreases the toxicity of chemotherapy without reducing its effectiveness (Lamson and 
Brignall, 2003; Drisko et al, 2003).  
 Bermudez et al. (2007) suggested that α-tocopherol (2) might be an important 
protective agent against ovarian cancer cell growth as well as potentially effective 
therapeutic adjuvant. α-Tocopherol (2) has also been suggested to prevent prostate 
cancer (Bektic et al., 2005; Kirsh et al., 2006; Kampa et al., 2000; Zang et al., 2000), 
skin cancer (Reddy et al., 2003) and renal cell carcinoma (Wu et al., 2009). Several 
studies have confirmed α-tocopherol (2) as an anticancer agent with the animal studies 
(Steele et al., 1994; Jiang et al., 2001). 
 Therefore, α-tocopherol (2) may be one of the constituents that contributed to 
the reducing capacity (section 4.2.1), antioxidant (section 4.2.2-4.2.4), and cytotoxic 
activities (section 4.4) of the ethyl acetate extracts of P. bleo.  
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(iii) Structural determination of phytol (3) 
 
 
 
 The EI-MS and the NMR spectral data obtained for compound 3 are shown as 
follows:  
 
EI-MS m/z (%):  
278 (2, [M
+
-H2O]), 137 (5, [C10H18]
+
), 123 (40, [M-CH2]
+
), 109 (15, [M-CH2]
+
), 95 (36, 
[M-CH2]
+
), 81 (38, [M-CH2]
+
), 71 (100, (CH3)2CHCH2CH2
+
), 57 (62, (CH3)2CHCH2
+
). 
 
1
H-NMR (CDCl3, 399.65 MHz) δ:  
0.82 (12H, H-16, H-17, H-18, H-19, methyls), 0.95-1.61 (19H, m,methyls and 
methyline protons), 1.68 (3H, s, H-20), 2.00 (2H, t, J= 7.6 Hz, H-4), 4.15 (2H, d, J= 7.1 
Hz, H-1), 5.42 (1H, t, J=7.1 Hz, H-2).  
 
13
C-NMR (CDCl3, 100.40 MHz) δ:  
59.4 (C-1), 123.1 (C-2), 140.3 (C-3), 39.9 (C-4), 25.1 (C-5), 36.6 (C-6), 32.8 (C-7), 
37.3 (C-8), 24.5 (C-9), 37.4 (C-10), 32.7 (C-11), 37.3 (C-12), 24.8 (C-13), 39.4 (C-14), 
28.0 (C-15), 22.6 (C-16), 22.7 (C-17), 19.7 (C-18), 19.7 (C-19), 16.2 (C-20). 
 
 Compound 3 was obtained as a yellow viscous oil and present as the major 
component (41.2 mg; Figure 3.4) in this plant. It was identified as phytol from GC-MS 
OHR R
43 
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analysis (NIST 05 mass-spectral library, 2002) and comparison with reported data 
(Ming et al., 2004), consistent with the molecular formula of C20H40O.  
 The fragmentation of mass spectrum of phytol (3) has been discussed in section 
4.8.1. Appendix F, F1, F2 and F3 show the mass spectrum, 
1
H-NMR spectrum, 
13
C-
NMR spectrum and DEPT spectrum of phytol (3), respectively which confirmed the 
presence of phytol (3) by comparison with published data (Ming et al., 2004).   
In addition, the structure of phytol (3) suggested that it might be one of the 
constituents that contributed to the antioxidant activity (section 4.2.2-4.2.4) of the ethyl 
acetate extract of P. bleo as an electron on oxygen atom may be donated in the assay 
involving electron transfer.  
  
(iv) Structural determination of ß-sitosterol (4) 
 
 
 
 
 
 The mass spectrum and the NMR spectral data obtained for compound 4 are 
shown as follows:  
 
 
 
 
 
 
 
HO
H
H
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EI-MS m/z (%):  
414 (100, [M]
+
), 396 (57, [M-H2O]
+
), 381 (43, [M-H2O-CH3]
+
), 354 (8), 329 (42), 303 
(38), 273 (20, [M-C10H21]
+
), 255 (27, [M-C10H23]
+
), 231 (16), 213 (29), 159 (28), 145 
(40), 133 (28), 119 (26), 105 (36), 95 (29), 81 (29), 69 (20), 55 (38).  
 
1
H-NMR (CDCl3, 399.65 MHz) δ:  
0.69 (3H, s, H-18), 0.82 (3H, s, H-27), 0.83 (3H, s, H-26), 0.85 (3H, s, H-29), 0.94 (3H, 
br, H-19), 1.02 (3H, s, H-21), 0.97-2.28 (m, CH2, CH), 3.54 (H-3), 5.36 (br, H-6).  
 
13
C-NMR (CDCl3, 100.40 MHz) δ:   
37.2 (C-1), 31.7 (C-2), 71.8 (C-3), 42.3 (C-4), 140.7 (C-5), 121.7 (C-6), 31.9 (C-7), 
32.2 (C-8), 50.1 (C-9), 36.5 (C-10), 21.1 (C-11), 39.8 (C-12), 42.3 (C-13), 56.8 (C-14), 
24.3 (C-15), 28.2 (C-16), 56.0 (C-17), 11.8 (C-18), 19.4 (C-19), 36.1 (C-20), 18.8 (C-
21), 33.9 (C-22), 26.0 (C-23), 45.8 (C-24), 29.1 (C-25), 19.8 (C-26), 19.2 (C-27), 23.1 
(C-28), 12.0 (C-29). 
 
 Compound 4 was obtained as white coloured needles, identified as ß-sitosterol 
through GC-MS analysis (NIST 05 mass-spectral library, 2002) and comparison with 
reported data (Nes et al., 1992). It showed one dark blue spot on the TLC plate when 
viewed under the short wave UV light. The mass spectrum (Appendix G) showed a 
molecular ion peak at m/z 414 corresponding to the molecular formula C29H50O. The 
NMR spectral data (Appendix G1 and G2) was also consistent with ß-sitosterol by 
comparison with that reported in the literature (Nes et al., 1992). Sitosterol was also 
found to be present in Pereskia aculeata (Tan et al., 2005; Thomas et al., 1987).     
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 In the mass spectrum (Appendix G), the peak at m/z 329, m/z 303 and m/z 273 
are characteristic peak fragmentations of ring B of ß-sitosterol (4) which contains 5-
monosubstituted nucleus. The scission of C17-C20 in the side chain gave the peak at m/z 
273. Loss of a water molecule gave a characteristic peak at m/z 396, which was 
followed by the loss of the methyl group to give a peak at m/z 381. Besides that, the 
loss of a water and side chain results in the peak of m/z 255.  
Sterols are important constituents of all eukaryotes and play a vital role in plant 
cell membranes. Plant sterols possess valuable physiological activities; they are 
biogenetic precursors of many hormones and oviposition stimulants of some insects 
(Harborne, 2001). Sitosterol was reported to poses anti-hyperlipoproteinaemic, 
antibacterial, antimicotic (Yasukawa et al., 1991) and antioxidant activities (Rensburg 
et al., 2000). Therefore, the presence of ß-sitosterol (4) in P. bleo might contribute to 
the antioxidant (section 4.2.2-4.2.4) and antimicrobial activity (section 4.3) of the ethyl 
acetate extract of P. bleo.   
 
(v) Structural determination of dihydroactinidiolide (5) 
 
 
 
 
 The EI-MS spectrum of compound 5 gave the following mass spectral 
fragmentations:  
EI-MS m/z (%):  
180 (15, [M]
+
), 137 (8), 111 (100), 109 (44), 67 (30).  
O
O
5
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 Compound 5 was obtained as red viscous oil and identified as 
dihydroactinidiolide by GC-MS analysis (NIST 05 mass-spectral library, 2002) and the 
reported spectroscopic data (Eidman and MacDougall, 2006; Borse et al., 2002; Huang 
et al., 2006). The mass spectrum gave a molecular ion peak at m/z 180, consistent with 
the molecular formula C11H16O2 (Appendix H).  
Dihydroactinidiolide (5), which is a metabolite of ß-carotene (Sakan et al., 
1967), was isolated from the ethyl acetate extract of P. bleo. It is a monoterpenoid and 
structurally similar to the C11-terpene lactones that arise from the biological or 
oxidative degradation of carotenoids and has been isolated from various plants and 
insect sources. It has also been identified as the flavor molecule in tea and tobacco 
(Eidman et al., 2006; Borse et al., 2002; Huang et al., 2006). To our knowledge, there 
is no cytotoxcity data of dihydroactinidiolide (5) reported in the literature.  
 
(vi) Structural determination of mixture of sterols (mixture A) 
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 The mixture A appeared as white colored needles, identified as consisting of 
campesterol (6, 14.33 %), stigmasterol (7, 4.95 %) and β-sitosterol (4, 70.21 %) 
through GC-MS analysis (Appendix I). The sitosterol and stigmasterol were also found 
to be present in Pereskia aculeata (Tan et al., 2005; Thomas et al., 1987).     
Plant sterols are compounds with similar structural skeleton as cholesterol 
(Berger et al., 2004) and found in significant amounts in various parts of plants 
including seeds, nuts and vegetable oils (Moghadasian, 2000). The most abundant plant 
sterols are sitosterol, campesterol and stigmasterol (Moreau et al., 2002). Plant sterols 
have been investigated as one of the safe potential alternative methods in lowering 
plasma cholesterol levels. Several human studies have shown that plant sterols/stanols 
significantly reduce plasma total and LDL cholesterol (Moghadasian, 2000).  
In addition to their cholesterol lowering effect, plant sterols may possess anti-
atherosclerosis (Moghadasian et al., 1997; Moghadasian et al., 1999), antibacterial 
(Yasukawa et al., 1991), anti-inflammation (Bouic, 2001) and antioxidation activities 
(Rensburg et al., 2000). Particularly, ß-sitosterol (4) was reported to poses anti-
hyperlipoproteinaemic, antibacterial, antimicotic (Yasukawa et al., 1991) and 
antioxidant activity (Rensburg et al., 2000; Homma et al., 2003; Wang et al., 2002).  
Therefore, the presence of a mixture of sterols (mixture A) in P. bleo might 
contribute to the antioxidant (section 4.2.2-4.2.4) and antimicrobial activity (section 4.3) 
of the ethyl acetate extract of P. bleo. The mass-spectral data of campesterol (6), 
stigmasterol (7) and β-sitosterol (4) are follows.  
EI-MS m/z (%) (Campesterol, 6):  
400 (42, [M
+
]), 382 (34), 367 (20), 315 (30), 289 (30), 55 (100).  
220 
 
 The mass spectrum gave a molecular ion peak at m/z 400, consistent with the 
molecular formula to be C28H48O (Appendix I1). It was identified as campesterol 
through GC-MS analysis (NIST 05 MS Library, 2002) and reported data (Gutierrez, 
2006).  
 
EI-MS m/z (%) (Stigmasterol, 7):  
412 (16, [M
+
]), 394 (4, [M-H2O]
+
), 369 (2), 351 (6), 300 (16), 271 (16), 255 (22), 229 
(5), 213 (22), 159 (52), 145 (54), 133 (58), 105 (58), 81 (82), 64 (69), 55 (100).  
 The mass spectrum (Appendix I2) showed the molecular ion peak at m/z 412, 
which corresponding to the molecular formula to be C29H48O. The comparison of mass 
spectral data with NIST mass-spectral library (NIST 05 MS Library, 2002) and 
reported data (Gutierrez, 2006) confirmed this compound as stigmasterol.  
 
EI-MS m/z (%) (ß-Sitosterol, 4):  
414 (84, [M]
+
), 396 (66, [M-H2O]
+
), 381 (40, [M-H2O-CH3]
+
), 354 (10), 329 (48), 303 
(49), 273 (30, [M-C10H21]
+
), 255 (48, [M-C10H23]
+
), 231 (28), 213 (62), 159 (66), 145 
(100), 133 (66), 119 (60), 105 (84), 95 (58), 81 (60), 69 (40), 55 (52).  
 The mass spectrum (Appendix I3) showed a molecular ion peak at m/z 414, 
consistent with the molecular formula C29H50O. A comparison of its mass spectral data 
with NIST mass-spectral library (NIST 05 MS Library, 2002) and published data (Nes 
et al., 1992) confirmed this compound as ß-sitosterol. 
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4.8.4 Chemical constituents from the bioactive ethyl acetate extract of P. 
grandifolia 
 
On repeated chromatographic purification of the active ethyl acetate fraction, 
compound 1 was identified as 2,4-di-tert-butylphenol, 2 as α-tocopherol, 4 as ß-
sitosterol, 8 as phytone and the mixture B was consisted of methyl palmitate (9), methyl 
oleate (10), methyl stearate (11) and 2,4-di-tert-butylphenol (1). All the compounds 
have not been reported for this plant. The structures of compounds 1, 2, 4, 8, 9, 10 and 
11 are illustrated in Figure 4.41. It is interesting to note that 2,4-ditert-butylphenol (1), 
α-tocopherol (2) and ß-sitosterol (4) were also isolated from P. bleo as previously 
reported (section 4.8.1).  
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Figure 4.41: Chemical constituents from the bioactive ethyl acetate extract of P. 
grandifolia 
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(i) Structural determination of 2,4-di-tert-butylphenol (1)  
 
 
 
 
 Compound 1 was identified as 2,4-di-tert-butylphenol by GC-MS analysis 
which gave its mass-spectral data as follows:  
 
EI-MS m/z (%):   
206 (15, [M]
+
), 191 (100, [M- CH3]
+
), 57 (32). 
  
 Compound 1 was obtained as yellow coloured crystalline powder. The mass 
spectrum gave the molecular ion peak at m/z 206, which suggested a molecular formula 
of C14H22O (Appendix J). The spectrum showed that a methyl group is lost readily at 
m/z 191. The mass-spectral data was also consistent with the published data (Kamitori 
et al., 1984).  
 Based on previous reports  (Yoshioka et al., 1995; Yu et al., 1997; Tanaka et 
al., 1997; Schreck et al, (1992; Mitova et al., 2003; Russo et al., 2009; Kozubek and 
Tyman, 1999), 2,4-di-tert-butylphenol (1) might be responsible for the reducing 
capacity (section 4.2.1), antioxidant activity (section 4.2.2-4.2.4), antimicrobial activity 
(section 4.3) and cytotoxic activity (section 4.4) of the ethyl acetate extract of P. 
grandifolia.  
 
 
OH
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(ii) Structural determination of α-tocopherol (2)  
 
 
 
  
 Compound 2 obtained as yellow vicous oil was identified as α-tocopherol by 
GC-MS which gave the mass-spectral fragmentation as follows:  
 
EI-MS m/z (%): 
430 (20, [M
+
]), 165 (100, C10H13O2), 136 (10), 121 (12), 57 (42).  
 
 The mass spectrum gave a molecular ion peak at m/z 430, which was consistent 
with the molecular formula C29H50O2 (Appendix K). Based on previous reports 
(Bermudez et al., 2007; Choi and Lee, 2009; Lamson and Brignall, 2003; Drisko et al, 
2003; Bektic et al., 2005; Kirsh et al., 2006; Kampa et al., 2000; Zang et al., 2000), α-
tocopherol (2) which is a phenolic compound might be one of the constituent 
responsible for the reducing capacity (section 4.2.1), antioxidant activity (section 4.2.2-
4.2.4), and cytotoxic activity (section 4.4) of the ethyl acetate extracts of P. grandifolia.  
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(iii) Structural determination of ß-sitosterol (4)  
 
 
 
 
 
 The EI-MS spectrum of compound 4 gave the following mass spectral 
fragmentations:  
EI-MS m/z (%):  
414 (100, [M]
+
), 396 (80, [M-H2O]
+
), 381 (40, [M-H2O-CH3]
+
), 354 (8), 329 (44), 303 
(40), 273 (20, [M-C10H21]
+
), 255 (30, [M-C10H23]
+
), 231 (14), 213 (34), 159 (34), 145 
(54), 133 (34), 119 (32), 105 (46), 81 (38), 69 (24), 55 (48).  
 
 The mass spectrum (Appendix L) showed a molecular ion peak at m/z 414 
corresponding to the molecular formula C29H50O. The comparison of its mass spectral 
data with NIST mass-spectral library (NIST 05 MS Library, 2002) and published data 
(Nes et al., 1992) confirmed this compound as ß-sitosterol. 
According to previous reports (Moghadasian et al., 1997; Moghadasian et al., 
1999; Yasukawa et al., 1991; Bouic, 2001; Rensburg et al., 2000; Homma et al., 2003; 
Wang et al., 2002), the presence of ß-sitosterol (4) might contribute to the antioxidant 
(section 4.2.2-4.2.4) and antimicrobial activity (section 4.3) of the ethyl acetate extract 
of P. grandifolia.  
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(iv) Structural determination of phytone (8)  
 
 
 
 The EI-MS spectrum of compound 8 gave the following mass spectral 
fragmentations:  
 
EI-MS m/z (%):   
268 (1, [M]
+
), 250 (3, [M-OH2]
+
), 235 (1), 225 (1), 210 (2), 194 (2), 179 (3), 165 (4), 
151 (2), 137 (5), 109 (22), 95 (20), 85 (25), 71 (44), 58 (100).  
 
Compound 8 was obtained as yellow coloured crystalline powder. The mass 
spectrum gave the molecular ion peak at m/z 268, which suggested the molecular 
formula of C18H36O (Appendix M). The comparison with NIST mass-spectral library 
(NIST 05 MS Library, 2002) and published data (Uechi et al., 2007) confirmed this 
compound as phytone. 
Phytone (8) is a phytol degradation biomarker in chlorophyll (Alves et al., 2001; 
Figueiredo et al., 2007) and was patented in United States in 1994 (Patent Number: 
5,318.783) as it showed biological activity against herbivorous insects, especially insect 
graminivores.  
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(v) Structural determination of mixture B  
  
 
 
 
 
 
 
 
 
 The mixture B appeared as yellow vicious oil and identified as consisting of 
2,4-di-tert-butylphenol (1, 80.82 %), methyl palmitate (9, 15.81 %), methyl oleate (10, 
1.74 %) and methyl stearate (11, 1.63 %) by GC-MS analysis (Appendix N).  
 The presence of 2,4-di-tert-butylphenol (1) in the mixture was identified by GC-
MS which gave the full mass spectral data (Appendix N1). Comparison with published 
data (Kamitori et al., 1984) also confirmed this identification.  
EI-MS m/z (%) (2,4-di-tert-butylphenol, 1):   
206 (16, [M]
+
), 191 (100, [M-CH3]
+
), 175 (4), 163 (5), 147 (2), 141 (1), 135 (2), 128 
(2), 121 (2), 115 (4), 107 (4), 91 (4), 74 (4), 65 (1), 57 (14), 51 (1). 
 The mass spectrum gave the molecular ion peak at m/z 206, which suggested a 
molecular formula of C14H22O (Appendix N1). A base peak at m/z 191 showed the loss 
of a methyl group.  
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 The EI-MS spectrum of compound 9 gave the following mass spectral 
fragmentations:  
EI-MS m/z (%) (methyl palmitate, 9):   
270 (6, [M]
+
), 239 (4, [M- OCH3]
+
, C16H31O1
+
), 227 (10), 213 (2), 199 (4), 185 (5), 171 
(5), 157 (2), 143 (22), 129 (8), 115 (4), 107 (1), 97 (7), 87 (70, CH2CH2CO2CH3
+
), 74 
(100, C3H6O2
+
), 65 (1), 55 (30).  
 The mass spectrum gave the molecular ion peak at m/z 270, which suggested a 
molecular formula to be C17H34O2 (Appendix N2). A comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl palmitate (or methyl hexadecanoate).  
 
 The EI-MS spectrum of compound 10 gave the following mass spectral 
fragmentations:  
EI-MS m/z (%) (Methyl oleate, 10):  
296 (2, [M]
+
), 264 (12), 246 (1), 235 (2), 222 (8), 207 (2), 194 (2), 180 (8), 166 (4), 152 
(6), 137 (10), 123 (14), 111 (20), 97 (39), 83 (42), 69 (56), 55 (100).  
 The mass spectrum gave the molecular ion peak at m/z 296, which suggested 
amolecular formula to be C19H36O2 (Appendix N3). A comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl oleate.   
 
 The EI-MS spectrum of compound 11 gave the following mass spectral 
fragmentations:  
EI-MS m/z (%) (Methyl stearate, 11):   
298 (6, [M]
+
), 267 (2), 255 (8), 241 (1), 227 (1), 213 (2), 199 (6), 185 (4), 143 (21), 129 
(6), 111 (3), 97 (8), 87 (69, CH2CH2CO2CH3
+
), 74 (100, C3H6O2
+
), 55 (30). 
229 
 
The mass spectrum gave the molecular ion peak at m/z 298, which suggested the 
molecular formula to be C19H38O2 (Appendix N4). A comparison with NIST mass-
spectral library (NIST 05 MS Library, 2002) and Adams (2001) confirmed this 
compound as methyl stearate (methyl octadeacanoate).  
 
4.9 Cytotoxic and apoptosis effects of chemical constituents isolated from the 
bioactive ethyl acetate extracts of P. bleo and P. grandifolia 
 
It is generally known that ethnomedical data substantially increases the chances 
of finding active plants relative to a random approach (Cordell et al., 1991; Chapuis et 
al., 1988; Cragg et al., 1994). The consequence is that, once having found activity in 
the plant from the ethopharmacological observation (e.g. raw or concoction brewed 
from the plant leaves shows effect for cancer treatment), there is a desire to determine 
the chemical structures of the chemical constituents that are responsible for the activity, 
as not all the chemical constituents in the extracts have the same activity.  
 In the present study, the chemical constituents isolated from the bioactive 
extracts of P. bleo and P. grandifolia were tested for their cytotoxic activity against five 
human carcinoma cell lines, namely KB, CasKi, HCT 116, MCF7 and A549, and non-
cancer cell line (MRC-5). Only chemical constituents which were active in cytotoxic 
activity and detected with DNA fragmentation were tested in the gene expression study. 
According to US NCI plant screening program, a pure compound is generally 
considered to have active cytotoxic effect if the IC50 value, following incubation 
between 48 to 72 hs is ≤ 4 μg/ml (Lee and Houghton, 2005; Boik, 2001; Geran et al., 
1997; Geran et al., 1972; Swanson and Pezzuto, 1990). In the current study, the 
chemical constituents that showed cytotoxic effect with IC50 value ≤ 6 μg/ml were 
subjected to apoptosis detection and apoptotic-related gene expression study.  
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 For the gene expression study, concentration of the chemical constituent needed 
to achieve 50 % growth inhibition (IC50) was used to stimulate the cells over the period 
of 6 h. The mRNA expression levels of the apoptotic-related genes, i.e. p53, caspase-3 
and c-myc in treated cells were carried out using the two-step LUX RT-qPCR assay as 
described in section 3.7.3. The mRNA level of ß-actin was used as internal reference 
gene for template levels.  
 
4.9.1 Cytotoxic and apoptosis effects of 2,4-di-tert-butylphenol (1)   
 (i) Cytotoxic activity of 2,4-di-tert-butylphenol (1) 
 Antioxidant phenols have been epidemiologically associated with a reduced 
incidence of cancer (Willet et al., 1995; Trichopoulou, 1995), while several in vitro and 
in vivo studies have indicated that they exhibit anticancer activity via different 
molecular pathways (Liang et al., 1999; Ahn et al., 1999).  Phenols such as rutin and 
syringic acid were reported to have chemopreventive activity in laboratory animal 
models through modulation of cell proliferation (Tanaka et al., 1999) and 
antiproliferative activity towards HL-60 cells (Hirota et al., 2000), respectively.  
 2,4-Di-tert-butylphenol (1) which is a phenolic compound, was isolated from 
P. bleo as well as P. grandfolia. In the present study, 2,4-di-tert-butylphenol (1) 
displayed very remarkable cytotoxic activity against KB cells with an IC50 value of 0.81 
µg/ml and strong cytotoxicity against MCF7 (IC50 5.75 µg/ml), A549 (IC50 6 µg/ml) 
and CasKi cells (IC50 4.5 µg/ml). The results of cytotoxicity screening (IC50 values in 
µg/ml and µM) of 2,4-di-tert-butylphenol (1) are summarized in Table 4.20. The in 
vitro growth inhibitions of 2,4-di-tert-butylphenol (1) against selected human cell lines 
are shown in Figure 4.42. Percentage of inhibition was increased with increment in 2,4-
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di-tert-butylphenol (1) concentrations. The above data thus support the findings that 
phenolic antioxidants exert cytoctoxic activity against cancer cells (Russo et al., 2009; 
Dedoussis et al., 2005; Kozubek and Tyman, 1999).  
 
Figure 4.42: The in vitro growth inhibitions of 2,4-di-tert-butylphenol (1) against 
selected human cell lines determined by neutral red cytotoxicity assay. Each value 
is expressed as mean ± standard deviation of three measurements. 
 
 
 
Table 4.20: Cytotoxic activity (IC50 values) of 2,4-di-tert-butylphenol (1) against 
selected human cell lines 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
2,4-di-tert-
butylphenol (1) 
0.81 
(3.93) 
5.75 
(27.91) 
4.5 
(21.84) 
29 
(140.78) 
6 
(29.13) 
20 
(97.09) 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
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 (ii) Induction of apoptosis by 2,4-di-tert-butylphenol (1) on selected cells    
Phenolic compounds such as rutin have been reported to induce apoptosis in 
various cancer cell lines (Romero et al., 2002). Gallic acid has also been shown to 
induce apoptosis in lung cancer cells (Ohno et al., 2001), human stomach cancer cells, 
colon adenocarcinoma cells (Yoshioka et al., 2000) and human erythroleukemic cells 
(Aoki et al., 2001). Furthermore, the phenolic antioxidant BHA which is structurally 
related to 2,4-di-tert-butylphenol (1), was reported to induce mitochondria-cytochrome 
c release-caspase activation pathway leading to apoptosis (Kong et al., 2001).  
In DeadEnd
TM 
Colorimetric Apoptosis Detection System (Promega), 2,4-di-tert-
butylphenol (1) was able to induce apoptosis in KB, MCF7, A549 and CasKi cell lines 
as indicated by the darker staining of nuclei of treated cells. The DNA fragmentation 
was evident after 24 h treatment. The exposure to the vehicle (DMSO; negative control) 
did not cause nuclear alterations as confirmed by the absence of staining.  The results 
thus support the findings that phenolic antioxidants induce apoptosis in cancer cells 
(Dedoussis et al., 2005).    
 
(iii) Expression level of apoptosis-related genes in 2,4-di-tert-butylphenol (1)-
treated cells 
KB cell line 
 Figure 4.43 shows the time dependency effects of mRNA levels of p53, 
caspase-3 and c-myc in KB cells induced 2,4-di-tert-butylphenol (1). The results 
strongly indicate that 2,4-di-tert-butylphenol (1) killed the KB cells through apoptosis 
mechanism via the activation of p53 and caspase-3. The KB cells treated with 2,4-di-
tert-butylphenol (1) showed significantly strong up-regulation in p53 and caspase-3 
expression. Figure 4.43 shows that the steady state mRNA levels of p53 and caspase-3 
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were increased drastically when the KB cells were treated with the extract at 15 min 
(99.9- and 145.9-folds increase as compared to control cells, respectively) and reduced 
to 45.2- and 7.6-fold, respectively, after 1 h incubation, increased again to 93.8- and 
101.9-fold, respectively, at 3 h and finally 227.6- and 31.8-fold, respectively, at 6 h.   
 
Figure 4.43: The mRNA expression of p53, caspase-3 and c-myc detected in KB 
cells treated with 2,4-di-tert-butylphenol (1) for different durations. Results are 
expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
 
MCF7 cell line  
Figure 4.44 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in MCF7 cells induced with 2,4-di-tert-butylphenol (1). Interestingly, the 
mRNA expression level of p53, caspase-3 and c-myc were highest at 6 h incubation 
(31-, 12- and 38.2-fold increase as compared to control cells, respectively). In general, 
an increased level of p53 expression was observed in MCF7 cells treated with 2,4-di-
tert-butylphenol (1) except a significant drop (p < 0.05) at 1 h of incubation. Whilst, a 
reduction of c-myc expression level was observed in treated MCF7 cells from 30 min to 
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3 h incubation after a drastic increase at 15 min (9.9-fold increase as compared to 
control cells). However, the c-myc expression increased again at 6 h (38.2-fold increase 
as compared to control cells). In summary, the result here strongly indicates that 2,4-di-
tert-butylphenol (1) killed the MCF7 cells through apoptosis mechanism mainly via the 
activation of p53 and c-myc.  
Figure 4.44: The mRNA expression of p53, caspase-3 and c-myc detected in MCF7 
cells treated with 2,4-di-tert-butylphenol (1) for different durations. Results are 
expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
 
CasKi cell line  
Figure 4.45 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in CasKi cells induced with 2,4-di-tert-butylphenol (1). It is noteworthy 
to mention that the trend of p53, caspase-3 and c-myc mRNA expression levels in 
CasKi cells induced with 2,4-di-tert-butylphenol (1) was similar. The mRNA 
expression levels of p53, caspase-3 and c-myc were lower than the control at incubation 
time of 15 min to 3 h and increased drastically when the cells were treated with the 
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extract at 6 h (3.7-, 1.8- and 2.0-folds increase as compared to the control cells, 
respectively). However, the statistical analysis did not show any significant difference 
in the expression level of caspase-3 compared to the control. In summary, the results 
indicate that 2,4-di-tert-butylphenol (1) killed the CasKi cells through apoptosis 
mechanism mainly via the activation of p53 while the role of caspase-3 and c-myc 
cannot be ruled out.  
Figure 4.45: The mRNA expression of p53, caspase-3 and c-myc detected in CasKi 
cells treated with 2,4-di-tert-butylphenol (1) for different durations. Results are 
expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
     
A549 cell line  
Figure 4.46 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in A549 cells induced with 2,4-di-tert-butylphenol (1). The results 
strongly indicate that 2,4-di-tert-butylphenol (1) killed the A549 cells through apoptosis 
mechanism mainly via the activation of p53. There was an increase in the level of p53 
expression observed in the A549 cells treated with the increasing of incubation time 
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with 2,4-di-tert-butylphenol (1). Figure 4.46 shows that the steady state mRNA level of 
p53 was 1.7-fold increased when treated with 2,4-di-tert-butylphenol (1) at 15 min. The 
p53 expression was significantly increased (p < 0.05) at 30 min (4.5-fold increase as 
compared to control cells) and 1 h (4.6-fold increase as compared to control cells), 
respectively. However, the expression levels of p53 were reduced to 1.7- and 1.1-fold, 
after 3 h and 6 h respectively. On the contrary, the expression levels of caspase-3 and c-
myc were slightly increased to 1.1- and 1.5-fold, respectively, after 15 min incubation 
and decreasing thereafter to the level below control for the incubation time of 30 min to 
3 h before slightly increased again to 1.2- and 1.4-fold, respectively, at 6 h.  
 
Figure 4.46: The mRNA expression of p53, caspase-3 and c-myc detected in A549 
cells treated with 2,4-di-tert-butylphenol (1) for different durations. Results are 
expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
 
 
 
237 
 
4.9.2 Cytotoxic and apoptosis effects of α-tocopherol (2)   
(i) Cytotoxic activity of α-tocopherol (2)   
 α-Tocopherol (2) was isolated from P. bleo as well as P. grandfolia. The results 
of cytotoxicity screening (IC50 values in µg/ml and µM) of α-tocopherol (2) are 
summarized in Table 4.21. The in vitro growth inhibitions of α-tocopherol (2) against 
selected human cell lines are shown in Figure 4.47. Percentage of inhibition was 
increased with the increment in α-tocopherol (2) concentrations.  
 In the present study, α-tocopherol (2) displayed pronounced cytotoxicity against 
CasKi (IC50 6 µg/ml) and A549 (IC50 6 µg/ml) but weak cytotoxicity against HCT 116 
cell line (IC50 31 µg/ml). The strong cytotoxicity of α-tocopherol (2) against CasKi 
cells confirms the research findings of Al-Sherbini et al. (2009) that α-tocopherol (2) 
was significantly decreased the viability of cervical cancer cells in a concentration 
dependant manner. Whilst, the weak cytotoxicity of α-tocopherol (2) against HCT 116 
cell line in the present study support the finding reported by Campbell et al. (2006) that 
α-tocopherol (2) is a poor inhibitor against HCT 116 colon cancer cells. In addition, the 
low cytotoxicty of α-tocopherol (2) against MRC 5 cells (IC50 30.5 µg/ml) in the 
present study also supporta the result reported by Melnikova et al. (1999). The other 
result of obtained here is also consistent with other reports (Hao et al., 2009; Bermudez 
et al., 2007; Lamson and Brignall, 1999; Drisko et al., 2003; Kogure et al., 2005; Wu et 
al., 2009) on cytotoxic activities in human cell lines.  
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Figure 4.47: The in vitro growth inhibitions of α-tocopherol (2) against selected 
human cell lines determined by neutral red cytotoxicity assay. Each value is 
expressed as mean ± standard deviation of three measurements. 
 
Table 4.21: Cytotoxic activity (IC50 values) of α-tocopherol (2) against selected 
human cell lines 
 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
α-Tocopherol (2) 
8 
(18.60) 
7.5 
(17.44) 
6 
(13.95) 
31 
(72.09) 
6 
(13.95) 
30.5 
(70.93) 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
 
(ii) Induction of apoptosis by α-tocopherol (2) on selected cells    
 In order to determine whether the cytotoxic effects of α-tocopherol (2) was due 
to apoptosis, CasKi and A549 cells were treated with α-tocopherol (2) for 24 h and 
modified TUNEL assay (DeadEnd
TM 
Colorimetric Apoptosis Detection System, 
239 
 
Promega) was performed. The nuclei of CasKi and A549 cells treated with α-
tocopherol (2) were stained dark brown while none of the cell nucleus was stained dark 
in negative control. The results here thus support the findings that α-tocopherol (2) is 
able to induce apoptosis in cancer cells (Bermudez et al., 2007; Schwartz et al., 2001; 
McCormick and Parker, 2004; Melnikova et al., 1999; Kline et al., 2001; Boscoboinik 
et al., 1991).  
 
(iii) Expression level of apoptosis-related genes in α-tocopherol (2)-treated cells 
CasKi cell line 
 Figure 4.48 shows the time dependency effects of mRNA levels of p53, 
caspase-3 and c-myc in CasKi cells induced α-tocopherol (2). After incubation with α-
tocopherol (2) for various duration, p53 expression was strongly up-regulated 
significantly (p < 0.05) whereas caspase-3 and c-myc expression was substantially 
down-regulated significantly (p < 0.05). Figure 4.48 shows that the steady state mRNA 
level of p53 was significantly increased (p < 0.05) when the cells were treated with α-
tocopherol (2) at 15 min (5.1-fold increase as compared to control cells) and increased 
significantly again at 30 min (10-fold increase as compared to control cells) at 1 h. In 
summary, the results strongly indicate that α-tocopherol (2) killed the CasKi cells 
through apoptosis mechanism mainly via the activation of p53. The result here thus 
support the findings that α-tocopherol (2) exhibits cancer formation by stimulating the 
expression of p53 cancer suppressor gene (Schwartz et al., 1993; Melnikova et al., 
1999; Kline et al., 2001). 
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Figure 4.48: The mRNA expression of p53, caspase-3 and c-myc detected in CasKi 
cells treated with α-tocopherol (2) for different durations. Results are expressed as 
means ± standard deviation. *: Significant difference from the control (p < 0.05). 
 
A549 cell line 
 Figure 4.49 shows the time dependency effects of mRNA levels of p53, 
caspase-3 and c-myc in A549 cells induced α-tocopherol (2). Figure 4.49 shows that the 
steady state mRNA level of caspase-3 was increased drastically when the cells were 
treated with α-tocopherol (2) at 15 min (6.9-fold increase as compared to control cells) 
and decreasing thereafter to 1.2-fold at 6 h. At the meanwhile, the p53 expression was 
slightly increased significantly (p < 0.05) at 15 min (1.3-fold increase as compared to 
control cells) and decreasing thereafter, to the level below baseline. In addition, a 
significant increase (p < 0.05) was observed in c-myc expression at 15 min (2.7-fold 
increase as compared to control cells) and decreased to 1.3- and 1.4-fold at 30 min and 
1 h, respectively, and decreasing thereafter, to the level below the baseline. Thus, the 
result here strongly indicates that α-tocopherol (2) killed the A549 cells through 
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apoptosis mechanism mainly via the activation of caspase-3 while the role of p53 and 
c-myc cannot be totally ruled out.  
 
Figure 4.49: The mRNA expression of p53, caspase-3 and c-myc detected in A549 
cells treated with α-tocopherol (2) for different durations. Results are expressed as 
means ± standard deviation. *: Significant difference from the control (p < 0.05). 
 
4.9.3 Cytotoxic effect of phytol (3)   
 In the present study, phytol (3) was isolated from the ethyl acetate extract of P. 
bleo. The in vitro growth inhibitions of phytol (3) against selected human cell lines are 
shown in Figure 4.50. Percentage of inhibition was increased with the increment in 
phytol (3) concentrations. According to previous study, phytol (3) showed some 
antiproliferative effect against P388 mouse lymphocytic leukemia cells (Phutdhawong 
et al., 2004), molt 4B lymphoid leukemia cells (Hibasami et al., 2002), HT-29 human 
colon cancer cells, MG-63 osteosarcoma cells, HeLa human cervix carcinoma cells, 
HL-60 human promyelocytic leukemia cells and AZ-521 gastric cancer cells (Lee et al., 
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1999; Block et al., 2004). Whilst, phytol (3) demonstrated relatively strong cytotoxic 
activity against KB cells (IC50 7.1 µg/ml) in comparison with other human cell lines in 
the present study (Table 4.22).    
 As reported by previous study, phytol (3) was found to induce apoptotic cell 
death (Komiya et al, 1999). However, phytol (3) was not subjected to apoptosis 
detection in the present study as only the chemical constituents that showed cytotoxic 
effect with IC50 value ≤ 6 μg/ml were subjected to apoptosis detection in the current 
study.  
 
Figure 4.50: The in vitro growth inhibitions of phytol (3) against selected human 
cell lines determined by neutral red cytotoxicity assay. Each value is expressed as 
mean ± standard deviation of three measurements. 
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Table 4.22: Cytotoxic activity (IC50 values) of phytol (3) against selected human 
cell lines 
 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
phytol (3) 
7.1 
(23.99) 
34 
(114.86) 
18 
(60.81) 
100 
(337.84) 
31 
(104.73) 
74.3 
(251.01) 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
 
4.9.4 Cytotoxic effect of ß-sitosterol (4)   
 ß-Sitosterol (4) was isolated from both P. bleo and P. grandifolia. The in vitro 
growth inhibitions of ß-sitosterol (4) against selected human cell lines are shown in 
Figure 4.51. The percentage inhibition was increased with increase in ß-sitosterol (4) 
concentrations. In the present study, β-sitosterol (4) did not display cytotoxic effects 
against the tested cell lines (Table 4.23). The results obtained here were in agreement 
with published data (Awad et al., 2000; Block et al., 2004; Bennani et al., 2007; 
Jackson et al., 2000; Moghadasian, 2000). There have been reports that plant sterols are 
able to stimulate estrogen dependent cancer cells in vitro (e.g. Ju et al., 2004). The 
MCF7 cell line used in this study was purchased from ATCC. It was reported that 
MCF7 cells from ATCC were unaffected by estrogen or antiestrogen (Osborne et al., 
1987). Thus, the result showed that the sterols have weak inhibition on the growth of 
MCF7 cells.  
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Figure 4.51: The in vitro growth inhibitions of ß-sitosterol (4) against selected 
human cell lines determined by neutral red cytotoxicity assay. Each value is 
expressed as mean ± standard deviation of three measurements. 
 
Table 4.23: Cytotoxic activity (IC50 values) of ß-sitosterol (4) against selected 
human cell lines 
 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
ß-Sitosterol (4) 
> 100 
(> 241.55) 
72 
(173.91) 
62 
(149.76) 
> 100 
(> 241.55) 
78 
(188.41) 
> 100 
(> 241.55) 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
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4.9.5 Cytotoxic and apoptosis effects of dihydroactinidiolide (5)  
(i) Cytotoxic activity of dihydroactinidiolide (5) 
 In this study, dihydroactinidiolide (5) demonstrated relatively strong cytotoxic 
effect against HCT 116 cells (IC50 5.0 µg/ml; Table 4.24) in comparison with other 
human cell lines. The in vitro growth inhibitions of dihydroactinidiolide (5) against 
selected human cell lines are shown in Figure 4.52. Percentage of inhibition was 
increased with the increment in dihydroactinidiolide (5) concentrations. 
 
Figure 4.52: The in vitro growth inhibitions of dihydroactinidiolide (5) against 
selected human cell lines determined by neutral red cytotoxicity assay. Each value 
is expressed as mean ± standard deviation of three measurements. 
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Table 4.24: Cytotoxic activity (IC50 values) of dihydroactinidiolide (5) against 
selected human cell lines 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
Dihydroactinidiolide 
(5) 
6.7 
(37.22) 
30 
(166.67) 
40 
(222.22) 
5 
(27.78) 
97 
(538.89) 
91.3 
(507.22) 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
 
(ii) Induction of apoptosis by dihydroactinidiolide (5) on HCT 116 cells    
 According to Table 4.24, dihydroactinidiolide (5) demonstrated relatively strong 
cytotoxic effect against HCT 116 cells. In order to determine whether the cytotoxic 
effects of dihydroactinidiolide (5) was due to apoptosis, HCT 116 cells were treated 
with dihydroactinidiolide (5) for 24 h and modified TUNEL assay was performed. The 
nuclei of HCT 116 cells treated with dihydroactinidiolide (5) were stained dark brown, 
but very few in control cells.    
 
(iii) Expression level of apoptosis-related genes in dihydroactinidiolide (5)-treated 
HCT 116 cells    
 Figure 4.53 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in HCT 116 cells induced with dihydroactinidiolide (5). Figure 4.53 
shows that the expression level of caspase-3 was increased drastically when the HCT 
116 cells were treated with dihydroactinidiolide (5) at 15 min (4.7-fold increase as 
compared to control cells) and 30 min (20.3-fold increase as compared to control cells) 
and decreasing thereafter. The result here strongly indicates that dihydroactinidiolide (5) 
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killed the HCT 116 cells through apoptosis mechanism mainly via the activation of 
caspase-3 while the role of p53 and c-myc cannot be totally ruled out. 
 
Figure 4.53: The mRNA expression of p53, caspase-3 and c-myc detected in HCT 
116 cells treated with dihydroactinidiolide (5) for different durations. Results are 
expressed as means ± standard deviation. *: Significant difference from the 
control (p < 0.05). 
 
4.9.6 Cytotoxic effect of sterol mixture (mixture A) 
In the present study, the sterol mixture [campesterol (6), stigmasterol (7) and β-
sitosterol (4)] did not display cytotoxic effects against the tested cell lines (Table 4.25). 
The in vitro growth inhibitions of sterol mixture against selected human cell lines are 
shown in Figure 4.54. The results obtained here were in agreement with published data 
(Awad et al., 2000; Block et al., 2004; Bennani et al., 2007; Jackson et al., 2000; 
Moghadasian, 2000).  
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Figure 4.54: The in vitro growth inhibitions of sterol mixture (mixture A) against 
selected human cell lines determined by neutral red cytotoxicity assay. Each value 
is expressed as mean ± standard deviation of three measurements. 
 
Table 4.25: Cytotoxic activity (IC50 values) of sterol mixture (mixture A) against 
selected human cell lines 
 
Mixture 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
Mixture of sterols 
(Mixture A) 
 
> 100 > 100 > 100 > 100 > 100 > 100 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
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4.9.7 Cytotoxic and apoptosis effects of phytone (8)  
(i) Cytotoxic activity of phytone (8)  
In the present study, phytone (8) was isolated from the ethyl acetate extract of P. 
grandifolia. As shown in Table 4.26, phytone (8) demonstrated pronounced activity 
against CasKi and HCT 116 cells (IC50 6 and 5 µg/ml, respectively). The in vitro 
growth inhibitions of phytone (8) against selected human cell lines are shown in Figure 
4.55. Percentage of inhibition was increased with increase in phytone (8) 
concentrations. 
 
Figure 4.55: The in vitro growth inhibitions of phytone (8) against selected human 
cell lines determined by neutral red cytotoxicity assay. Each value is expressed as 
mean ± standard deviation of three measurements. 
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Table 4.26: Cytotoxic activity (IC50 values) of phytone (8) against selected human 
cell lines 
 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
Phytone (8) 
7.2 
(26.87) 
8.7 
(32.46) 
6 
(22.39) 
5 
(18.66) 
7 
(26.12) 
31.3 
(116.79) 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
 
(ii) Induction of apoptosis by phytone (8) on selected cells    
 In order to determine whether the cytotoxic effects of phytone (8) was apoptotic 
in nature, CasKi and HCT 116 cells were treated with phytone (8)  for 24 h and 
modified TUNEL assay (DeadEnd
TM 
Colorimetric Apoptosis Detection System, 
Promega) was performed. The nuclei of CasKi and HCT 116 cells treated with phytone 
(8) were stained dark brown while none of the cell nucleus was stained dark in the 
negative controls.  
 
(iii) Expression level of apoptosis-related genes in phytone (8)-treated cells 
CasKi cell line 
Figure 4.56 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in CasKi cells induced with phytone (8). A significantly strong up-
regulation (p < 0.05) in p53 expression was observed. As shown in Figure 4.56, the 
mRNA level of p53 was significantly increased (p < 0.05) at 15 min (314.5-fold 
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increase as compared to control cells), 30 min (543.4-fold increase as compared to 
control cells) and 1 h (763.9-fold increase as compared to control cells). However, the 
expression level was significantly dropped (p < 0.05) to 14.7-fold at 3 h but 
significantly increased (p < 0.05) again to 115.7-fold at 6 h. On the other hand, 
significantly up-regulation (p < 0.05) was also observed in caspase-3 and c-myc 
expression (Figure 4.57). However, the expression level of caspase-3 and c-myc was 
not as high as p53 (Figure 4.57). Thus, the results strongly indicate that phytone (8) 
killed the CasKi cells through apoptosis mechanism via the activation of p53 while the 
role of caspase-3 cannot be totally ruled out.  
 
Figure 4.56: The mRNA expression of p53, caspase-3 and c-myc detected in CasKi 
cells treated with phytone (8) for different durations. Results are expressed as 
means ± standard deviation. *: Significant difference from the control (p < 0.05). 
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Figure 4.57: The mRNA expression of caspase-3 and c-myc detected in CasKi cells 
treated with phytone (8)for different durations. Results are expressed as means ± 
standard deviation. *: Significant difference from the control (p < 0.05). 
 
HCT 116 cell line 
Figure 4.58 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in HCT 116 cells induced with phytone (8). The expression of p53, 
caspase-3 and c-myc were highest at 30 min, with 2.8-, 2.7- and 1.6-fold increase as 
compare to the control cells, respectively. Interestingly, the gene expression pattern of 
p53, caspase-3 and c-myc mRNA in treated-HCT 116 cells was similar, which the 
mRNA expression levels were down-regulated at 15 min, up-regulated at 30 min and 
down-regulated again at 3 h. The results here thus suggest that the apoptotic effects of 
phytone (8) in the HCT 116 cells were associated with p53, caspase-3 and c-myc 
activation.  
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Figure 4.58: The mRNA expression of p53, caspase-3 and c-myc detected in HCT 
116 cells treated with phytone (8) for different durations. Results are expressed as 
means ± standard deviation. *: Significant difference from the control (p < 0.05). 
 
4.9.8 Cytotoxic and apoptosis effects of mixture B  
(i) Cytotoxic activity of mixture B  
As shown in Table 4.20, 2,4-di-tert-butylphenol (1) displayed very remarkable 
cytotoxic activity against KB cells with IC50 value of 0.81 µg/ml and strong 
cytotoxicity against MCF7 (IC50 5.75 µg/ml), A549 (IC50 6 µg/ml) and CasKi cells 
(IC50 4.5 µg/ml). Surprisingly, as shown in Table 4.27, the mixture B which consisted 
of 2,4-ditert-butylphenol (1), methyl palmitate (9), methyl oleate (10) and methyl 
stearate (11) showed promising cytotoxic effects against CasKi (IC50 6 µg/ml) and 
A549 (IC50 5 µg/ml). However, they also displayed cytotoxic activity against normal 
MRC-5 cells with IC50 6.9 µg/ml. 2, 4-Di-tert-butylphenol (1) is the major component 
(80.82 %) in the mixture.  
The cytotoxicity of the mixture against the MRC-5 normal cells is not 
contributed by this compound as in its pure form, it only exert a mild effect on the 
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MRC-5 normal cell line (IC50 20 µg/ml). The cytotoxicity of this mixture may have 
been contributed by other components in the mixture. The data reported here thus 
suggest that methyl esters might exert cytotoxic effect against normal MRC5 cells but 
not on KB, MCF7 and HCT 116 cells.  
This finding on cytotoxicity of methyl esters is supported by Takeara et. al 
(2008) who reported that methyl palmitate exerted cytotoxic effect on T-cell leukemia 
cell line (Molt-4) with IC50 value of 2.28 µg/ml while methyl stearate was cytotoxic to 
acute promyeloblastic leukemia cell line (HL-60) and Molt-4 cell line with IC50 values 
of 3.08 and 4.65 µg/ml, respectively. 
 
Figure 4.59: The in vitro growth inhibitions of mixture B against selected human 
cell lines determined by neutral red cytotoxicity assay. Each value is expressed as 
mean ± standard deviation of three measurements. 
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Table 4.27: Cytotoxic activity (IC50 values) of mixture B against selected human 
cell lines 
Compound 
Cytotoxicity (IC50) in µg/ml (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
Mixture B 40 23.5 6 28 5 6.9 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
 
(ii) Induction of apoptosis by mixture B on selected cells    
 According to Table 4.27, mixture B demonstrated pronounced activity against 
CasKi and A549 cells (IC50 6 and 5 µg/ml respectively). In order to determine whether 
the cytotoxic effects of mixture B was due to apoptosis, CasKi and A549 cells were 
treated with mixture B  for 24 h and modified TUNEL assay (DeadEnd
TM 
Colorimetric 
Apoptosis Detection System, Promega) was performed to detect the presence of 
apoptosis. The nuclei of CasKi and A549 cells treated with mixture B were stained dark 
brown. However, none of the cell nucleus was stained dark in the negative controls.  
 
(iii) Expression level of apoptosis-related genes in mixture B-treated cells 
CasKi cell line 
Figure 4.60 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in CasKi cells induced with mixture B. The expression of p53, caspase-3 
and c-myc were highest at 6 h (32.5-fold increase as compare to the control cells), 3 h 
(7.5-fold increase as compare to the control cells) and 6 h (11.1-fold increase as 
compare to the control cells), respectively. The expression level of p53 was down-
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regulated at 15 min and 30 min, but drastically up-regulating thereafter. The results 
here indicate that mixture B killed the CasKi cells through apoptosis mechanism mainly 
via the activation of p53 although the role of caspase-3 and c-myc cannot be ruled out.  
 
Figure 4.60: The mRNA expression of p53, caspase-3 and c-myc detected in CasKi 
cells cells treated with mixture B for different durations. Results are expressed as 
means ± standard deviation. *: Significant difference from the control (p < 0.05). 
 
A549 cell line 
Figure 4.61 shows the time dependency effects of p53, caspase-3 and c-myc 
mRNA levels in A549 cells induced with mixture B. The up-regulation in p53, caspase-
3 and c-myc expressions were observed. The expression of p53, caspase-3 and c-myc 
were highest at 3 h (2.0-fold increase as compare to the control cells), 1 h (3.1-fold 
increase as compare to the control cells) and 3 h (1.7-fold increase as compare to the 
control cells), respectively. The result here strongly indicates that mixture B killed the 
A549 cells through apoptosis mechanism mainly via the activation of p53, caspase-3 
and c-myc.  
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Figure 4.61: The mRNA expression of p53, caspase-3 and c-myc detected in A549 
cells treated with mixture B for different durations. Results are expressed as 
means ± standard deviation. *: Significant difference from the control (p < 0.05). 
 
4.9.9 Comparison of cytotoxic and apoptosis effects of chemical constituents 
isolated from the bioactive extracts of P. bleo and P. grandifolia 
The results of cytotoxicity screening of the chemical constituents are 
summarized in Table 4.28. As shown in Table 4.28 and Table 4.29, the chemical 
constituents present in a particular bioactive extract have different activity. The 
observed activity in the extract might be due to synergism between chemical 
constituents present in the extract. The synergism among these chemical constituents 
which contribute to the cytotoxic activity is not only dependent on the concentration of 
the constituents, but also on the structure and interaction(s) between the constituents 
(Houghton and Raman, 1998). This can explain the differences in the cytotoxic effect 
between crude extracts and isolated compounds against the same cell lines. For 
example, the cytotoxic effect of the P. bleo methanol extract (Table 4.29) on the KB 
cell lines showed an IC50 of 6.5 µg/ml and such impressive activity was supported by 
some of the isolated compounds [dihydroactinidiolide (5), 2,4-di-tert-butylphenol (1), 
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α-tocopherol (2) and phytol (3)]. In contrast, the cytotoxic effect of the crude methanol 
extract of P. bleo on the MCF7 cell line (Table 4.29) gave IC50 of 39.0 µg/ml (mild) 
whilst two isolated compounds 2,4-di-tert-butylphenol (1) and α-tocopherol (2), 
showed good inhibitory activities with IC50 values of  5.75 and 7.5 µg/mL, respectively. 
In summary, the cytotoxic activity observed for ethyl acetate extract of P. bleo 
(section 4.4) was ascribable to the presence of the cytotoxic active compounds 2,4-di-
tert- butylphenol (1), α-tocopherol (2), phytol (3) and dihydroactinidiolide (5). On the 
other hand, the cytotoxic activity observed for ethyl acetate extract of P. grandifolia 
(section 4.4) was ascribable to the active compounds 2,4-di-tert- butylphenol (1), α-
tocopherol (2), phytone (7) and mixture B.  
Based on the cytotoxicity result (Table 4.28), although the cytotoxic activities 
of these chemical constituents were not as effective as doxorubicin, in comparison to 
the latter they have low toxicity against normal MRC5 cell line (Table 4.28). The use of 
the isolated chemical constituents as single anticancer agents would not merit 
consideration. However, their use in combination with cytotoxic therapeutic drugs 
might reduce the adverse effects of some of these drugs. Support for this suggestion is 
provided by Amir et al. (2007), who reported that in addition to having potent 
antitumor properties as single agents, natural products have also demonstrated potential 
synergy with established cytotoxic therapeutic drugs in pre-clinical studies. At this 
stage, it is not possible to justify the use of isolated compounds in comparison to 
doxorubicin in the treatment of cancer. A more comprehensive investigation is required.  
In addition, the selected human cancer cells treated with isolated chemical 
constituents clearly demonstrated DNA fragmentation when detected using modified 
TUNEL assay (DeadEnd
TM 
Colorimetric Apoptosis Detection System, Promega),  
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indicating apoptotic cell death as the major mechanism involved. Apoptosis detection is 
further supported by gene expression studies whereby the mRNA expression levels of 
three apoptotic-related genes, c-myc, p53 and caspase-3 in cells treated with chemical 
constituents were investigated. It was found out that the apoptosis elicited by the 
isolated chemical constituents on selected cancer cells was mediated by c-myc, p53 and 
caspase-3 in different expression levels. These findings were in agreement with many 
studies that demonstrated the role of c-myc, p53 and caspase-3 in inducing apoptosis.  
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Table 4.28: Cytotoxic activity (IC50 values) of chemical constituents isolated from 
the bioactive ethyl acetate extracts of P. bleo and P. grandifolia 
Compound 
Cytotoxicity (IC50) in µg/m (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
2,4-Di-tert- butylphenol 
(1) 
0.81 
(3.93) 
5.75 
(27.91) 
4.5 
(21.84) 
29 
(140.78) 
6 
(29.13) 
20 
(97.09) 
α-Tocopherol (2) 8 
(18.60) 
7.5 
(17.44) 
6 
(13.95) 
31 
(72.09) 
6 
(13.95) 
30.5 
(70.93) 
Phytol (3) 7.1 
(23.99) 
34 
(114.86) 
18 
(60.81) 
100 
(337.84) 
31 
(104.73) 
74.3 
(251.01) 
β -Sitosterol (4) >100 
(>241.55) 
72 
(173.91) 
62 
(149.76) 
> 100 
(> 241.55) 
78 
(188.41) 
> 100 
(> 241.55) 
Dihydroactinidiolide (5) 
 
6.7 
(37.22) 
30 
(166.67) 
40 
(222.22) 
5 
(27.78) 
97 
(538.89) 
91.3 
(507.22) 
Mixture A > 100 > 100 > 100 > 100 > 100 > 100 
Phytone (7) 7.2 
(26.87) 
8.7 
(32.46) 
6 
(22.39) 
5 
(18.66) 
7 
(26.12) 
31.3 
(116.79) 
Mixture B 40 23.5 6 28 5 6.9 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
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Table 4.29: Cytotoxic activity (IC50 values) of bioactive extracts and chemical 
constituents isolated from the bioactive ethyl acetate extract of P. bleo 
Extract / Compound 
Cytotoxicity (IC50) in µg/m (µM) 
KB MCF7 CasKi HCT 116 A549 MRC-5 
Methanol extract 6.5 40.5 41.0 39.0 56 61.0 
Ethyl acetate extract  4.5 58.0 22.0 28.0 41 > 100.0 
2,4-Di-tert- butylphenol 
(1) 
0.81 
(3.93) 
5.75 
(27.91) 
4.5 
(21.84) 
29 
(140.78) 
6 
(29.13) 
20 
(97.09) 
α-Tocopherol (2) 8 
(18.60) 
7.5 
(17.44) 
6 
(13.95) 
31 
(72.09) 
6 
(13.95) 
30.5 
(70.93) 
Phytol (3) 7.1 
(23.99) 
34 
(114.86) 
18 
(60.81) 
100 
(337.84) 
31 
(104.73) 
74.3 
(251.01) 
β -Sitosterol (4) >100 
(>241.55) 
72 
(173.91) 
62 
(149.76) 
> 100 
(> 241.55) 
78 
(188.41) 
> 100 
(> 241.55) 
Dihydroactinidiolide (5) 
 
6.7 
(37.22) 
30 
(166.67) 
40 
(222.22) 
5 
(27.78) 
97 
(538.89) 
91.3 
(507.22) 
Mixture A > 100 > 100 > 100 > 100 > 100 > 100 
Doxorubicin
a 
1.3x10
-2
 
(0.023) 
7.6x10
-2
 
(0.139) 
6.0x10
-3 
(0.011) 
3.6x10
-1
 
(0.663) 
2.2x10
-1 
(0.401) 
5.5x10
-1 
(1.01) 
a 
Doxorubicin was used as the reference compound 
 
4.10 Screening for alkaloids of P. bleo and P. grandifolia 
Doetsch et al. (1980) reported the isolation of four alkaloids, namely 3,4-
dimethoxy-β-phenethylamine, mescaline, 3-methoxytyramine and tyramine from P. 
bleo and three alkaloids, p-methoxy-β-hydroxy-β-phenethylamine, 3-methoxytyramine 
and tyramine from P. grandifolia (Figure 2.12). P. bleo and P. grandifolia used in the 
study of Doetsch et al. (1980) was collected from Fairchild Tropical Gardens, Miami, 
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Fla., USA and botanical gardens, University of Michigan, Ann Arbor, Mich, USA 
respectively. On the other hand, the Pereskia species in this study was collected from 
Selangor, Malaysia. The locally grown P. bleo and P. grandifolia were also screened 
for alkaloids in the present study to confirm the presence of alkaloids.      
In the preliminary alkaloidal test, a few drops of Wagner’s reagent were added 
to an aliquot containing plant extract, a (++) for definite turbidity in P. bleo and (+) for 
slight turbidity in P. grandifolia were observed. However, the result recorded was 
preliminary evidence that alkaloids are present, a confirmatory test was then conducted. 
When a few drops of Wagner’s reagent were added to the filtrate, (+) for slight 
turbidity was observed in P. bleo and P. grandifolia. A (+) result recorded was 
indicative of the presence of primary, secondary or tertiary alkaloids.     
Test for quaternary and/ or amine oxide bases was pursued. A few drops of 
Wagner’s reagent were added to a solution of extract giving a (++) for definite turbidity 
in P. bleo and (+) for slight turbidity in P. grandifolia. The (++) and (+) result observed 
in the test may be taken as an indication of the presence of quaternary and/ or amine 
oxide bases. 
In summary, the screening indicated the presence of alkaloids in locally grown 
Pereskia spp. but the concentration was very low as (+) result was recorded in the 
confirmatory test of alkaloids. Thus, extraction and isolation of alkaloids was not 
pursued in the present study. It is highly probably the environment and location in 
which plants of the same species were found has a profound effect on the concentration 
levels of a particular secondary metabolites (in this case the alkaloids).  
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CHAPTER 5 
CONCLUSION 
 
P. bleo and P. grandifolia have been traditionally used for treatment of cancer-
related diseases by locals. The findings of the current study thus provide scientific 
validation on the use of the leaves of P. bleo and P. grandifolia. In view of the 
increasing popular consumption of medicinal plants as alternative therapy, it is 
therefore necessary to conduct serious research to support the therapeutic claims and 
also to ensure that the plants are indeed safe for human consumption. The present 
research findings have clearly met the objectives of the study.  
The experimental approach in the present study is based on bioassay-guided 
fractionation. In this endeavor, the crude methanol and fractionated extracts of P. bleo 
and P. grandifolia were firstly prepared for biological assessment, such as antioxidant, 
antimicrobial and neutral red cytotoxicity assays to identify the bioactive extracts of 
both Pereskia spp.  
For P. bleo, the ethyl acetate extract showed the highest reducing capacity 
measured by Folin-Ciocalteau method and the highest antioxidant activity in ß-carotene 
bleaching assay significantly (p < 0.05). The hexane extract of P. bleo showed 
significantly (p < 0.05) the highest antioxidant activity when determined by the 
scavenging effect on DPPH radicals and reducing power assay.  
For P. grandifolia, the reducing capacity, DPPH scavenging and the ß-carotene 
bleaching activities of the ethyl acetate extract was significantly the highest among the 
extracts (p < 0.05). On the other hand, the hexane extract of P. grandifolia possessed 
significantly (p < 0.05) highest reducing power capacity among the extracts.  
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Based on the antioxidant assays, it is thus suggested that the antioxidant 
activities of hexane extracts in both Pereskia spp. were not solely contributed by 
phenolic compounds but other components in the extracts. The hexane extracts of both 
Pereskia spp. were found to contain mainly methyl esters. It is highly probable that the 
lone pairs of electron on the carbonyl oxygen can be easily donated to the ferric ions in 
the reducing power assay. Methyl palmitate, methyl linoleate, methyl α-linolenate and 
phytol were identified from the hexane extract of P. bleo by GCMS analysis whilst 
methyl palmitate, methyl linoleate, methyl α-linolenate and methyl stearate were 
identified from the hexane extract of P. grandifolia 
Next, the extracts of both Pereskia spp. did not demonstrate promising 
antimicrobial activities against the tested microorganisms, except the ethyl acetate 
extracts of both Pereskia spp. which showed some mild activities against the tested 
bacteria. The results suggested that there might be some active antimicrobial 
components in the extracts but present in low quantity and were not present in 
sufficient concentrations to be effective. The results of P. bleo here were thus in 
agreement with Ruegg et al. (2006).   
Subsequently, the extracts of P. bleo and P. grandifolia were investigated for 
their cytotoxic effects against selected human cell lines, namely the Human 
Nasopharyngeal Epidermoid Carcinoma Cell Line (KB), Human Cervical Carcinoma 
Cell Line (CasKi), Human Colon Carcinoma Cell Line (HCT 116), Hormone-
Dependent Breast Carcinoma Cell Line (MCF7) and non-cancer Human Fibroblast Cell 
Line (MRC-5) by using an in vitro neutral red cytotoxicity assay.  
The ethyl acetate extracts of both Pereskia spp. in general gave higher 
inhibition and stimulation values against various cancerous cell lines compared to other 
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extracts. The ethyl acetate extract of P. bleo was selectively toxic against KB cells. 
Both of the ethyl acetate extracts displayed the distinctively cytotoxicity effect on KB 
cell line, which reached IC50 at relatively low concentration. The ethyl acetate extract of 
P. bleo has a higher activity (IC50 value against KB cells of 4.5 µg/ml) in comparison to 
the ethyl acetate extract of P. grandifolia (IC50 16.0 µg/ml). Ethyl acetate extract of P. 
grandifolia, on the other hand displayed a good inhibition against MCF7 cells with IC50 
of 20.0 µg/ml. The active ingredients in ethyl acetate extract may lead to valuable 
compounds that may have the ability to kill KB cancer cells but exert no damage to 
normal cells (IC50  > 100.0 µg/ml against normal cells, MRC-5). 
The hexane extract of P. grandifolia also demonstrated a remarkably high 
inhibition towards KB cells with IC50 value of 5 µg/ml, in comparison to that of P. bleo.  
The water extracts of both Pereskia spp. were found to have no effect on the cancer cell 
lines (IC50 > 100.0 µg/ml in all cases). All the extracts of both Pereskia spp. 
demonstrated weaker cytotoxicity profile against the CaSki and A549 cells compared to 
other cells and no activity against normal cells (IC50 > 100.0 µg/ml). 
In addition, cell deaths of the selected cancer cells elicited by the cytotoxic 
active extracts of both Pereskia spp. were found to be apoptotic in nature based on a 
clear indication of DNA fragmentation, which is a hallmark of apoptosis. The LUX 
RT-qPCR analysis showed the mRNA expression levels of c-myc were markedly 
increased in the cancer cells treated with the cytotoxic active extracts while the p53 and 
caspase-3 expression were only slightly increased as compared to c-myc in all cases, 
except for the P. grandifolia ethyl acetate extract in KB cells. The apoptotic effects of 
the P. grandifolia ethyl acetate extract in KB cells were associated with increases in all 
three c-myc, p53 and caspase-3 activation. The results thus suggested that the cytotoxic 
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active extracts of P. bleo and P. grandifolia contained bioactive compounds capable of 
inducing apoptosis in selected cancer cell lines.  
From the results of the biological screenings of both Pereskia spp., it is 
observed that the hexane and ethyl acetate extracts generally have stronger biological 
activities than the crude methanol extracts. This was probably due to the increase in 
concentration of active chemical constituents in the fractionated extract as a 
consequence of fractionation. Further chemical investigations were thus directed to the 
ethyl acetate extracts of both Pereskia spp. Fractionation into hexane and then ethyl 
acetate extraction was avoided as the yield of ethyl acetate extracts obtained was very 
low.  
Chemical investigations of the bioactive ethyl acetate extracts led to the 
isolation and identification of some chemical constituents. For P. bleo, 2,4-di-tert-
butylphenol (1), α-tocopherol (2), phytol (3), ß-sitosterol (4), dihydroactinidiolide (5) 
and a mixture of sterols [mixture A; campesterol (6), stigmasterol (7) and β-sitosterol 
(4)] were obtained. 2,4-Di-tert-butylphenol (1), α-tocopherol (2), phytol (3) and plant 
sterols [particularly ß-sitosterol (4)] may have contributed to the reducing capacity and 
antioxidant activity of the ethyl acetate extract of P. bleo. Whilst, the mild 
antimicrobial activity of ethyl acetate extract of P. bleo might be due to the presence of 
2,4-di-tert-butylphenol (1), ß-sitosterol (4) and the mixture of sterols (mixture A).  
2,4-Di-tert-butylphenol (1), α-tocopherol (2), ß-sitosterol (4) and the mixture 
[mixture B; methyl palmitate (9), methyl oleate (10), methyl stearate (11) and 2,4-di-
tert-butylphenol (1)] were isolated from P. grandifolia. 2,4-Di-tert-butylphenol (1), α-
tocopherol (2) and ß-sitosterol (4) may have contributed to the antioxidant activity of 
the ethyl acetate extract of P. grandifolia. The mild antimicrobial activity of the ethyl 
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acetate extract of P. grandifolia maybe due to 2,4-di-tert-butylphenol (1) and ß-
sitosterol (4). 
It is interesting to note that 2,4-ditert-butylphenol (1), α-tocopherol (2) and ß-
sitosterol (4) were isolated from both Pereskia spp. The cytotoxic activities of the 
isolated constituents were evaluated against five human carcinoma cell lines, namely 
KB, CasKi, HCT 116, MCF7 and A549 cell lines; and non-cancer human fibroblast cell 
line (MRC-5) using the neutral red cytotoxicity assay. The chemical constituents 
demonstrated cytotoxic activity were further detected with DNA fragmentation and 
further subjected to the gene expression study. 
According to the cytotoxicity results, the cytotoxic activity observed for the 
ethyl acetate extract of P. bleo was ascribable to the presence of the cytotoxic active 
compounds 2,4-di-tert-butylphenol (1), α-tocopherol (2), phytol (3) and 
dihydroactinidiolide (5). On the other hand, the cytotoxic activity observed for ethyl 
acetate extract of P. grandifolia was ascribable to the active compounds 2,4-di-tert-
butylphenol (1), α-tocopherol (2), phytone (7) and mixture B.  
Although the cytotoxic activities of these chemical constituents were not as 
effective as doxorubicin, in comparison to the latter they have low toxicity against 
normal MRC5 cell line. Although the isolated chemical constituents cannot be used as 
single anticancer agents, but their use in combination with established cytotoxic 
therapeutic drugs might reduce the adverse effects of some of these drugs.  
Furthermore, the selected human cancer cells treated with cytotoxic active 
chemical constituents clearly demonstrated DNA fragmentation when detected using 
modified TUNEL assay, indicating apoptotic cell death as the major mechanism 
involved. This was further supported by investigation on the mRNA expression levels 
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of three apoptotic-related genes, c-myc, p53 and caspase-3 in cells treated with 
chemical constituents, in order to determine the mechanism of sample-induced 
apoptosis. It was found out that the apoptosis elicited by the isolated chemical 
constituents on selected cancer cells was mediated by c-myc, p53 and caspase-3 giving 
different expression levels. These findings were consistent with many studies that 
demonstrated the role of c-myc, p53 and caspase-3 in inducing apoptosis.  
The crude methanol extracts of both Pereskia spp. were also evaluated for the 
acute oral toxicity to determine the safety parameters of both Pereskia spp. The result 
obtained was in agreement to that of in vitro experiments, further confirming the results 
that crude extracts of P. bleo and P. grandifolia did not show cytotoxicity against 
normal cells. Thus, the crude extracts of both Pereskia spp. were considered to be safe 
in acute oral toxicities in experimental mice.  
The alkaloid screening was also performed to confirm the presence of alkaloids 
as reported by Doetsch et al. (1980). The alkaloid screening of the locally grown P. 
bleo and P. grandifolia indicated the presence of alkaloids, but the concentration was 
very low. Thus, extraction and isolation of alkaloids was not pursued in the present 
study. The difference of alkaloid concentration in the studies might be due to the plant 
material was collected from different places.  
Lastly, a protocol for the evaluation of mRNA expression levels of apoptotic 
genes by real-time reverse transcriptase–polymerase chain reaction (RT-qPCR) using 
LUX (Light Upon eXtension) primers has been established in the present study. The 
LUX RT-qPCR assay significantly simplifies and accelerates the process of producing 
reproducible quantification of mRNAs. The mRNAs were reverse transcribed, 
amplified, detected and quantitated in real time. However, this technique has not been 
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commonly employed in natural product field and there are no reports so far on LUX 
RT-qPCR methods for gene expression study on natural products. Thus, the protocol 
developed can be recommended for gene expression study in natural products.  
In conclusion, the findings of P. bleo and P. grandifolia in the present study 
support the common belief that ethnopharmacological selection of P. bleo and P. 
grandifolia is a useful criterion in drug discovery. As suggestions, further studies on the 
mutagenic and toxicity effect over a longer period of time involving detection of effects 
on vital organ functions should be carried out to ensure that the plants are safe for 
human consumption.  
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APPENDIX  
 
Appendix A 
Cell culture techniques 
 
1. Preparation of medium (Medium 199, RPMI 1640 Medium, McCOY’S 5A 
Medium and Basic Eagle Minimum Essential Medium)  
 
Basic Medium  
The medium was prepared by dissolved medium (Medium 199, RPMI 1640 Medium, 
McCOY’S 5A medium and Eagle Minimum Essential Medium) powder (Sigma) and 
2.0 g of sodium bicarbonate (NaHCO3, Merck, Germany) in 1000 ml of distilled water. 
The pH of the medium was calibrated to pH 7.4 (Hanna Instruments 8417). The 
medium was then filter sterilized through a 0.22 µm filter membrane (Schleicher & 
Schuell) into sterile bottles and kept at 4 °C for up to four months. 
 
Complete growth medium  
Complete growth medium was prepared by using 90 ml of basic medium, 
supplemented with 10 % foetal bovine serum (FBS, PAA Lab, Austria), 100 µg/ml 
penicillin or streptomycin (PAA Lab, Austria) and 50 µg/ml of fungizone (PAA Lab, 
Austria). The medium was filter sterilized using a 0.22 µm filter membrane (Schleicher 
& Schuell). The colours of the medium were reddish orange and were kept at 4°C for 
up to two weeks.  
 
Revival medium 
Revival medium was prepared as complete growth medium described above, except 
revival medium was supplemented with 20 % instead of foetal bovine medium.  
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Cryopreservation medium 
Cryopreservation medium was prepared by 50 % Foetal Bovine Serum (FBS, PAA Lab, 
Austria), 40 % basic culture medium and 10 % dimethylsulfoxide (DMSO) as 
cryoprotectant. 
 
2. Preparation of solutions 
Phosphate Buffered Saline (PBS) 
The Phosphate Buffered Saline (PBS) was prepared using 1.52 g sodium phosphate 
anhydrous (NaHPO4, Merck, Germany), 0.58 g potassium dihydrogen orthophosphate 
(KH2PO4, Merck, Germany) and 8.5 g sodium chloride (NaCl, BDH AnalaR) were 
dissolved in distilled water and the volume was made up to 1000 ml. The pH of the 
buffer was adjusted to 7.2 using a pH meter (Hanna Instruments 8417). The buffer was 
then filtered using a 0.22 µm filter membrane and autoclaved for 15 min at 15psi, 
121°C. 
 
Trypsin-EDTA 
Trysin-EDTA solution was prepared by dissolving 0.25 g trypsin (Amresco, USA) and 
0.03 g EDTA (Sigma, USA) in 100 ml of distilled water. The solution was sterilized by 
filtration using a 0.22 µm filter membrane and stored at -20 °C. 
 
0.4 % Tryphan Blue 
0.4 % Tryphan Blue solution was prepared by dissolving 0.2 g tryphan blue in 50 ml 
distilled water.  
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3. Procedure for cell revival 
The vial of cells was removed from liquid nitrogen and plunged into a beaker of 
ice. It was then transferred to a 37 °C water bath for quick thawing. The O-ring and cap 
were kept out of the water when thawing to reduce the possibility of contamination. 
The vial was removed from the water bath as soon as the contents are thawed, and 
decontaminated by spraying with 70 % ethanol.  The cells were transferred into 1 ml of 
revival medium (Medium 199, RPMI 1640 Medium, McCOY’S 5A Medium or Eagle 
Minimum Essential Medium) in a polypropylene tube (Falcon, USA) and spun at 1000 
rpm for 5 min. The supernatant was discarded and the pelleted cells were resuspended 
in 5-7 ml of complete growth medium by gently pipetting and incubated in a 25 ml 
tissue culture flask (Falcon, USA) at 37 °C in a 5 % CO2 incubator. 
 
4. Procedure for maintenance of cells 
KB cells were maintained in Medium 199 (Sigma); CasKi, A549 and MCF7 
cells in RPMI 1640 medium (Sigma); HCT 116 in McCOY’S 5A Medium (Sigma) and 
MRC-5 cells in EMEM (Eagle Minimum Essential Medium) (Sigma). The culture was 
incubated in a 5 % CO2 incubator (Shel Lab water-jacketed) kept at 37°C in a 
humidified atmosphere. The culture was subcultured every 2 or 3 days and routinely 
checked under an inverted microscope (IMT-2 Olympus, Japan) for any contamination. 
 
5. Procedure for subcultivation of cells 
Adherent cells were attached and formed a single layer in the culture flask. The 
culture was examined with an inverted microscope to check for any evidence of 
microbial contamination and to determine if the majority of cells were still attached to 
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the bottom of the flask. If pH becomes acidic, cells will detach and grow as a 
suspension that can be transferred by pipettng.  If cells were attached, culture medium 
was discarded. The cell layer was washed twice using 6 to 7 ml of PBS solution to 
remove all traces of serum. 1 ml of 0.25 % trypsin-EDTA solution and 3 ml of PBS 
solution were added to the flask and cells were observed under an inverted microscope 
until the cell layer was dispersed. Cells that were difficult to detach were incubated at 
37°C to facilitate dispersal. The entire contents of the flask were transferred aseptically 
into a centrifuge tube by pipetting. 1 ml of complete growth medium was added and 
cells were centrifuged for 5 min at 1000 rpm. The supernatant was discarded and 
pelleted cells were resuspended in 3 to 4 ml of complete growth medium by gently 
pipetting. Appropriate aliquots of the cell suspension were added to new culture flasks. 
The flask was then further incubated at 37 °C in a 5 % CO2 incubator. 
 
6. Procedure for cryopreservation of cells 
 Cell stocks were preserved and stored in liquid nitrogen. Cell suspensions were 
spun down at 1000 rpm for 5 min using a bench centrifuge (Clements 2000) after the 
medium was discarded. The supernatant was discarded and pelleted cells were 
resuspended in 3 to 4 ml of cryopreservation medium by gently pipetting. Appropriate 
aliquots of the cell suspension were added to new cryopreservation vial (Nunc) and 
stored in and placed in a -70 °C freezer overnight. The vial was then transferred into 
liquid nitrogen (-196°C). Cells were cryopreserved so that a new stock could be revived 
in case the maintained cells became contaminated.   
 
 
301 
 
Appendix B 
Gas chromatogram of hexane extract of P. bleo  
 
 
 
 
 
 
 
 
 
 
Appendix B1 
Mass spectrum of methyl palmitate 
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Appendix B2 
Mass spectrum of methyl linoleate 
 
 
 
 
 
 
 
 
Appendix B3 
Mass spectrum of methyl α-linolenate 
 
 
 
 
 
 
 
 
 
 
 
H3C(H2C)3H2C O
O
Methyl linoleate  
[M]
+
 C18H31O1
+
 
O
O
Methyl α-linolenate 
[M]
+
 
303 
 
Appendix B4 
Mass spectrum of phytol 
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Appendix C 
Gas chromatogram of hexane extract of P. grandifolia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C1 
Mass spectrum of methyl palmitate 
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Appendix C2 
Mass spectrum of methyl linoleate 
 
 
 
 
 
 
 
 
 
 
 
Appendix C3 
Mass spectrum of methyl α-linoleate 
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Appendix C4 
Mass spectrum of methyl stearate 
 
 
 
 
 
 
 
 
 
 
Appendix D 
Mass spectrum of 2,4-di-tert-butylphenol (1) 
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Appendix D1 
1
H-NMR spectrum of 2,4-di-tert-butylphenol (1) 
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Appendix D2 
13
C-NMR spectrum of 2,4-di-tert-butylphenol (1) 
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Appendix D3 
DEPT spectrum of 2,4-di-tert-butylphenol (1)
135° 
45° 
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Appendix E 
Mass spectrum of α-tocopherol (2) 
 
 
 
 
 
 
 
 
 
 
Appendix F 
Mass spectrum of phytol (3) 
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Appendix F1 
1
H-NMR spectrum of phytol (3) 
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Appendix F2 
13
C-NMR spectrum of phytol (3) 
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Appendix F3 
DEPT spectrum of phytol (3)
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Appendix G 
Mass spectrum of ß-sitosterol (4) 
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Appendix G1 
1
H-NMR spectrum of ß-sitosterol (4) 
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Appendix G2 
13
C-NMR spectrum o f ß-sitosterol (4) 
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Appendix H 
Mass spectrum of dihydroactinidiolide (5) 
 
 
 
 
 
 
 
 
 
 
Appendix I 
Gas chromatogram of mixture A 
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Appendix I1 
Mass spectrum of campesterol (6) 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix I2 
Mass spectrum of stigmasterol (7) 
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Appendix I3 
Mass spectrum of ß-sitosterol (4) 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix J 
Mass spectrum of 2,4-di-tert-butylphenol (1) 
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Appendix K 
Mass spectrum of α-tocopherol (2) 
 
 
 
 
 
 
 
 
 
 
Appendix L 
Mass spectrum of ß-sitosterol (4) 
 
 
 
 
 
 
 
 
 
 
 
 
[M]
+
 
 
C10H13O2 
OHO
R
RR
32  
HO
H
H
S
H H
24 
4 
[M]
+ 
[M-H2O]
+ 
[M-H2O-CH3]
+ 
[M-C10H21]
+ 
[M-C10H23]
+ 
321 
 
Appendix M 
Mass spectrum of phytone (8) 
 
 
 
 
 
 
 
 
 
Appendix N 
Gas chromatogram of mixture B 
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Appendix N1 
Mass spectrum of 2,4-di-tert-butylphenol (1) 
 
 
 
 
 
 
 
 
 
 
Appendix N2 
Mass spectrum of methyl palmitate (9) 
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Appendix N3 
Mass spectrum of methyl oleate (10) 
 
 
 
 
 
 
 
 
 
 
 
Appendix N4 
Mass spectrum of methyl stearate (11) 
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